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Neurulation is a complex morphogenetic process of neural tube closure to form 
the central nervous system during embryonic development. Its driving forces originate 
from both the neuroepithelium and the surrounding mesoderm. Failure of neural tube 
closure leads to neural tube defects (NTDs), one of the most common birth defects.  
 
Neurulation is a highly synchronic process with a highly-ordered regulation, but 
the exact molecular mechanism is still unclear. There are more than 200 genes that have 
been found related with neural tube closure. Mutation of these genes cause NTDs in mice 
by interrupting functions of cell proliferation, cell differentiation, cell migration, cell 
adhesion and the integrity of cytoskeleton. In addition, several signaling pathways have 
been identified to be involved in the neural tube closure process, such as the planner cell 
polarity (PCP) pathway, the sonic hedgehog (Shh) signaling pathway, the retinoid acid 
(RA) signaling, and the BMP signaling. A comprehensive molecular mechanism need to 
be provided in order to understand the neurulation process more clearly and target the 
critical genes that synchronize neural tube development.  
 
Glycosaminoglycans (GAGs) have been found to participate in many cellular 
functions such as those mentioned above and regulate multiple signaling pathways that 
related with neurulation. They are the most abundant carbohydrate conjugates that exist 
ubiquitously at the cell surface or extracellular matrix. In addition, their distribution 
during neurulation is stage and tissue specific which makes it critical to explore their 
roles further.  
 
This study intended to set up a framework for investigating the genetic 
mechanism of spinal neurulation. It was carried out using tissue of neuroepithelium and 
surrounding mesoderm separately selected by laser capture microdissection (LCM) in 
combination with Affymetrix microarray to provide a transcriptomic profile of neural 






By transcriptomic analysis, hundreds of median hinge point (MHP) - and 
dorsolateral hinge point (DLHP) - related genes have been screened out, most of them are 
novel genes that have been found involved in neurulation for the first time. These genes 
have multiple functions such as proliferation and adhesion.  For the pathways such as 
BMP, Shh, or Wnt pathway, more genes related with these pathways have been found to 
be involved in neurulation for the first time. In addition, dozens of GAG genes have been 
found to be differentially expressed during this event, and their expressions are spatially 
and temporally specific. Most of these genes were first reported to be related with 
neurulation process, especially during the formation of hinge points and closure of neural 
tube.   
 
Β-1, 4-galactosyltransferase1 (B4galt1) is one of the biosynthesis enzymes of 
GAGs which is differentially expressed in the microarray datasets during the neurulation 
process in mouse embryo. It has been found to be critical for synthesizing different 
species of GAGs. Moreover, B4galt1 itself has been found to function in GAG 
distribution and as cell surface receptors with multiple functions. Knockdown of B4galt1 
expression in mouse neuroepithelial (NE4C) cells by siRNA significantly inhibited cell 
proliferation and cell adhesion ability. This may account for its role in neurulation.  
 
In summary, this study has generated a transcriptomic profile of neuroepithelium 
and the surrounding mesoderm separately during the critical stages of mouse neurulation 
using microarray in combination with LCM. It is the first time that the complex 
neurulation process was dissected in specific spatial and temporal way. By setting up a 
framework of neurulation-related genes, this study has allowed neurulation investigators 
to investigate the complex process in a new and comprehensive manner. The functional 
study of B4galt1 shed light on the importance of GAG genes, and held promise for 
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1  Introduction 
1.1  Introduction of neurulation   
Neurulation is a complex morphogenetic process by which the rudiment of the adult central 
nervous system develops (Copp et al., 2003). It is composed of several co-dependent events 
overlapping temporally to some degree. In vertebrates, neurulation is divided into primary 
neurulation and secondary neurulation. Primary neurulation begins at the late stage of 
gastrulation, including initiation, elevation, apposition and fusion of the neuroepithelium and 
ends by the closure of the neural tube to form the precursor of the central nervous system, 
including the brain and most of the spinal cord. Subsequently, secondary neurulation forms the 
remaining sacral and all of the coccygeal regions of the spinal cord by different mechanisms 
(Catala, 2002; Kibar et al., 2007). Failure of closure of the neural tube during embryo 
development leads to neural tube defects (NTDs), the second congenital malformation in human 
(De et al., 2006; Wallingford, 2005).  
Scientists have put a lot of efforts into investigation of neurulation in order to find solutions 
to NTDs. Currently, more than 200 genes are found related with neural tube closure (Copp and 
Greene, 2010b). Mutation of these genes cause NTDs in mice by interrupting functions of cell 
proliferation, cell differentiation, cell migration, cell adhesion and the integrity of cytoskeleton. 
Several signaling pathways have been identified involving in neural tube closure process, such as 
the planar cell polarity (PCP) pathway, the sonic hedgehog (Shh) signaling pathway, the retinoid 
acid (RA) signaling, and the bone morphogenetic protein (BMP) signaling. Although the exact 
molecular mechanism is still unclear, scientists tend to agree that neurulation is a highly 
synchronic process where highly-ordered regulation may exist.   
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Glycosaminoglycans (GAGs) are presented at cell surface or extracellular matrix, interacting 
with growth factors, morphogens, and adhesion molecules (Zhang, 2010a; Zhang, 2010b), and 
participating in many cellular functions such as cell proliferation, cell adhesion, and cell 
migration. They have also been found to regulate multiple signaling pathways such as Wnt, hh, 
etc. Different kinds of GAGs are found distributed at different axial levels of neurulation process. 
The roles of GAGs in neurulation activate the interests of biological scientists since early 19ths 
(Copp and Bernfield, 1988b). They are found distributed through multi-stages of mouse embryos, 
and accumulate specifically at the site of neural fold elevation, but not in the primitive streak 
where neurulation has not yet begun, and decreased progressively where neurulation was already 
complete (Copp and Bernfield, 1988b).  
 
1.1.1 Primary neurulation 
In vertebrates, primary neurulation begins when gastrulation ends, the notochord induces 
the ectoderm above it to become thick flat neuroectoderm-called the neural plate. The neural 
plate bends first in the midline to form the neural groove at early stage of neurulation, and the 
straight parts at both sides of the groove are called neural folds. Later at mid-stage of neurulation, 
bends take place at the lateral edges of the neural folds and the tips of the neural folds elevate 
and apposite each other in the upper midline to fuse into a closed neural tube (Copp et al., 2003; 
Greene and Copp, 2009). The neural tube later differentiates into the most important parts of the 
central nervous system, the brain and the spinal cord.  Cells at the very lateral edges of the neural 
folds separate as the neural crest cells and migrate to become various different but important 
cells, such as pigment cells and the cells of the peripheral nervous system. The mesoderm 
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surrounding the neuroectoderm at the sides will develop into the somite which become future 
muscles, bones, etc.  
To nominate the gestation time of embryo, in vertebrates, embryonic day 0.5 (E0.5) 
means if timed matings were made at night, noon on the day of discovering a copulation plug. 
The first somite presents at around E8.0 in the mouse embryo, and neural tube closure begins at 
the level of cervical/hindbrain boundary at around 4 to 5 somite stage (Sakai, 1989). Then 
closure extends cranially (towards the head) to form the anterior neuropore and caudally 
(towards the tail) to form the posterior neuropore. The posterior neuropore (PNP) refers to the 
region of open, elevating neural folds caudally adjacent to the just closed neural tube which 
represents the next axial region to experience neural tube closure. The anterior neuropore will be 
closed at E9.0 and the posterior neuropore will be closed at E10.0 to declare the end of primary 
neurulation. 
Neurulation is a very short period in human. Gastrulation in human embryo begins at the 
2nd week and neurulation starts at the end of gastrulation and ends within the fourth week of 
pregnancy when the pregnant mother unaware of their pregnant. Genetic analysis of neural tube 
development has shown that different neurulation events have different molecular mechanisms. 
Failure of neural tube closure will lead to neural tube defects (NTDs), a common congenital 
disease most of which will be still birth (Botto et al., 1999). Most of the few survivors are due to 
failure of closure at spinal region which called spina bifida and they have to face many problems 






1.1.1.1 Initiation of neurulation 
Neural induction is the formation of the neural plate from the dorsal midline ectoderm 
into the neuroepithelium (De et al., 2006). Prior to neurulation, the notochord is formed from the 
mesoderm and secrets a variety of signals such as bone morphogenetic protein-4 (BMP-4). These 
signals induce the overlying ectodermal cells to differentiate into epidermis which will become 
skin. This action is blocked by neural inducers such as chordin, noggin, follistatin, cerberus, 
Xnr3 (Xenopus nodal-related 3), and TSG (twisted gastrulation), which are secreted from the 
surrounding tissues such as the spemann’s organizer, a tissue located in the dorsal side of the 
gastrula in Xenopus, (or hensen’s node, a mouse homologous to the Xenopus organizer), and 
present in the ectoderm (Kuroda et al., 2004; Weinstein and Hemmati-Brivanlou, 1999). 
Ectodermal cells that do not receive BMP-4 are allowed to become neural ectoderm which will 
become the future brain and spinal cord (De Robertis and Kuroda, 2004).  
Wnt signaling interferes with BMP4 function by blocking the activity of glycogen 
synthase kinase 3 (Gsk3) and activating the transcription function of beta-catenin (Baker et al., 
1999). Wnt signaling was also found to specify posterior neural identity in combination with the 
BMP antagonists. A further study in Xenopus also showed that down regulation of Bmp 
signaling in dorsal ectoderm by Wnt signaling may be mediated by Xiro1, one of the Xiro 
homeodomain proteins of the Iroquois (Iro) family, which were shown to control the size of the 
neural plate in Xenopus embryo. A number of Wnt inhibitors, such as Frzb-1, sFRP-2, Crescent, 
Dickkopf-1, and Cerberus, secreted by organizer region, play important roles in neural induction 
by inhibition of Wnt signaling.  
Growth factors are also found to contribute to neural induction (Weinstein and Hemmati-
Brivanlou, 1999). Members of FGF signaling were reported to induce gastrula stage ectoderm 
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into posterior neural tissue in Xenopus and chick, and inhibition of FGF receptors blocks neural 
induction (Launay et al., 1996). Fibroblast growth factor (FGF) signaling, as secreted diffusible 
glycoproteins, can bind to extracellular receptors (FGF receptors, FGFR) and mediate their 
effects. They are required at neural induction stage to enable later neural differentiation (Streit et 
al., 2000; Wilson et al., 2000).  
Insulin-like growth factors (IGFs) have also been identified as neural inducers acting as 
either potent Wnt inhibitors or through a common mechanism as BMP antagonists by low levels 
of Smad1 activity (Pera et al., 2001; Pera et al., 2003).  
 
1.1.1.2 Shaping of neuroepithelium  
Global deformations of the neural plate are driven by the changes of cell shape, number 
and position as the neural plate grows with neurulation. As cell number changes, cell position 
changes by intercalation. These changes result from the process of convergent extension (CE) 
which is found mainly regulated by the planar cell polarity (PCP) pathway. 
CE was first studied in amphibian gastrulation, and then it has been studied in many other 
species. Cell tracing experiment demonstrated that wedged cells moving only short distances 
within tissues while the collective effect of this polarized cell motility caused a rapid change in 
tissue shape. Time-lapse recordings showed that a mediolateral intercalation in the future 
mesoderm and neural plate were formed by lamelliform protrusions which were directed to 
connect to adjacent cells. This intercalation results in medial-to-lateral narrowing (Convergence) 
in the middle and rostro-caudal lengthening (extension) along the body axis (Keller, 2002). 
In neurulation, cells experiencing CE move medially with intercalation and result in a 
neural plate lengthening craniocaudally and narrowing transversely (Keller et al., 2008). These 
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cells were directed by polarized cellular protrusions to move and intercalate with adjacent cells. 
The process of CE results in an elongated neural plate with broad cranial region and narrow 
spinal region and is crucial for neural tube closure.  
At the molecular level, CE is regulated by PCP pathway which is the so-called non-
canonical Wnt signaling pathway because it shares components with the Wnt signaling pathway 
but does not function through the activation of β-catenin (Jones and Chen, 2007).  
Planar cell polarity signaling (PCP), also known as tissue polarity for cells within the 
plane of an epithelium become polarized during the process and at least one of the core PCP 
genes were involved (Mlodzik, 2002; Zohn et al., 2003). Polarization of cells has been so far 
observed in many biological processes such as distal orientation of wing hairs in Drosophila, 
convergent extension, neural tube closure, hair bundle orientation in inner ear, hair follicle 
orientation in the skin and the more complex organization of the ommatidia (eye units) 
(Wallingford et al., 2002a; Wang et al., 2005; Wang et al., 2006a; Wang et al., 2006b; Wang et 
al., 2006c; Wang and Nathans, 2007). The PCP signaling seems conserved among these 
processes and species.  
The Wnt ligand binds to transmembrane receptor Frizzled (Fz) to activate the Dishevelled 
(Dsh in Drosophila and Dvl in vertebrates). In vertebrates, this process is regulated by the 
proteins of Vangl, Celsr, Prickle (Pk), and Diego (Jenny and Mlodzik, 2006; Klein and Mlodzik, 
2005; Schlessinger et al., 2009; Veeman et al., 2003; Wallingford et al., 2002b). Dishevelled 
then activates the downstream cascades of GTPases Rho-Daam1-ROCK (Rho-associated kinase), 
resulting in cytoskeletal rearrangements (Habas et al., 2001). Dsh also activates Rac which then 
stimulates JNK signaling (Jun –terminal Kinase) with the functions of regulating cytoskeletal 
organization and transcription (Habas et al., 2003).   
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Disruption of the core-genes of PCP signaling lead to neural tube defects in vertebrates. 
These genes include Wnt ligands, such as Wnt5α (Qian et al., 2007), its receptors such as 
frizzled-3 and frizzled-6 (craniorachischisis in double knockout) (Wang et al., 2006d), the core 
transduction components such as dishevelled (Dvl) (Wallingford and Harland, 2001; Wallingford 
and Harland, 2002), Vangl2 (the homolog of Drosophila strabismus/Van gogh, results in Loop-
tail mice) (Kibar et al., 2001; Murdoch et al., 2001) , Celsr1 (the homolog of Drosophila 
flamingo/starry night, results in the Crash mice) (Curtin et al., 2003), Scrb1 (results in the 
Circletail mouse) (Murdoch et al., 2003), the tyrosine kinase Ptk7 (Lu et al., 2004).  
  The common feature of these mutations is craniorachischisis, resulting from failure of 
convergent extension which abrogating the formation of MHP, leaving the neural folds too far 
from each other to close. These findings indicated the potential important link between 
convergent extension and neurulation and the importance of PCP pathway genes as candidates 
for NTDs.  
 
1.1.1.3 Bending of the neuroepithelium-formation of MHP and DLHPs 
Morphological studies during mouse spinal neurulation found a series of morphogenetic 
changes along the neuroaxis, and three modes were defined according to the morphology of the 
neural plate bending within the PNP region to represent the continuous process of spinal 
neurulation (Shum and Copp, 1996). In mode 1, at E8.5, bending occurs in the neuroectoderm 
overlying the notochord, creating a median hinge point (MHP). The non-bending portion of the 
neural folds remains straight, demonstrating a V-shaped image on transverse sections. Mode 1 
exists mainly at upper spinal level of the neuroaxis. In mode 2, at E9.0, additional bending 
occurs at the lateral edges of the neural folds and the dorsolateral hinge points (DLHPs) forms in 
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addition to the MHP, but the other portions of the neuroepithelium do not bend. Neuroepithelium 
with the three bending sites form a rhombus-shaped image on the transverse sections. Mode 2 
exists in neuroaxis of both the cranial and the posterior spinal region. In mode 3, at E9.5, the 
entire neuroepithelium exhibits bending, resulting in a circular-shaped image on the transverse 
sections. The MHP is not distinguished at the caudal spinal region of neuroaxis.   
This bending and closing process is accompanied by cell shape changes (Colas and 
Schoenwolf, 2001). The neural plate cells first change shape from cubical to columnar as a 
region taller than the rest of the surface ectoderm. Then the cells become wedge-shaped at MHP 
and DLHP region including an apical narrowing and basal widening. Cells become high-
columnar at the non-bending portions of neuroectoderm (NT), making the NT distinguished 
obviously from the surrounding mesoderm (MD) (Hildebrand and Soriano, 1999; Smith et al., 
1994; Wallingford et al., 2002b).   
Observation from these morphological studies hypothesize that neurulation of the 
neuroepithelium in early stage (mode 1) is driven basically by extrinsic forces generated in 
surrounding tissues such as the paraxial mesoderm and surface ectoderm, while neurulation in 
late stage (mode 3) is driven largely by intrinsic forces generated by the neuroepithelium itself. 
And mode 2 is a transition period in which both the intrinsic and extrinsic forces play roles 
(Shum and Copp, 1996).   
Animal models demonstrated that both MHP and DLHPs play significant roles in the 
development of neural tube closure. In some mouse NTD models such as Circle tail (Ct), Loop-
tail (Lp), and Crash mutants, they display nonappearance of MHP with an unusually wide floor 
plate, the neural fold tips were too far from each other so that the neural tube remains open 
(Curtin et al., 2003; Hildebrand and Soriano, 1999; Murdoch et al., 2001).  
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Current studies have demonstrated that DLHPs may play more important roles in neural 
tube closure in the spinal region than MHP does (Curtin et al., 2003; Hildebrand and Soriano, 
1999; Murdoch et al., 2001; Ybot-Gonzalez et al., 2002). These scientists demonstrated that 
disruption of DLHP can definitely damage neural tube closure, while some mutants with MHP 
damage may not induce NTDs especially at lower spinal levels. They were also able to identify 
that this disruption may be due to mutation of certain genes, such as Shh (Curtin et al., 2003; 
Hildebrand and Soriano, 1999; Murdoch et al., 2001; Ybot-Gonzalez et al., 2002), BMP and its 
antagonists (Curtin et al., 2003; Hildebrand and Soriano, 1999; Murdoch et al., 2001; Stottmann 
et al., 2006; Ybot-Gonzalez et al., 2007), Grhl family genes (Gustavsson et al., 2008; Rifat et al., 
2010) or Zic genes (Nyholm et al., 2009).  
In vertebrates, Shh is secreted from notochord and floor plate cells and is not only 
essential for bending of the neuroepithelium at the midline but preventing dorsolateral bending at 
the upper spine level (Ybot-Gonzalez et al., 2002). At this time, another dorsolateral bending 
inhibitor, BMP2, is secreted from the dorsal-most surface ectoderm. At early neurulation stage 
mouse embryos, loss of function of Shh pathway inhibitory genes, such as Ptc1 (Goodrich et al., 
1997), Gli2 (Ding et al., 1998), Gli3 (Hui and Joyner, 1993), Fkbp8 (Shirane et al., 2008), Rab23 
(Eggenschwiler et al., 2001; Shirane et al., 2008), Tulp3 (Norman et al., 2009), and 
overexpression of Shh stimulating proteins such as Smo and Shh itself (Echelard et al., 1993; 
Shirane et al., 2008), can lead to NTDs in upper spinal level, possibly due to failure of formation 
of MHP. In contrast, loss of function of stimulating proteins such as Smo and Shh itself do not 
produce NTDs (Chiang et al., 1996; Shirane et al., 2008; Zhang et al., 2001). In contrast, in 
lower spinal level of mouse embryos at late neurulation stage, closure of the neural tube depends 
essentially on the DLHPs rather than the MHP. Embryos ablated of notochord were able to close 
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the neural tube by forming ectopic DLHPs along the entire neuraxis in the absence of MHP 
(Ybot-Gonzalez et al., 2002). This view was supported by a series of experiments using mouse 
with the targeted mutation of Shh pathway genes, such as Shh, HNF3β (Foxa2), Gli2 or Gli1/2 
(Ang and Rossant, 1994; Chiang et al., 1996; Ding et al., 1998; Matise et al., 1998; Park et al., 
2000; Weinstein et al., 1994), none of them display spinal NTDs but display a circular lumen of 
the neural tube along the neuraxis, implying a default-DLHP mechanism in the lower spinal 
region. 
At the lower spinal region, production of Shh from the notochord is significantly reduced, 
whereas secretion of Noggin, a BMP-antagonist, from the tips of the neural folds, conquers the 
BMP-mediated inhibition and facilitates DLHPs formation (Ybot-Gonzalez et al., 2007). Zic 
family genes were found to be involved in bending of the neuroepithelium during neurulation. 
The expression pattern of Zic genes in Wnt3a mutant mice changed in the presence of notochord, 
its dorsal constriction is consistent with the Shh expression (Nagai et al., 1997). Mutation of Zic2 
in mouse embryo results in extensive spina bifida, with normal MHP but abrogation of DLHP 
formation (Nagai et al., 2000). A more recent experiment using Zebrafish demonstrated that both 
Wnt signaling and Zic genes were required for DLHP formation during cranial neurulation 
(Nyholm et al., 2009). 
 
1.1.1.4 Closure of the neuroepithelium 
Bending of the neuroepithelium enables the paired lateral neural folds to contact with 
their tips at the dorsal midline. Fusion of the neuroepithelium occurs at the contact region to 
close the neural tube. This closure is facilitated by the formation of cellular protrusions at the tips 
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of the neural folds and cell adhesion and forms the roof plate of the neural tube (Geelen and 
Langman, 1979).  
The cellular and molecular mechanisms of fusion and closure of the neural tube are not 
clear. Several lines of evidence indicate the involvement of cell adhesion molecules such as Eph 
receptors, the neural cell adhesion molecules (NCAMs), as well as cadherins. Eph was the first 
identified member of the tyrosine protein kinase receptors family with a conserved cysteine-rich 
domain, two fibronectin repeats, and a tyrosine protein kinase domain. Eph receptors and their 
ephrin ligands are implicated in playing roles in neural tube formation. Mice that lack Eph-A5, a 
cell surface ephrin ligand, or Eph-A7 receptor, a potential ephrin A5 ligand, exhibit cranial NTDs 
(Holmberg et al., 2000). Yet no further evidence is added to elucidate the potential mechanism. 
The neural cell adhesion molecule (NCAM) is a GAG-binding protein, expressed in the 
developing neural tube. The expression pattern of NCAM during neural tube development in 
mouse embryo implicated a role in closure of neural tube (Bally-Cuif et al., 1993) null mutations 
in NCAM in mice do not result in neural tube defects, questioning their essential role in neural 
tube closure (Cremer et al., 1997; Radice et al., 1997a). However, a study of investigating the 
role of NCAM1 in 132 spina bifida families established the expression pattern of NCAM1 in the 
central nervous system of human embryos, shed light on a possible contribution of variations of 
NCAM1 to NTDs risk (Deak et al., 2005).  
Cadherins belong to cell adhesion molecule family. They have been found to be 
differentially expressed during neural plate formation. N-cadherin is expressed in the neural plate, 
while E-cadherin is expressed in the surrounding ectoderm (Rutishauser and Jessell, 1988). 
When both the neural tube and the surface ectoderm in Xenopus embryos express N-cadherin, 
they fail to separate the two tissues and result in NTDs (Detrick et al., 1990). However, Mouse 
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with null mutations in N-cadherin gene undergoes normal neural tube closure, implicating that 
these cadherin molecules may not play a major role in neural tube formation.  
 
1.1.2 Secondary neurulation 
Secondary neurulation starts at the end of primary neurulation. In human, this process 
develops from the caudal eminence, which is the counterpart of the tailbud in other mammals 
such as chick or mice, to the formation of the most distal segment of the spinal cord (Muller and 
O'Rahilly, 1987). The caudal eminence or the tail bud contains a group of stem cells which first 
proliferate and then differentiate to different kinds of tissues in the caudal region such as hindgut, 
somites, and notochord, etc (O'Rahilly and Muller, 1989). These stem cells then condense and 
cavitate to form a tube to connect with the central canal formed during primary neurulation.  The 
newly formed neural tube shapes the remaining sacral and coccygeal part of the spinal cord.  
Previous studies have thought that secondary neurulation is not just an extention of primary 
neurulation. The manner and timing is different as well as their roles in CNS development 
(Saitsu et al., 2004). But one study suggested that primary and secondary neurulation  are parts 
of a continuous process with similar molecular and cellular mechanisms (Catala, 2002).    
 
1.1.3 Neural tube defects (NTDs) 
Neural tube defects (NTDs) are a group of congenital anomalies of the central nervous 
system (CNS) (Copp et al., 2003). It is among the most common birth defects only secondary to 
congenital cardiovascular defects. The prevalence of this congenital disease is reported at around 
1 to 10 per 1000 births worldwide: 0.75 to 1.12/1000 in America (Mitchell, 2005), 2.74/1000 
births in China (from Birth defects report in China,2000), and 0.58/1000 births in Singapore (Tan 
et al., 2007). The common types of NTDs due to failure of neural tube closure during neurulation 
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are anencephaly and spina bifida (Botto et al., 1999). They are “open” NTDs with tissues 
exposed to outside of the unclosed neural tube. In contrast, encephalocele is the kind of post-
neurulation NTD due to failure of the secondary neurulation. It often occurs in the occipital 
region and is covered with skin. The mechanism of NTD developed from secondary neurulation 
is usually due to failure of separation of the neural tube from the attached tissues of the tail bud 
(Rossi et al., 2004). Most infants with anencephaly die, some survivors with spina bifida face the 
threat of death or severe physical and developmental disabilities.  
Epidemiological studies found that recurrence risk is enhanced among siblings, frequency 
in twins is higher than in singletons and occurrence of disease is associated with particular genes 
(Padmanabhan, 2006). Spina bifida often takes place in autosomal trisomies. These findings  
point toward the existence of a strong genetic mechanism of NTDs. Clinical studies of 
periconceptional supplementation of folate (FA) reduce significantly not only the first 
occurrence but the recurrence of NTD in the offspring encouraged investigations on the genes 
involved in FA metabolism during neural tube development (Czeizel and Dudas, 1992). 
Experiments using animal embryos such as mouse, rat, chick, pig, rabbit, Xenopus, etc, provided 
insights into the mechanism of NTDs and suggested a gene-gene, and gene-environment 
mechanism in NTD, yet no clear evidence for causation genes of NTD have been declared.  
There are more than 200 NTD genes so far, most of them are related with the unknown 
genetics of the common human NTDs, exencephaly (EX), spina bifida (SB), and 
craniorachischisis (CE) (Copp and Greene, 2010b). In mouse mutants, EX has a much higher 
number than SB, while in human, the case numbers of the two are almost the same, which 
indicates that candidate genes induce EX only in mouse but may induce SB in human. The 
mouse mutants examined during the time of normal neural tube closure displayed a dominant 
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failure of neural folds elevation compared with the small portion of inadequate adhesion and 
fusion (Efna) as well as reopening of a poorly  closed tube (Fkbp8, Prkaca) (Harris and Juriloff, 
2007). In both mouse and human NTDs, the common region of failure of neural folds elevation 
were the mid-brain and the posterior neuropore, the former causes EX in mouse and anencephaly 
in human, while the later results in SB in both. CE was seen mainly in mouse mutants, with a 
widened floorplate, and the neural folds are too far to contact.  
Glycosaminoglycans (GAGs) are a group of heteropolysaccharides that have long been 
found related with neural tube closure （Copp and Bernfield, 1988b）. Newly synthesized 
GAGs accumulated especially in the active neurulation sites, while mutation of some GAG genes 
such as Sdc4, Ndst1 can lead to neural tube defects in mouse embryos. These findings implicated 
an important role of GAG genes in neural tube closure and hold a promising for further 
investigation.  
 
1.2 Microarray analysis 
Scientists can only study a relatively small number of genes at a time by traditional 
methods. The development of microarray technology can generate gene expression profiling of a 
creature with thousands of genes in a single experiment. With microarray analysis, researchers 
can explore dynamic aspects of normal developmental process or genetic basis of various 
diseases. 
 
1.2.1 Microarray and its classification  
Microarray is a technology for analyzing a large number of genes in small supports. The 
supports could be glass microscope slides, silicon chips or nylon membranes, with gene 
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sequences known as probes attached onto it at fixed locations in an orderly arrangement. The 
gene sequences attached to the supports can be DNA, cDNA, or oligonucleotides. These 
immobilized target DNA hybridize with laboratory prepared fluorescent labeled cDNA or cRNA 
samples. The binding of the labeled molecules to the corresponding sites on the array reveals the 
genes expressed in each cell. Therefore, simultaneously monitoring the expression intensities of 
thousands of genes in one experiment can provide a global view of gene expression patterns in 
biological samples, promoting a better understanding of the underlying mechanisms of the 
biological events.   
There are two basic microarray types: genomic or transcriptomic microarray. They are 
mainly different from each other in the kind of immobilized DNA, the type of control and 
sample DNA used in the hybridization solution, and the information that is generated from the 
chip. Genomic microarray, also called “spotted microarray”, uses oligonucleotides, cDNA or 
PCR products as probes to be spotted on the array surface (Bertucci et al., 2001). It represents the 
nucleic acid profiles and is ready to hybridize with cDNA or cRNA samples. This kind of 
microarray can be manufactured using only a portion of the whole genome according to purpose 
of different experiments. It’s relatively cheaper, but may be less sensitive owing to its small 
batch size and reduced efficiency.   
Transcriptomic microarray are used to generate transcriptomic profilings to measure gene 
expression patterns or change in mRNA levels (Conway and Schoolnik, 2003; Dalma-
Weiszhausz et al., 2006). The transcriptome is defined as the steady-state of all RNAs formed in 
a tissue at a defined time in development. The Affymetrix oligonucleotide microarrays use 
shorter sequence probes in high density directly onto the array surface with the purpose of 
matching specific parts of mRNA. By this method, most genes in one organism can be detected 
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on one Chip (Dalma-Weiszhausz et al., 2006). For example, the Affymetrix GeneChip Mouse 
genome 430 2.0 array allows wide-ranging analysis of over 39000 transcripts and variants, 
covering over 34000 well known mouse genes (Auer et al., 2009). 
Microarrays can also be classified according to the methods of labeling probes. The two-
color microarrays actually use two different fluorescent dyes, cy3 and cy5, to label cDNA of two 
different samples (Shalon et al., 1996), for example, diseased and control samples. The two 
labeled cDNA samples will be hybridized on the same microarray chip. The same gene will give 
two different colors for comparing their expression difference between the two samples. 
Although this method allows two samples in one chip to be processed under exactly the same 
experiment condition, the low quality of one sample can affect the gene expression of another. 
Another limitation is that it cannot be used to compare more than 2 samples from more than 2 
groups.  
Fortunately this problem can be addressed by the one-color microarray. Affymetrix 
microarrays is a one-color microarray, which means that all the cRNA probes in the sample were 
labeled with one dye and hybridized on one chip. Control probes are designed in the Chip to 
normalize the target probes. Different experiment samples are applied onto different chips 
separately. More chips are needed in one experiment. This makes it relatively costly. But the 
one-sample-on-one-chip method avoids inter-chip interference of raw data by other samples, 
especially when quality of one of the samples is low. Moreover, there is no limitation of sample 
numbers and easier comparison between data from different experiments.  
  Because of the complex features of biological science and numerous genes with various 
functions involved in the same biological process, traditional candidate gene approaches cannot 
meet the needs of understanding the genetic basis of certain biological process in a broad view. 
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Microarray technology provides a great tool to investigate the comprehensive biological systems 
with at least two advantages. One advantage is in its high-throughput to provide a global picture 
of all genes within the whole genome. Differentially expressed genes can be simply discerned by 
comparing the expression profiles. Another advantage of microarray analysis is to reveal a new 
or enhanced pathway of interested biological function.  Novel genes with unknown functions can 
be discerned by the following verification experiments as well.    
 
1.2.2 Application of microarray in biological science 
The characteristics of microarray technology enable measurement of thousands of genes 
expressed simultaneously. It has been widely used for monitoring transcription patterns or gene 
expression changes during developmental processes, under certain disease or experimental 
conditions such as gene mutation, diagnostics, pharmacogenomics or drug treatment (Choudhuri, 
2004; Conway and Schoolnik, 2003; Stoughton, 2005). Researchers have explored the gene 
expression changes of different stages of embryogenesis, at the very early oogenesis (Niemann et 
al., 2007), preimplantation (Hamatani et al., 2004), and gastrulation stages (Hue et al., 2007). 
The above studies have provided extensive knowledge representing early stages of mouse 
embryogenesis, the later studies could refer to the genes provided in these studies before they 
design new experiments. But no genome-wide expression profiling has been provided regarding 
neurulation, the most important developmental stage of nervous system development. Jiang, et al 
compared the expression difference of cranial neural tube closure between embryos of diabetic 
mice and normal embryos at the same stage (E11.5) (Jiang et al., 2008). They found 390 
differentially expressed genes with more than two-fold changes, and identified several genes 
with certain functions which could disturb proliferation of neurogenesis in embryos of diabetic 
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mice and their survival. This work provided a framework for later studies of diabetic disease. 
Since the genes found were from embryos of diabetic mice, they may not reflect the normal 
status of embryogenesis. Moreover, differences may also exist between neural tube development 
of cranial and spinal region.   
In summary, microarray experiment is expected to play significant roles in investigating 
the genetic mechanism of nervous system development. Yet no microarray experiment has been 
done to explore the difference between stages of neural tube formation in physiological states. 
The current research was designed to explore the transcriptomic profiling of critical time points 
of the closing neural tube in the spinal region of mouse embryos, with the hope of revealing 
important aspects of neurulation, such as finding novel genes and group genes into functional 
pathways in order to illustrate the genetic mechanism of neural tube defects (NTDs), a congenital 
disease caused by failure of neural tube closure. 
1.2.3 Bioinformatics for microarray analysis 
Microarray technology has been used widely in various biomedical areas, including 
research area and microarray-based clinical tests. Therefore, microarray data analysis is 
important for its potential impact on development of biomedical research fields. There are two 
steps to analyze the quality of a microarray experiment. In the first step, analysis is focused on 
experiment designing, set up quality control, and the process of performing. These analyses 
depend more on professional knowledge and expertise in use of microarrays, and can be done 
before and during the experiment process. The second step analysis refers to the final purpose 
such as establishing a relationship between disease and certain treatment, finding targeting genes, 
or setting up molecular pathways and networks, promoting understanding of biological 
implications from a huge amount of microarray data. The second step analysis will be performed 
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after the experiment and depend more on commercially available software in addition to 
professional knowledge (Mocellin and Rossi, 2007; Wang, 2008).  
There are various commercially available software for analysis of microarray data. The 
techniques and algorithms are different, but the main principles and purpose are similar: to 
generate a differential gene expression profile, find the key variables affecting the difference, 
and find links between genes within the profile and crosstalk nets among profiles.  
 
1.2.3.1 GeneChip Operating Software (GCOS) 
Affymetrix offers a Microarray Analysis Suite (MAS) and its successor GeneChip 
Operating Software (GCOS) for organization and analysis of the Affymetrix microarray data 
(Dalma-Weiszhausz et al., 2006).  It is an integrated software package for data storage, sample 
organization, image acquisition, cell intensity calculation and normalization, background noise 
controlling and gene expression comparison.  
This software employs a detection algorithm to evaluate the Present (P), Absent (A), or 
Marginal (M) of the transcripts. Then the expression value of each transcript is calculated by 
Signal Algorithm. The intensity of the probe sets are normalized between experiment and 
baseline array. The changed transcripts have a robust increase or decrease when “Present”.  
One of the advantages of GCOS is set a default average Signal intensity. This can quantitatively 
calculate signal intensity which helps users know more about the expression strength in addition 
to fold change to assess the gene function. Another advantage is capable of comparing files from 





1.2.3.2 DNA-Chip Analyzer (dChip) 
DNA-Chip Analyzer (dChip) is an software package for analysis of probe-level 
Affymetrix gene expression microarray (Schadt et al., 2001). It meets the basic service for 
comparison of differentially expressed genes. In addition, it presents the hierarchical clustering 
analysis which can group genes according to their expression pattern in a clustering tree. Genes 
with the closest distance are merged together indicative of their high similarity in standardized 
expression values.  
dChip can be used to compare data from different array types or species. It is a great 
advantage especially when samples are rare and experiment cannot be repeated or unknown 
genes are investigated. Hierarchical clustering is offered by dChip software and replicate 
samples or samples with similar variables are expected to be clustered together. 
 
1.2.3.3 GeneSpring 
GeneSpringTM software (Silicon Genetics, Redwood City, CA, USA) includes a set of 
analytical tools such as Robust Multi-array Average (RMA), Guanine Cytocine Robust Multi-
array Average (GCRMA), and Probe Logarithmic Intensity Error (PLIER) to analysis data from 
multiple array formats. The RMA algorithm is used to analyze the Affymetrix data begins by 
correcting the raw intensity values against their background, the background-corrected perfect-
match intensities are log2-transformed followed by normalization using the quantile 
normalization method (Irizarry et al., 2003). The advantage of RMA is obtaining an expression 
measure by the justification of discrepancies arose during experimental procedures such as 
staining, as well as avoiding the affects from MM probes. The GCRMA platform is an enhanced 
form of RMA designed to account for background noise and non-specific binding, and calculate 
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PM and MM value based on sequence information as probe affinity, so it is possible to obtain 
more accurate gene expression values. PLIER is an improved method for calculating signal by 
accounting for handling error. It is designed based on the model-based expression analysis and 
robust multiple analysis and featured by avoiding bias.       
In experiments that genes generated by one software are too many that they are beyond 
the ability for further analysis, combined use of different software are suggested to narrow down 
the new candidate gene lists. Millenaar FF et al (Millenaar et al., 2006) compared the reliability 
of 6 different calculating methods (MAS5, dChip PMMM, dChip PM, RMA, GC-RMA and 
PDNN) for the same Affymetrix microarray data and find that only 27% to 36% genes 
overlapped between the different methods. This study shows that combined use of different 
software can effectively narrow down the targeted genes if too many genes are found, though 
loss of some of the critical genes might occur. Proper literature research should be needed for 
more accurately picking up biologically meaningful targeted genes. 
 
1.2.3.4 Gene ontology (GO) tool and the NetAffxTM Analysis Center 
Gene Ontology (GO) (http://www.geneontology.org/) is one of a functional annotation tool 
from the database for annotation, visualization and integrated discovery (DAVID) website 
(Ashburner et al., 2000). It is a practical tool for understanding biological meaning behind large 
list of genes. It is a joint project from multiple organism databases: FlyBase, Mouse Genome 
Informatics (MGI) (http://www.informatics.jax.org/searches/GO_form.shtml), and the Saccharomyces 
Genome Database (SGD). Information for specific genes or proteins is also linked to multiple 
keyword databases in order to provide flexible biological knowledge. GO provides at least three 
categories to characterize a gene list: biological process, molecular function, and cellular 
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component. The biological process refers to what is the biological purpose of the gene product, 
molecular function refers to how the gene products carry out their purpose, and cellular 
component presents where the gene products take actions. Through GO ontology, a list of data 
sets can be turned into multiple sets of well-defined terms with well-defined functions.  
The Affymetrix NetAffxTM Analysis Center (www.affymetrix.com/analysis/) provides 
comprehensive functional annotations for creating of statistically and biologically significant 
gene lists by the Gene Ontology (GO) Mining Tool. It makes users life easier by offers gene 
function interpretations among several databases simultaneously based on their molecular 
functions. 
 
1.3   Introduction to laser capture microdissection (LCM) 
The development of microarray makes it possible to investigate genome, transcriptome, 
or proteome. Genome is the whole set of DNAs in cells of individual being. DNA can undergo 
transcription into RNA. The transcriptome includes the steady state levels of all the RNAs in 
individual cells and transcriptome profiling can reflect the whole or a selected part of the whole 
transcriptome of individual cells or tissues. RNAs can undergo translation into proteins and the 
steady state level of all the protein species is called proteome. Expression profiling at RNA 
levels represents the status of the epigenome more closely than expression profiling at protein 
levels as different cell state can have different signaling molecules.   
The big challenge of getting reliable microarray results is the heterogeneity in tissue 
context as gene expression levels can be affected by cell types and status. For example, in the 
same lump of tissue samples, gene expression is different in cancer cells compared with normal 
cells. In a developing organ, genes expression levels can also be fundamentally different among 
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epithelium, mesenchyme or endoderm. Cell numbers of different cell types usually very different 
in one tissue or organ, so investigating the gene expression profiling of whole mount tissues may 
give confounding results for discussion. The invention of laser capture microdissection (LCM) 
offers a tool for isolating interested cells or tissue types from heteogeneous tissue contexts 
(Bonner et al., 1997; Emmert-Buck et al., 1996).  
   
1.3.1 LCM systems and their working principles 
LCM is a technique used for harvesting selected cells even single cells from tissue 
sections or cultured cells by laser cutting under the guidance of microscope (Bonner et al., 1997; 
Emmert-Buck et al., 1996). It was first devised by a group of collaborative researchers from the 
National Institutes of Health (NIH) and the first commercial instrument was manufactured by 
Arcturus Engineering (Mountain View, CA). The main principles of the laser microdissection are: 
visualization of interested cells via an inverted light microscopy; transfer of low power laser 
energy of near-infrared (IR) for melting the thermolabile polymer or UV for photo volatilization 
of cells surrounding a selected area; removal of the cut cells from the heterogeneous context. 
There are three types of commercially available LCM systems with similar components 
but different modes of harvesting cells: (1) Thermoplastic polymer film attached to a MicroCap 
situated just up to targeted cells, the film melted by laser and bounded to underlying cells after 
selection and microdissection and lifted away from the tissue section. Pixcell is the original 
manual instrument conceived by NIH and manufactured by Arcturus Molecular Devices (Bonner 
et al., 1997; Emmert-Buck et al., 1996; Espina et al., 2006). (2) The polymer film attached to a 
slide for tissue sections, interested cells were selected and catapulted by a laser pressure into the 
cap of a special collection tube situated just top of the sections. The automated system from 
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Arcturus Molecular Devices belongs to this type. This technique was named laser 
microdissection and pressure catapulting (LMPC) from PALM instruments (Burgemeister, 2005; 
Niyaz et al., 2005). (3) The polymer film attached to slides also, but the interested cells were 
selected and dropped into a collection device. This type instrument was named Leica AS-LMD 
(Edwards, R.A. 2007). Each technique can harvest cell with several microns’ precision, allowing 
procurement of single cell even portions of chromosomes. The harvested cells can be used for 
various downstream analyses such as isolating DNA, RNA, protein, and lipid samples for RT-
PCR, microarray, Western blot, or 2D gel electrophoresis. 
 
1.3.2 The application of LCM in developmental biology 
LCM allows users to isolate interested cells or tissues from either frozen sections or 
formalin-fixed, paraffin-embedded tissue sections. Because of its capability of isolating 
interested cells from heterogeneity contexts, it has been widely applied on various disease 
conditions to compare the pathology of diseased tissue cells with normal cells, for example, it is 
especially well applied in comparing cancer cells with more malignant, less malignant, and 
normal cells. It also has been smattered in various stages of biological development process of 
many organs of all kinds of species, such as heart (Kuhn et al., 2007), lung, kidney (Stemmer et 
al., 2006; Woroniecki and Bottinger, 2009), pancreas (Marselli et al., 2009), brain, et ctr.  
One of the key points for successful application of LCM is to pick up the interested cell 
populations accurately. Various staining methods used on tissue sections can help distinguish 
different cellular components under the light of microscope. The most often used dyes are 
hematoxylin, eosin, methylene blue, Wright-Giemsa and toluidine blue, thionin, according to 
different cell types and the users’ preference. The dyes used may have an extra advantage of 
26 
 
molecular integrity by absorbing laser energy to prevent heat deposition. In some cases when 
interested cells are very meager, or it is more difficult to distinguish, immunohistochemical 
staining could be used for the selection of morphologically similar yet immunophenotypically 
different cells (Fend et al., 1999; Kuhn et al., 2007).  
If downstream applications such as microarray analysis require RNA with high quality 
and quantity, certain strategies will be needed during processing of original tissue samples since 
the performance of LCM need more time which may practically affect the RNA quality. To 
protect RNA integrity, RNA-Later can be used on tissue samples before section. Some 
researchers tried to recover RNA from archived tissue samples and get ideal RNA results. The 
disadvantage of RNA-Later is that tissue immerged in RNAlater is soft and difficult to section, 
and tissue morphology can be damaged during section process. Other strategies used to protect 
RNA integrity include using snap-frozen tissues, preparing fresh and RNase free reagents and 
staining sections quickly (Stemmer et al., 2006).  
Only limited quantities of LCM dissected samples can be acquired within certain period of 
time, the RNA isolated from it cannot meet the requirement of microarray analysis. To solve this 
problem, the RNA amplification method has been developed in addition to the in vitro 
transcription method (Ginsberg, 2005; Portillo et al., 2009). Researchers use RNA amplification 
method in combination with in vitro transcription for microarray process successfully getting 
RNA with good quality and high quantity. As such, the gene expression profiling from LCM 






1.4 RNA interference (RNAi) technology 
1.4.1 What is RNAi? 
RNA interference (RNAi) is a natural process existed in many organisms ranging from 
plants to mammals that introduction of RNA into cells interfere with the function of an 
endogenous gene in a sequence context (Jorgensen, 1990; Romano and Macino, 1992). Fire and 
his colleagues discovered the phenomenon of gene-silencing in 1998 by specifically targeting a 
functional gene (unc22) using an exogenous dsRNA to effectively produce a reduced gene 
activity of the silenced gene (Fire et al., 1998). Similar phenomena were found when other genes 
were targeted. The RNAi was first successfully demonstrated in several mammalian cells in 2001 
and raised its potential application in biomedical research and therapy (Elbashir et al., 2001).   
How RNAi works to regulate gene expression and function?  The mechanisms of RNAi 
pathway were similar in Drosophila and mammals (Hamilton and Baulcombe, 1999; Hammond 
et al., 2000; Tuschl et al., 1999; Zamore et al., 2000). In this process, small double-stranded 
RNAs (dsRNAs) including small interfering RNA (siRNA) or short hairpin RNA (shRNA) are 
homologous in sequence to the silenced gene. They are either cleaved into small interfering RNA 
duplex by the RNaseIII-type enzyme called Dicer, or chemically or enzymatically synthesized, 
or synthesized by DNA-based systems. Consequently, siRNAs are incorporated into the RNA-
induced silencing complex (RISC), which mediates the binding and cleavage of the target 
mRNA. This process is sequence-specific, homology-dependent, and triggering gene abolition 
through degradation or by inducing translational inhibition. Since its discovery in the late 1990s 
by Fire and Mello, RNAi has been progressed to become a powerful biological tool for its high 
specificity and selectivity and has been used for the investigation of gene function, as well as in 
target validation, translational repression, transcriptional inhibition, and DNA degradation.  
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1.4.2 Applications of RNAi 
RNAi become a useful research tool for reverse genetic studies, which establish the gene 
function by targeted disruption. RNAi-mediated silencing is usually incomplete, a “knockdown” 
but not a “knockout”. To maximize silencing effects, several siRNA sequences (usually 3-6) are 
used for each targeted gene. Transfection of siRNAs into rapidly dividing cells has a maximal 
silencing effect 2-3 days after transfection, and the silencing effect could last for a week. 
However, in nondividing cells, such as macrophages or neurons, this siRNA-mediated silencing 
effect can last for several weeks. To prolong silencing effects, viral expression systems have 
been employed to express shRNAs, which is a siRNA precursor synthesized by DNA-based 
vector and processed intracellularly into siRNAs.    
The sequencing of human genome has provided most of the genes expressed in humans 
as well as some other organisms. This provided a huge amount of information for RNAi to 
silence any gene in the genomes of human or any other organisms. In C elegans as well as in 
Drosophila, gene silencing can be induced by expressing long dsRNAs, and RNAi-mediated 
genome-wide screening have been used to characterize the biological function of predicted genes 
in a high-throughput manner.  In mammalian genome, however, long dsRNAs can trigger an 
interferon response, so short designed dsRNAs have been used for genome-wide RNAi screens 
in mammalian cells. shRNAs can be used to generate transgenic animals with stably silenced 
gene expression. One of the advantages of these knockdown animals is less time involved (only a 
few months) because it only requires inserting a single transgene. Another advantage is that it 





1.5 Introduction of glycosaminoglycans (GAGs) 
1.5.1 Glycosaminoglycans (GAGs) and Proteoglycans (PGs)  
Glycans are complex carbohydrate conjugates that mediate various cell-cell and cell-
matrix interactions. The most abundant linear unbranched glycans in the body are 
Glycosaminoglycans (GAGs). GAGs are long, negatively charged heteropolysaccharides that 
have molecular weight of roughly 10 to 100 kDa, containing a repeating disaccharide unit 
(Gandhi and Mancera, 2008; Jackson et al., 1991). They present on the cell surfaces or in the 
extracellular matrix (ECM) and can be classified as sulphated and non-sulphated. Sulphated 
GAGs include heparin, heparan sulphate (HS), chondroitin sulphate (CS), dermatan sulphate 
(DS), and keratin sulphate (KS), while hyaluronic acid (HA) is non-sulphated.  
GAGs vary according to disaccharide unit contents, sulphation positions, as well as 
geometry of the glycosidic linkage. HS and CS are two main types of GAGs comprising 
repeating hexosamine-uronic acid disaccharides that are sulphated at various positions (Zhang, 
2010a). Heparin and HS are called glucosaminoglycans for they contain glucosamine, and 
Heparin is most highly sulphated. CS and DS contain galactosamine and are called 
galactosaminoglycans. DS is one type of CS containing IdoA residues.  
GAGs can be sulphated at different positions of the amino sugar or the sugar backbone to 
form hundreds of thousands of different molecules. The geometry of the glycosidic linkage also 




Fig. 1.1 Diagrammatic representation of GAGs linked to a proteoglycan core protein. Both 
heparan sulfate and chondroitin sulfate are linked to specific serine residues of proteoglycan by 
the linkage tetrasaccharide Xyl (green)-Gal (yellow)-Gal (yellow)-GlcA (blue). Alternating 
addition of GlcNAc and GlcA results in heparan sulfate, while alternating addition of GalNAc 
and GlcA leads to chondroitin sulfate.   
 
GAGs can form proteoglycans (PGs) by linking to core proteins through a specific 
tetrasaccharide which are composed of one glucuronic acid (GlcA), two galactose residues (Gal), 
and a xylose residue (Xyl) (GAG-GlcA-Gal-Gal-Xyl-O-CH2-protein) (Fig. 1.1) (Zhang, 2010a). 
The tetrasaccharide linker is linked to a Serine residue (S) in the protein core through an O-
glycosidic bond. Some forms of KS are attached to Asn in the protein core through an N-
asparaginyl bond. The protein cores of proteoglycans have many S and Tryptophan (T) residues 
which allow various GAG attachments. Core proteins act as GAG carriers in PGs, besides, they 
usually determine the type (HSPGs or CSPGs), the number of GAG chains, and the ultimate 
destination (apical, luminal, intra- or extracellular) of the finished PGs (Zhang, 2010a). For 
example, glypicans as HSPGs carry more than 80% HS and much less CS, while the two CSPGs, 
biglycan and aggrecan, carry much more of CS and very low percentages of HS (Chen and 
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Lander, 2001). To explain these phenomena, a site-preference to multiple acidic residues, 
hydrophobic residues and Ser-Gly units for HS synthesis has been noticed.   
PGs can be produced by almost all mammalian cells and exist in the extracellular matrix, 
plasma membrane, and some of them play functions in biological process (Zhang, 2010a). There 
are more than 23 types of PGs found in the nervous system (Hartmann and Maurer, 2001).   
  
1.5.2 Biosynthesis of GAGs 
GAGs are synthesized in the Golgi apparatus. The common so-called GAG-protein 
tetrasaccharide linker, GlcA β1,3-Gal β1,3-Gal β1,4-Xyl-β1-O-(Ser), is first synthesized by 
addition of  a Xyl (xylose) to specific Ser residue on the proteoglycan core protein by two 
xylosyl-transferases, then two Gal (galactose) residues are added to the Xyl residue by 
galactosyltransferase I and II, followed by the addition of GlcA (glucuronic acid) by 
glucuronosyltransferase I (Zhang, 2010a).  
After completion of the tetrasaccharide linkage region, GAGs synthesis on this linkage is 
triggered by the addition of the first HexNAc (N-acetyl-hexosamine, GalNAc or GlcNAc) 
residue. Addition of GalNAc to the nonreducing terminal GlcA by the key enzyme N-
acetylgalactosaminyl transferase I commits the CS synthesis, followed by subsequent alternating 
addition of GlcA and GalNAc by chondroitin synthase (Silbert and Sugumaran, 2002). In 
contrast, HS synthesis occurs if GlcNAc is added to the linkage region by N-
acetylglucosaminyltransferase followed by alternating addition of GlcA and GlcNAc residues by 
HS copolymerases (EXT-1 and EXT-2) from their corresponding UDP-sugars (Sugahara and 
Kitagawa, 2002). Chain modification of CS and HS are carried out by a series of enzymes which 
make the CS and HS the most abundant molecules in nature.    
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The enzymes for synthesizing the linkage region, GAGs (HS or CS) extension, as well as 
their modifications are very important for distribution and functions of GAGs. For example, 
GalT I, GalT II and GlcAT I (Almeida et al., 1999; Okajima et al., 1999) have been found 
largely expressed in human tissues, consistant with the omnipresent distribution of GAGs. Cells 
deficient in GalT-I, GlcAT-I, or GalT-II fail to synthesize the GAGs, while transfection of each 
enzyme cDNA into the corresponding mutant cells restores GAG synthesis (Bai et al., 2001; 
Okajima et al., 1999; Wei et al., 1999).    
 
1.5.3 Biological roles of GAGs 
The key properties of GAGs are high viscosity, low compressibility and rigidity (Gandhi 
and Mancera, 2008). They are found in mucous secretions as mucopolysaccharides for their 
viscous lubricating properties. These molecules provide structural integrity to cells and 
passageways between cells because of their rigidity.  
GAGs can bind and regulate multiple protein partners, such as chemokines, cytokines, 
growth factors, morphogens, enzymes and adhesion molecule, and contribute to many biological 
processes, thus play multiple roles in development, health and disease through different 
molecular mechanisms (Casu and Lindahl, 2001; Jackson et al., 1991; Zhang, 2010b). More than 
200 GAG-binding proteins have been described in literature (Zhang, 2010a). Heparin/HS are 
found to interact with more than 20% of the plasma proteins that are present on the cell surfaces 
and in the extracellular matrix (Saito and Munakata, 2007).  CS acts as a biological activator 
independent of HS (Margolis and Margolis, 1997; Saito and Munakata, 2004). It is found to 
participate in modulation of axon growth, wound healing, NFkB transcriptional activation of 
endothelial cells. Moreover, GAGs can be involved to signaling pathways including, but not 
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limited to, Wnt signaling (Munoz et al., 2006), Sonic hedgehog (Shh) (Rubin et al., 2002), BMP 
signaling pathways (Ruppert et al., 1996), fibroblast growth factor (FGF)/FGFR (McDowell et 
al., 2006), platelet derived growth factor (PDGF/PDGFR) (Rolny et al., 2002), which are well 
known for embryonic development, in particular, neurulation process.  
 
1.5.4 Galactosyltransferase (GalT, GalTase) 
Glycosyltransferases (Glyco-T) are a super-family of enzymes residing in the Golgi 
apparatus of a cell, catalyzing the synthesis of carbohydrate moieties of cellular glycoconjugates 
(glycoproteins, glycolipids, and proteoglycans) by transferring a monosaccaride moiety from an 
activated glycosyl donor to an glycosyl acceptor molecule, forming a glycosidic bond, resulting 
in a carbohydrate, glycoside, oligosaccharide, or a polysaccharide (Paulson and Colley, 1989; 
Roseman, 2001).  
Galactosyltransferase (GalT) is a type of Glyco-T that catalyzes the transferring of 
galactose from uridine-diphosphate-α-D-galactose (UDP-gal) to an acceptor sugar molecule. The 
galactosyltransferase subfamilies include β1, 4-(β4Gal-T), β1, 3-(β3Gal-T), β1, 6-(β6Gal-T), α1, 
3-(α3Gal-T), and α1, 4-(α4Gal-T). All of these enzymes use UDP-α-D-Gal as the sugar donor 
but generate β-1,4-, β1,3-, β1,6-, α1,3-, and α1,4-linkages, respectively. Each of the above 
mentioned subfamily has additional members. For example, at least seven members have been 
found in the β4Gal-T subfamily, β4Gal-T1 to β4Gal-T7 (Amado et al., 1999). Although the 
β4Gal-Ts have 25% to 55% sequence homology and similar enzymatic functions, they are 
distinctive in structure, location, expression and tissue specific differences, and any alteration in 
the activity of subfamily members have been associated with various diseases.  Among these 
GalTs, the β-1,4-galactosyltransferase (β4Gal-T) is the first mammalian Glyco-T that was cloned 
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in 1986, followed by the cloning and identifying of more Glyco-T and galactosyltransferase 
subfamily members and acceptor substrate specificities (Shaper et al., 1986). It is the initiation 
enzyme of biosynthesis of PGs and one of the biosynthesis enzyme of many kinds of GAGs.  In 
addition, it also has functions in cell growth and cell adhesion, which are the most important 
functions for formation and closure of the neural tube. But the expression and function of 
B4galt1 in mouse embryo during neurulation has not been well studied.  
  
1.5.5 Structure, expression and functions of B4galt1 
β-1,4-galactosyltransferase1 (β4Gal-T1) is one of the first mammalian 
glycosyltransferases to be purified, cloned, sequenced, and its crystal structure has been 
established.  β4Gal-T1 has 6 exons and encodes a type II integral membrane protein, synthesized 
mainly in the cytoplasm and localized in the Golgi apparatus as well as at the cell surface (Qasba 
et al., 2008). Like other β4Gal-Ts, it has an amino-terminal cytoplasmic tail, a transmembrane 
(TM) anchor domain, and an extended stem structure and large carboxyl-terminal catalytic 
domain (Fig. 1.2.A).  
The β4Gal-T1 mRNA encodes for two isoforms differing at the cytoplasmic region  
(Fig. 1.2.B and Fig. 1.2.C). The longer form has 24 amino acids at the amino-termini, placing 
two Met residues in the cytoplasmic domain, while the short form has only 11 amino acids at the 
cytoplasmic region.  Several studies supported that both long and short isoforms are found in the 
Golgi, but only a small percentage of long isoform is localized on the plasmic membrane and can 
function as a cell surface receptor (Hathaway et al., 2003; Lopez et al., 1991; Russo et al., 1990; 
Shaper et al., 1988). The transmembrane region is hydrophobic and plays an important role in the 
stability of the protein.  The length of the TM region is consistent with the thickness of the lipid 
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layer and may play a role in their sorting and targeting mechanism (Masibay et al., 1993). The 
stem region has 45 to 145 residues in bovine β4Gal-T1. It can enhance the in vitro folding 
efficiency and flexible orientation of the catalytic domain in both bovine and human species 
(Boeggeman et al., 2003). The long catalytic domain of β4Gal-T1 facing the Golgi lumen has a 
GT-A fold, a globular protein with two dissimilar N- and C-terminal domains. The N-terminal 
domain identifies the nucleotide donor, while the C-terminal domain binds the acceptor substrate. 
The active sites reside between the two domains. A metal-binding site is also positioned in the 
cleft of the enzyme. β4Gal-T1 is a constituent of the trans-Golgi apparatus. It is one of the GAG 
synthesizing initiation enzymes that is responsible for adding the first Gal residue to Xyl residue 
in the tetrasaccaride linker. In addition, it catalyzes the transferring of galactose in a β-1,4-
linkage from uridine diphosphate galactose (UDP-Gal) to N-acetylglucosamine (GlcNAc) 

















B  Long form 
 
C  Short form 
 
Fig. 1.2 Schematic representation of B4galt1 structure. (A) The genomic organization of 
mouse B4galt1 gene including six exons which encode two similar but not identical proteins. (B) 
and (C) show the two forms of proteins with a type II transmembrane topology. Both of them 
have identical transmembrane domain (TM, pink), short stem (yellow) and large carboxy-
terminal catalytic domain (blue) but differ in the short amino-terminal cytoplasmic domain (C, 
light blue) with 13 amino acids difference. Figure was modified from Rodeheffer C.R. and Shur 
B.D.(2002): Targeted mutations in β1,4-galactosyltransferase I reveal its multiple cellular 
functions. Biochimica et Biophysica Acta 1573:258-270.  
 
β4Gal-T1 is also detected on the plasma membrane of a wide variety of cell types, 
including early embryonic cells, spermatogenic cells, neuronal cells, epithelia, and mesenchymal 
cells,  where it may function as cell surface receptors mediating multiple cell-cell and cell-matrix 
interactions (Roseman, 1970; Roth et al., 1971; Shur, 1993). Cell surface β4Gal-T1 mediates 
diverse biological functions by interacting with the multiple ligands, including:  
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(1) Laminin. GalT functions as the cell surface laminin receptor which recognizes specific 
oligosaccharide residues within laminin (Runyan et al., 1986).   
(2) Focal adhesion kinase (FAK). Clustering of cell surface GalT in fibroblasts results in tyrosine 
phosphorylation of FAK and disorganization of actin stress fibers (Wassler and Shur, 2000).  
(3) The presence of terminal GlcNAc glycosides on numerous glycoproteins in the extracellular 
environment and on cell surfaces(Rodeheffer and Shur, 2002).  
(4) E-cadherin. On F9 embryonal cells, surface GalT I interacts with E-cadherin, a 
transmembrane receptor involved in cell-cell adhesion (Shur, 1983).  
(5) EGF receptor. Surface GalT I has been shown to interact with the EGF receptor and affect its 
phosphorylation and activity, directly affect the cell proliferation rate (Hinton et al., 1995). 
(6) Collagen IV. A study identifies GalTase as a calcium-dependent receptor for cell attachment 
to collagen type IV, a molecule commonly found associated with laminin within basement 
membranes. Enzyme perturbation or substrate pregalactosylation on cells possessing calcium-
dependent mechanisms of adhesion can block the cell attachment to collagen IV (Eckstein and 
Shur, 1992). 
 
1.5.6 B4galt1 in development 
β4Gal-T1 localizes in the Golgi complex as galactose transferase and in a variety of body 
fluids as lactose synthetase. In addtition, it is also detected on the plasma membrane and cell 
surface function as receptors in cell-cell and cell-matrix interactions (Hathaway et al., 2003).  
Surface β4Gal-T1 can affect cell proliferation directly (Roth and White, 1972). Cell growth was 
inhibited by exogenous reagents to perturbe the GalTase function (Maillet and Shur, 1994), or by 
addition of UDP-galactose to transformed cells to increase surface galactosylation (Klohs et al., 
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1982). Stably transfected cell lines with reduced surface GalTase grow faster than control cells, 
while those with overexpressed surface GalTase grow slower (Marchase et al., 1988). Moreover, 
the expression of GalTase was cell-cycle specific. GalT I-null animals exibit an increased rate of 
cell proliferation in some epithelial cell types (Asano et al., 1997).  
The surface glycosyltransferase functions as an adhesion molecule by forming a stable 
adhesive bond with its glycoside substrate in the extracellular matrix or on an adjacent cell 
surface. In both Swiss 3T3 fibroblasts and F9 embryonal carcinoma cells, overexpression of the 
truncated long GalTase (TLGT) devoid of the catalytic domain affects the association of 
endogenous cell surface Gal Tase with the cytoskeleton, resulting in failure of intercellular 
adhesion (Evans et al., 1993). Further experiments identified binding sites on cytoskeleton for 
GalTase. 
Both long form and short form of B4galt1 are found in Golgi, but only the long form can 
function as a surface receptor (Hathaway et al., 2003). As a type II transmembrane protein, the 
catalytic region of B4galt1 is exposed on the cell surface and can bind to terminal GlcNAc 
residues which are presented on various extracellular and cell surface glycoproteins and 
glycolipids. The cytoplasmic domain intracellularly would be predicted to interact with specific 
signaling networks if surface catalytic region acts as a signal-transducing receptor. On the other 
hand, sequences of the cytoplasmic domain of long form GalT I was expected to regulate the 
expression of long form at the cell surface.  
Surface GalT I can be detected on various cell types, and if the cellular environment 
change, the expression levels and location change accordingly (Hathaway and Shur, 1992; Scully 
et al., 1987). GalT I might be able to interact with multiple extracellular ligands and have diverse 
biological functions. Its function is specific and regulated by the membrane microenvironment. 
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In addition to the terminal GlcNAc glycosides, GalT I can bind to laminin 1 in the extracellular 
matrix (ECM) to facilitate lamellipodia formation on migratory cells, or to facilitate the sperm-
egg interaction by binding to the glycoprotein ZP3. GalT I can also function in cell-cell 
interaction by binding with other ligands such as E-cadherin, collagen IV, etc.  
Though the relationship of GAGs and neurulation process is reported long ago, a few 
reports can be found for the direct relationship of B4galt1 with neurulation. The distribution of 
cell-surface glycosyltransferase activities implies the possibility that cell-surface 
glycosyltransferase are crucial to the embryonic morphogenesis. If so, perturbation of cell-
surface glycosyltransferase activity may disturb the normal morphogenetic process. In an 
experiment using chick embryos, perturbation of cell-surface transferase activity during 
gastrulation stage would lead to morphogenetic defects such as NTD embryos manifested as 
abnormal embryos lacking of posterior components starting around the level of the hind limbs, or 
twist in the midtrunk level of the spinal column (Shur, 1977).  
Cell surface B4galt1 (GalTase) seems to play a part in neural tube formation. An 
experiment using anti-GalTase Fab to specially recognize chick embryo GalTase and inhibite 
GalTase activity, induced neural tube defects in 61% of treated embryos, exibiting incomplete or 
improper neural tube closure with failure of neural fold elevation and lateral hinge formation 
(Hathaway and Shur, 1992). The possible mechanism for this might be that during the early 
neurulation time, there are a significant portion of the cell surface GalTase which mediate the 
contact of neural crest cells with the basal lamina that shapes the neural tube. Inhibiting of 
GalTase by anti-GalTase Fab perturbed the contaction by disturbing the binding of GalTase in 
the extracellular matrix or on adjacent cells. Since the critical significance of B4galt1 in 
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development, especially its association with neural tube closure, it is necessary to investigate the 
expression and function of B4galt1 in the neural tube formation.   
 
1.6 Scope of Study 
The genetic mechanism for the formation of neural tube along the neuroaxis is still not clear. 
Though more than 200 genes have been found related with closure of the neural tube, most of 
them were investigated by mutation of single or multiple genes, and the experiment conditions 
were varied. A comprehensive profile of the whole picture of the neurulation process was 
lacking. Microarray analyses have been used as a productive tool for capturing expression 
profilings of developmental process, such as preimplantation and gastrulation embryos, even on 
NTD embryos from treated diseased mice (Hamatani et al., 2004b; Hue et al., 2007; Jiang et al., 
2008), and have made contributions to the knowledge of mouse embryo development, but no 
such work has been done on neurulation stage embryos.  
The mechanism of neurulation is different at cranial and spinal region. Investigating gene 
expression profiling using roughly the whole embryo could not reflect the specific genetic 
mechanism of neurulation due to tissue heterogeneity. More accurate tissue acquirement method 
such as laser capture microdissection (LCM) is needed.     
Currently, the role of glycosaminoglycan (GAG) genes in development has been recognized. 
A few studies also dipped into the expression and function of GAG genes in the nervous system 
development. But none of these studies have investigated the expression and role of GAG genes 
in the specific neurulation process.   
The main objective of this study was to investigate the genetic mechanism of the spinal 
neurulation. The specific objectives of this study were to: 
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1) Generate specific transcriptomic profilings of neurulation in spinal region in mouse embryos 
by combined usage of Affymetrix GeneChips and LCM method, to set up a framework for future 
studies in this area.   
2) Propose possible molecular interactions of different pathways and cascades involved in spinal 
neurulation according to the results of transcriptomic analysis. 
3) Look into spatial and temporal expression of GAG genes in spinal region of mouse 
neurulation embryos. Investigate the knockdown effects of differentially expressed GAG genes 
on neuroepithelial cells by siRNA, and postulate the possible roles of GAG genes in the genetic 
mechanism of neurulation.   
The results of the current study may have significance in providing the framework of 
gene expression on closing neural tube and the methodology of transcriptomic analysis in 
combination with LCM used firstly on neurulation studies. This framework can grant a 
comprehensive understanding of the mammalian spinal neurulation and aid in discovering the 
underlying genetic mechanism by functional studies of specific kinds of genes or cross-talks 
between different pathways. We can intensely explore the expression of GAG genes in the 
framework and study the roles of GAG genes in spinal neurulation.  
It is understood that neurulation is a complex embryogenesis process. Morphological 
studies have found three modes marked transformation of neuroepithelium at three critical stages: 
E8.5, E9.0, and E9.5. MHP appears at E8.5, exists at E9.0, and disappears at E9.5, while DLHPs 
appear at E9.0 and exist through E9.5 till the end of the primary neurulation. Previous studies 
have found that disruption of MHP or DLHPs can lead to neural tube defects, and these defects 
may be due to alterations in biological functions such as proliferation, differentiation, adhesion, 
transcription, cell polarity etc by interrupting different molecule pathways. GAG genes have 
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been found involved in various cellular processes and interaction with multiple pathways during 
embryonic development. Expression of GAG genes along the neuraxis during spinal neurulation 
indicates a critical role in formation of the neural tube, but its potential role is not clear (Copp 
and Bernfield, 1988b; Yip et al., 2002). Any change in GAG associated genes may greatly 
influence the cellular functions and NT formation.  
I selected two kinds of tissues at three critical timepoints according to morphological 
changes during neurulation and investigated. Although the transcriptomic profiling of one tissue 
at one timepoint can only reflect the spatial and temporal gene expression, the comparison 
analysis of gene expression between different timepoints may reflect the gene relationships 



































2 Materials and methods 
2.1  Collection of mouse embryos and preparation of cryosections 
Pregnant Swiss Albino mouse were euthanized by CO2 asphyxiation at E8.5, E9.0, and 
E9.5. Timed matings were made at night, noon on the 8th day of finding a copulation plug is 
designated as embryonic day 8.5; morning on the 9th day is called E9.0; and noon on the 9th day 
is called E9.5. The uterus with mouse embryos inside were dissected out and put inside Petri 
dishes with DMEM containing 10% FBS. Mouse embryos were dissected out from the uterus. 
Their decidua, the amnion, as well as the Reichart’s membrane were carefully dissected away. 
Intact embryos were staged based on the criteria of the Edinubrgh Mouse Atlas Project 
(http://www.emouseatlas.org/emap/home.html) and the work of Kaufman (1992), then were 
selected by global observation and the somite number was counted under the stereo dissection 
microscope.  Preliminary experiment was done to decide on somite number of mouse embryos at 
different stages with the accordingly typical modes on sections according to Shum, A. S. et al 
(Shum and Copp, 1996). Embryos at stage of E8.5 with somite number of 9 to 12, E9.0 with 
somite number of 20 to 23, and E9.5 with somite number of 27 to 30 were choosen for 
embedding or fixed by 100% methanol and saved for further use (Copp et al., 1982).  
To protect RNA quality and quantity, several methods were adopted: snap-frozen mouse 
embryos, RNA-later-ICE incubated cryosections, and optimized quick staining methods. Briefly, 
mouse embryos were embedded in cryomold with OCT™ (Tissue Tek™) and snap-frozen by 
liquid nitrogen immediately after microdissection and saved in -80°C till cryosection.  
Cryosections were cut through posterior neuropore (PNP) region at 8-µm at container 
temperature (CT) -20°C, object temperature (OT) -15°C using a cryostat, attached to RNase free 
glass slides (treated by RNase Zap). Each section was immersed in prechilled RNA-later®-ICE 
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for 15 mins in a RNase-AWAY treated humid chamber (Sigma, Cat H6644) in -20°C before 
saved in -80°C for LCM microdissection.  
Immediately before microdissection, the staining and dehydration solutions such as 
haematoxylin, ethanol and xylene were prepared freshly for use, and the slides were brought to 
equilibrium at room temperature (RT) for 5 mins after being taken out from -80 °C. It is 
necessary to fix the sections in 70% ethanol for 1 min before performing quick staining. Then 
wash out the OCT in distilled water, apply 100 µL of haematoxylin (Merck, Darmstadt, 
Germany) to cover all the sections on one slide for 10 secs, and wash away additional 
haematoxylin under running tap water for 10 secs. Transfer the slides to distilled water (II) for 10 
secs, and then perform dehydration in serial ethanol of 75%, 95%, and 100% for 5 secs each. The 
sections were cleared by xylene twice, drying in the slide box for 5 mins and proceeded for LCM. 
 
2.2  Laser capture microdissection  
Before performing LCM on the dried sections, pipette 50 μL of RNA Extraction Buffer 
(XB) in 0.5 mL tube and prewarmed at 42°C before use for containing the LCM samples. The 
Arcturus microdissction program (version 2.0) was used for the Arcturus Pixcell™ laser capture 
microdissection system (Arcturus, Mountain View, CA). The microdissection parameters were 
set as laser power at 70 mW and duration at 2.0 ms. Neuroepithelium and the surrouding 
mesenchyme with similar size were dissected separately under direct visualization under the 
microscope (Arcturus Pixcell™). The microdissected tissues were attached to the CapSure™ 
Macro LCM Caps (Arcturus Engineering). The LCM samples were collected in Extraction 
Buffer (XB) by the aid of the CapSure Cap–microcentrifuge tube assembly. Then the LCM 
samples can be proceeded to extract RNA or saved at –80°C. 
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2.3  Isolation of RNA from Laser-Captured Tissue cells 
Total RNA from microdissected cell populations was extracted using a PicoPure™ RNA 
Isolation Kit (Arcturus, KIT0204) according to the manufacturer’s protocols. All the principal 
reagents were provided by the kit. DNase I (Qiagen, Cat 79254) treatment was applied to avoid 
genomic DNA contamination. Briefly, conditional buffer (CB) was added to wet the filter 
membrane of the purification column. 70% ethanol was mixed with the cell extract and added 
into the preconditioned purification column. The column was then centrifuged and the flow-
through was throwed away. Wash buffer (W1) was added to wash the filter membrane, followed 
by DNase I incubation to remove the genomic DNA contamination. The purification column was 
then washed by W1 again and wash Buffer 2 (W2) twice, then centrifuged to remove any 
residual reagents. The cleaned purification column was transferred onto a microcentrifuge tube 
and RNA bound onto the membrane was washed down by elution buffer (EB). RNA was 
aliquoted and saved in -80°C for testing and future work. 
 
2.4  RNA quality and quantity assessment 
RNA quantity was assessed by NanoDrop spectrophotometer ND-1000 (NanoDrop 
technologies, Wilmington, DE, USA). RNA quality was tested by Agilent 2100 Bioanalyzer 
(Agilent Technologies, CA, USA) according to the manufacturer’s instructions.  
NanoDrop software provided analysis options for total RNA by measuring full-spectrum 
(220-750nm) UV-Vis absorbance. It was performed by just applying one micro liter of total 
RNA samples onto the testing table, selecting the option of RNA and clicking the testing button. 
The RNA quality was represented by ratio of 260/280 UV absorbance and quantity was 
presented as ng/µl.  
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To test RNA by Agilent 2100 Bioanalyser, the RNA 6000 Pico kit (Agilent Technologies, 
CA, USA) provided all the reagents needed and the 2100 expert software was used. All the 
procedures were performed according to the manufacturer’s instructions. 
Firstly, the Bioanalyser system was prepared by setting up the chip priming station, the 
Bioanalyser machine, and the vortex mixer. The electrodes were cleaned by the electrode cleaner 
before use. The second step was to prepare the gel. All reagents were equilibrated to room 
temperature for 30 mins before use. 550 µl of RNA 6000 Pico gel matrix (red labelled) was 
pipetted into the top container of a spin filter and the spin filter was spinned at 4000 rpm for 10 
mins. The filtered gel was aliquoted into 65 µl per tube and store at 4°C before use. The next step 
was to prepare the gel-dye mix. RNA 6000 pico dye concentrate (blue cap) was vortexed for 10 
secs and spined down. 1 µl of dye concentrate was added to a tube of 65 µl filtered gel and the 
gel and dye were mixed well by vortex thoroughly and centrifuge. The gel-dye mix should be 
protected from light and used within one day. The RNA samples were heat-denatured  at 70 °C 
for 2 mins.  
A new RNA pico chip was placed on the adjusted chip priming station, 9.0µl of the gel-
dye mix was pipetted and dispensed into the bottom of the well marked “G” for 30 secs. Close 
the chip priming station when the plunger was positioned at 1 ml. The plunger of the syringe was 
pressed down to be held by the clip for 30 secs and was released when the plunger was moving 
back to the 0.3 ml mark, held for 5 secs, then was slowly pulled back to the 1ml position. 9.0 µl 
of the gel-dye mix, 9.0 µl of the RNA 6000 Pico conditioning solution (white cap), 5.0 µl of the 
RNA 6000 Pico marker (green cap), 1 µl of the diluted Pico ladder, and 1 µl of each sample were 
pipetted into specific wells according to the manuals. The prepared chip with samples was 
vortexd by the IKA vortex mixer at 2400 rpm for 60 secs.  
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Finally, the vortexed chip was inserted in the holder of the Bioanalyser. The “Eukaryotic 
Total RNA Pico Series II” was selected for the assay by the 2100 expert software. RNA Integrity 
Number (RIN) (Schroeder et al., 2006) was calculated by Agilent 2100 expert software. A RIN 
of 7-10 is indicative of high RNA quality and used for microarray work, whereas a RIN of 1 
grade a completely degraded RNA sample (Fleige and Pfaffl, 2006). 
 
2.5  Transcriptomic analysis using Affymetrix GeneChipTM Microarray 
The 18 independent LCM RNA samples, triplicates for three stages (E8.5, E9.0, and E9.5) 
of two kinds of tissues (NT and MD), were prepared for hybridization on the microarray chips 
using the Two-Cycle target labelling and control reagents (Affymetrix, P/N 900494) in 
combination with the MEGAscript® high yield transcription kit (Ambion Inc, P/N 1334) for 
amplification and labelling. The labelled Bio-cRNA was fragmented and hybridized on the 
Affymetrix Mouse 430 2.0 Genechips. The Affymetrix GeneChip microarray system was used 
for probe array wash, stain, and scan. All procedures were performed according to the 
manufacturer’s instructions (Affymetrix, Santa Clara, CA). The volumes were described for one 
reaction use, but all of the 18 samples were prepared at the same time to decrease discrepancy 
from different patches.  
 
2.5.1  Preparation of T7-Oligo (dT) Primer/Poly-A RNA controls  
The supplied Poly-A RNA controls act as positive controls to examine the whole target 
labelling process and the quality of the target RNA materials. Firstly, poly-A RNA serial 
dilu tions for 15  ng  of to tal RNA were prepared . 2  μl of the poly-A control stock and  38  μl of 
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poly-A control buffer were mixed for the first dilution. 2 μl of the first dilution and 98 μl of poly-
A control dil buffer were mixed for the second dilution. 2 μl of the second dilution and 98 μl of 
poly-A control buffer were mixed for the third dilution. To prepare the fourth dilution, as 15 ng 
RNA is the intermediate starting amounts, calculating the ratio proportionally to the same final 
concentration of the spike-in controls in the sample was needed. For 15ng starting RNA, the ratio 
is 1:6.67, so 2 μl of the third dilution and 11.33 μl of poly-A control dil buffer were mixed for 
the fourth dilution. Finally, 2 μl of the fourth dilution of Poly-A RNA controls, 2 μl of 50 μM 
T7-Oligo (dT) Primer, and 16 μl RNase-free water were mixed together. This 20 T7-Oligo (dT) 
Primer/Poly-A RNA controls mix was used for one reaction for preparation of the First-Cycle, 
First-Strand cDNA.  
 
2.5.2  Synthesis of the First-Cycle, First-Strand cDNA 
15 ng  to tal RNA, 2  μl of the T7-Oligo (dT) Primer/Poly-A RNA controls mix, RNase-
free water were mixed to the volume of 5 μl and incubated at 70°C for 6 mins and cooled on ice. 
In a separate tube, for a single reaction, 2 μl of 5 x first strand reaction mix, 1μl of 0.1M DTT, 
0 .5  μl of RNase in h ibitor, 0.5  μl of 1 0 mM d NTP and  1 μl of Su p erSrip t II were mix ed  for 
preparation of the First-Cycle, First-Strand Master mix. 
The 5  μl of First-Cycle, First-Strand Master mix was combined with each total RNA 
sample/ T7-Oligo (dT) Primer/Poly-A RNA controls mix from the previous step to a final 
volume of 10 μl and incubated at 42°C for 1 hour. The sample was heated at 70°C for 10 mins to 





2.5.3  Synthesis of the First-Cycle, Second-Strand cDNA  
To prepare the first-cycle, second strand master mix, the following reagents were added 
for one reaction use: 4.8 μl of RNase-free water, 4.0 μl of freshly diluted 17.5 mM MgCl2, 0.4 μl 
of 10mM dNTPs, 0.6μl of E.coli DNA polymerase I, 0.2 μl of RNase H to a final volume of 10 
μl. 10  μl of the first-cycle, second strand master mix was pipetted to each sample of the First-
Cycle, First-Strand cDNA Synthesis reaction to a total volume of 20 μl and incubated at 16°C for 
2 hours and at 75°C  for 10mins, then cool on ice. 
 
2.5.4  IVT Amplification of cRNA after First-Cycle cDNA synthesis 
30 μl of the first-cycle, IVT master mix were prepared for one reaction use by mixing of 
5 μl of 10 x reaction buffer, 5 μl of ATP solution, 5 μl of CTP solution, 5 μl of UTP solution, 5 
μl of GTP solution, 5 μl of enzyme. The above prepared 30 μl of the first-cycle, IVT master mix 
was added to each 20 μl of cDNA sample from the first round synthesis to a final volume of 50 
μl and incubated at 37°C for 16 hours.  
 
2.5.5  Cleanup of cRNA after First-Cycle Synthesis and IVT 
The cRNA synthesized by the first cycle amplification and IVT was cleaned by vortexing in 50 
μl of RNase-free water and then 350 μl of IVT cRNA binding buffer.  The bound cRNA lysine 
was washed by 250 μl 100% ethanol, 500 μl of IVT cRNA wash buffer, and 500μl of 80% 
ethanol on the IVT cRNA cleanu p  spin  column. The cleaned  cRNA were dilu ted  b y 1 3  μl of 
RNase-free water. 1 μl of the cRNA was aliq u ot for assessin g  cRNA yield by Nanodrop. The 




2.5.6  Synthesis of the Second-Cycle, First-Strand cDNA  
Random primer was diluted in RNase-free water to a final concentration of 0.2 μg/μL. 2 
μl of the diluted random primers was added to the purified cRNA from the last step, RNase-free 
water was added to a final volume of 11 μl and incubated at 70 °C for10 mins. The second-cycle, 
first-strand master mix was prepared by adding the following reagents for a single reaction: 4 μl 
of 5 x 1st strand reaction mix, 2 μl of 0.1 M DTT, 1 μl of RNase inhibitor, 1 μl of 10 mM dNTP 
and 1 μl of SuperSript II. The 9 μl of the second-cycle, first-strand master mix was ransferred to 
each cRNA/random primer sample to a final volumn of 20 μl and incubated at 42°C for 1 hour. 1 
μl of RNase H was pipetted to each sample to a final volume of 21 μl and incubated at 37°C for 
20 mins. The RNase H was deactivated by heating up the sample at 95°C for 5 mins.  
 
2.5.7  Synthesis of the Second-Cycle, Second-Strand cDNA  
4 μl of dilu ted  T7-Oligo (dT) primer (5μM) was added to the sample from the second-
cycle, first-strand cDNA synthesis step for a final volume of 25 μl and incubated at 70°C for 6 
mins. The second-cycle, second-strand master mix was prepared by mixing the following 
reagents for one reaction use: 88 μl of RNase-free water, 30 μl of of 5 x 2nd strand reaction mix, 
3 μl of 10mM dNTPs, 4 μl of E.coli DNA polymerase I to a final volume of 125 μl.  The mixture 
was incubated  at 16°C for 2 hours. 2 μl of T4 DNA polymerase was added into the incubated 
mixture and incubated for another 10 mins at 16°C. 
 
2.5.8  Double-Stranded cDNA Cleanup 
600 μl of cDNA binding buffer were added to the synthesized double-stranded cDNA by 
brief vortexing. The mixture was centrifuged in the cDNA cleanup spin column sitting in a 2 mL 
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collection tu be. The b ind ed  cDNA was washed  b y 7 5 0  μl of the cDNA wash buffer by 
centrifugation. The cleaned cDNA was diluted with 14 μl of cDNA elution buffer and around 12 
μl would be eluted for the next step.  
 
2.5.9  Biotin-Labeled cRNA synthesis  
The IVT reaction mix was prepared by adding the following reaction components in a 
RNase-free microfuge tube: 8 μl of RNase-free water, 4 μl of 10 x IVT labelling buffer, 12 μl of 
IVT labelling NTP mix, 4 μl of IVT labelling enzyme mix to generate Biotin-labled cRNA. The 
mixture was transferred into the cDNA template and incubated at 37 °C for 16 hours. 
 
2.5.10  Biotin-Labeled cRNA Cleanup and Quantification 
The 40 μl of Biotin-labled cRNA was diluted by brief vortexing in 60 μl of RNase-free 
water. 350 μl of IVT cRNA binding buffer was added to the mixture and vortex for 3 secs. The 
cRNA was mixed with 250 μl of 100% ethanol and the total of 700 μl mixture was added to the 
IVT cRNA cleanup spin column sitting in a 2 mL collection tube for binding by centrifugation at 
13000 rpm for 15 secs. The binded cRNA was washed by 500 μl of IVT cRNA wash buffer and 
500 μl 80% ethanol and diluted into 21 μl of RNase-free water. Measure the cRNA quality and 
quantity by Nanodrop. The remaining cleaned Biotin-labled cRNA was ready for fragmentation. 
 
2.5.11  Fragmentation of cRNA 
The sample fragmentation reaction mix was prepared by adding 20 μg (1 to 21 μl) of 
cRNA, 8  μl of 5  x fragmentation buffer, and  RNase-free water to  a final volume of 40  μl and 
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incubated at 94°C for 35 mins and cool on ice. 1 μl of the fragmented cRNA was aliquoted for 
analysis on the Bioanalyzer. The remaining fragmented cRNA was saved at -20°C for 
hybridization. 
2.6  Target Hybridization, washing, staining, and scanning of genechips 
Related reagents were prepared for hybridization, washing, staining, and scanning use. 
1. 12 x MES stock buffer 100 mL was prepared by adding the following into a bottle: 
6.461 g of MES hydrate, 19.33 g of MES sodium salt, 800 mL of molecular biology grate water, 
mix and adjust volume to 100 mL by DEPC-water, the pH value was adjusted at between 6.5 and 
6.7, then filter through a 0.2 μm filter.  The buffer was stored at 2°C to 8°C, and shield from light 
by aluminized paper. 
2. 2 x hybridization buffer 50 mL was prepared by adding the following into a bottle: 8.3 
mL of 12 x MES stock buffer, 17.7 mL of 5 M NaCl, 4.0 mL of 0.5 M EDTA, 0.1 mL of 10% 
Tween-20, and 19.9 mL water, store at 2°C to 8°C, and shield from light by aluminized paper. 
3. Non-stringent wash buffer A of 1000 mL was prepared by adding the following into a 
bottle: 300 mL of 20 x SSPE, 1.0 mL of 10% Tween-20, 699 mL water, filter through a 0.2 μm 
filter. 
4. The stringent wash buffer B of 1000 mL was prepared by adding the following into a 
bottle: 83.3 mL of 12 x MES stock buffer, 5.2 mL of 5 M NaCl, 1.0 mL of 10% Tween-20, and 
910.5 mL water, store at 2°C to 8°C, and shield from light by aluminized paper. 
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5. 2 x stain buffer of 50 mL was prepared by adding the following into a bottle: 8.34 mL 
of 12 x MES stock buffer, 18.5 mL of 5M NaCl, 0.5 mL of 10% Tween-20, and 22.66 mL water, 
filter through a 0.2 μm filter, store at 2°C to 8°C, and shield from light by aluminized paper. 
2.6.1  Target Hybridization  
Firstly, probe array was equilibrated to room temperature for 30 mins before use. 
Hybridization cocktail was prepared by adding the following reagents as for one standard array 
u se: 1 5  μg of fragmented  cRNA, 5 μl of 3 nM control olig onucleotid e B2 , 1 5 μl of 2 0  x 
Eukaryotic hybridization controls (bioB, bioC, bioD, cre), 3 μl of 10 mg/mL herring sperm DNA, 
3 μl of 50 mg/mL BSA, 150 μl of 2 x hybridization buffer, 30 μl of DMSO, and water to final 
volume of 300 μl. The hybridization cocktail was heated in a heat block at 99 °C for 5 mins, then 
to a 45 °C heat block for 5 mins. In the intervening time, the chips were wetted by putting two 
microtips in the septa at the back of the chip, one for allowing venting of air from the 
hybridization chamber, and another for wetting the array by filling in 80 μl 1 x hybridization 
buffer through the septa. The probe arrays filled with 1 x hybridization buffer were incubated at 
45 °C for 10 mins with rotation at 60 rpm. The hybridization cocktail was centrifuged from step 
3 at 13000 rpm for 5 mins to remove any insoluble material. The buffer solution was taken out 
from the probe array cartridge and 200 μl of the clarified hybridization cocktail was loaded into 
each array. The probe array was incubated with hybridization cocktail in the Hybridization oven 






2.6.2   Wash and Stain of Probe Array after Hybridization 
At the latter part of the 16-hour hybridization, the fluidics station and reagents required 
for probe array wash and stain were prepared ready for use. In this experiment, fluidics station 
450/250 and program of GeneChip® Operating Software (GCOS) were used for probe array 
wash, stain, and scan. 
Briefly, the fluidics station was primed before washing. The SAPE solution mix was 
prepared by adding the following reagents in a tube: 600 μl of 2 x stain buffer, 48 μl of 50 mg/ml 
BSA, 12 μl of 1 mg/ml streptavidin phycoerythrin (SAPE), 540 μl of DI H2O to a final volume 
of 1200 μl. Mix well and aliquote 600 μl to an extro microtube. The antibody solution mix was 
prepared by adding the following reagents in a tube: 300 μl of 2 x stain buffer, 24 μl of 50 mg/ml 
BSA, 6 μl of 10 mg/ml goat IgG stock, 3.6 μl of 0.5 mg/ml biotinylated antibody, 266.4 μl of DI 
H2O to  a fin al volume of 6 0 0  μl. The correct exp eriment name and  ap p rop riate antibody 
amplification protocol was selected and run in the fluidics station dialog box. The probe array 
was inserted into the selected module of the fluidics station. The cartridge lever was set in the 
down position. The three experiment sample vials were placed into the sample holders 1, 2, 3 on 
the fluidics station in the order of vial 1-SAPE 1- sample holder 1, vial 2-antibody- sample 
holder 2, vial 3-SAPE 2- sample holder 3, the needle lever was pressed down to snap the needles 
into respective vials and to start the run. At the end of the run, the three experiment sample vials 
was removed and replaced with empty vials. The cartridge lever was pressed down to the eject 
position and remove the probe arrays from the fluidics station modules. The stained probe array 
was proceeded to scan on the GeneChip® Scanner 3000. The cartridge lever was pulled up to 




2.6.3   Probe Array scan 
The probe array was scanned using the Affymetrix GeneArray® scanner 3000 after the 
wash protocols were completed. The glass surface of the probe array was cleaned and both of the 
two septa on the back of the probe array cartridge were sealed with Tough-Spots prior to 
scanning to prevent leaking of fluids. The probe array cartridge was inserted into the scanner and 
the autofocus was tested to make sure that the Tough-Spots did not interfere with the focus. The 
experiment name of the probe array to be scanned was selected, the corresponding array was 
loaded into the scanner, and the scanning process was started by clicking the Start button. The 
images were quantified using Affymetrix GeneChip Operating Software (GCOS) and saved as an 
image file (.dat). The .cel image file was automatically generated from the .dat file, and a .chp 
file was created from a .cel image file. An expression analysis report file (.rpt) was generated for 
reviewing the quality control parameters. 
 
2.7  Gene expression data analysis 
2.7.1   Quality assessment of a .dat/.cel image data  
Quality assessment of the image data was performed by the GCOS software. The average 
signal intensity of the array was set to a default target signal of 500. The expression signal of a 
probe set above 500 is designated as present and below 500 is designated as absent. The 
boundaries of the probe area were defined by hybridization of B2 oligo which serves as a 
positive hybridization control and was used by the software to place a grid over the image. The 
grid should align well before assessing the image. The pixel-to-pixel variation of probe cells on a 
GeneChip array was measured by the average background and Noise (Raw Q). Poly-A controls 
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of dap, lys, phe, and thr were present in all the samples with increasing values which indicate 
proper of the entire target labeling process. The hybridization controls of bioB, bioC, bioD, and 
cre were used to evaluate sample hybridization efficiency, assess RNA sample quality and adjust 
signal values among replicates.  β-actin and GAPDH were used to assess RNA samples and 
assay quality. The ratio of 3’/5’ probe set was assessed for amplification efficiency. The percent 
present of probe set of all samples and differences among triplicates were assessed.  
2.7.2  Statistical algorithms for expression analysis of GeneChip probe arrays 
The .cel file of each array was analyzed by GCOS. The detection algorithm in GCOS uses probe 
pair intensities to generate a Detection p-value. It measures the target-specific intensity 
difference of the probe pair (perfect intensity (PP)-mismatch intensity (MM)) compared to its 
overall hybridization intensity (PM +MM) and assign a Detection call of Present (P), Marginal 
(M) or Absent (A). The p-value is reversely related with the Present of a given transcript. The 
smaller the p-value and the more likely the given transcript is truly present in the sample. Signal 
for each probe set was calculated using the One-Step Tukey’s Biweight Estimate to signify the 
relative level of transcript expression. The real signal was estimated by taking the log of Perfect 
Match intensity after subtracting the Mismatch intensity.  
In a comparison analysis, a Change p-value and Signal log Ratio was generated using the 
Wilcoxon’s Signal Rank test to quantify changes in gene expression. Change p-values close to 
0.0, 1.0 or 0.5 indicate increase, decrease or no change in transcript expression in the experiment 
array compared to the baseline. The Signal Log Ratio helps to cancel out differences in 
individual probe intensities due to different probe binding coefficients. The log scale used is base 
2, thus, a Signal Log Ratio of 1.0, -1.0, and 0 indicates an increase or decrease of the transcript 
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expression by 2 fold or no change. Selecting transcripts with a fold change of > 2 for increase or 
< -2 for decrease can help to get consistent verification biological results.    
2.7.3  Comparison analysis by GeneChip Operating Software (GCOS)  
Affymetrix provides software tools for data storage and analysis. GCOS was one of the 
integrated software packages for generating profiles of gene expression and comparison. Data 
were transferred into GCOS program and stored in local workstation. GCOS manager was used 
to create publish databases, in addition, to import and export data for analysis. Single array 
analysis was performed by analyzing the image data and generated the analysis results file (.chp) 
and the expression analysis report file (.rpt). The quality control parameters in the .chp files were 
reviewed for control gene presentations, percent present scaling, housekeeping control gene 
signal output and 3’/5’ ratios, average background and noise (Raw Q).   
Normalization was not necessary when performing signal array analysis but was required 
when comparison was performed between different arrays. Stage of E8.5 was set as baseline 
when compared with E9.0 or E9.5, and E9.0 was set as baseline when compared with E9.5. Data 
were compared with the statistical algorithm of change and change P-value. Probe sets of 
changed p-value of less than 0.05 and had 66% or more change on experiment versus baseline 
arrays were queried out and displayed as pivot table.  The pivot table was used to display 
analysis output and descriptions for transcripts represented on the probe array. Data was sorted 
by Signal Log Ratio (fold change).   
 
2.7.4  DNA-Chip Analyser (dChip) 
dChip gene information file MOE 430 2.0, Gene Ontology file which include function, 
ontology and process.ontology, were downloaded from website (www.dchip.org). Affymetrix 
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array data files (in CEL or DAT format), and the CDF files were provided by GCOS. Affy CEl 
file converting tool which converted the version 4 CEL file to the text-format version 3 CEL file 
so that dChip can read.  
Normalization was done to adjust the brightness of the arrays to comparable level by 
normalizing arrays at PM and MM probe level before computing model-based expression levels. 
Next, an array with median overall intensity was chosen by default as the baseline array, and  
other arrays were normalized at probe intensity against it. The model-based expression method 
was performed to have a globel view of mismatch probe (PM/MM difference) and confirm the 
expression changes reported by sample comparison or clustering. Model-based expression 
indexes (MBEI) indicated the signals that were not specific and may not biologically meaningful. 
The outlier detection method was used to identify single, array, and probe outliers. The base of 
log transformation was set to 2 for convenient interpretation. Filter genes criteria were set as: (1) 
the ratio of the standard deviation and the mean, also known as Coefficient of Variation (CV), 
was less than 10.  (2) P call% in the array was more than 20%. (3) transcripts whose expression 
values were larger than a threshold presented in more than 50% samples. The filtered transcripts 
that met the above criteria were used for comparison analysis and hierarchical clustering. 
When comparing samples, earlier stage samples were selected as baseline (B) and later 
stage samples were selected as experiment (E). For example, E8.5 was “B” and E9.0 was “E” 
when compare E8.5 with E9.0, while E9.0 was “B” and E9.5 was “E” when compare E9.0 with 
E9.5. The filtering criteria for comparing samples were: (1) fold change between E and B were 
more than 1 or less than 1 (E - B > 1 or E - B < 1). Confidence interval of fold change is within 
95%. (2) threshold for absolute fold change difference (E/B or B/E) more than 1 or less than 1, 
and  absolute mean difference (E - B or B - E) more than 1 or less than 1 (log fold change). (3) 
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The default p-value threshold was less than 0.05. (4) Percentage of genes called “Present” was 
more than 0 in B while more than “66%” in E, and vice versa. (5) p-value less than 0.05 for the 
paired t-test. (6) False discovery rate (FDR) was assessed for 100 times. Genes that passed these 
filter criteria were exported in an output compare result file for further analysis.  
 
2.7.5  GeneSpring GX 9 
Preliminary analysis of the scanned chips was performed using Affymetrix GeneChip® 
Operating Software as described above. The CEL. Files (raw Affymetrix data) to show 
normalized signal intensity values generated with the Affymetrix GCOS software were imported 
into GeneSpring GX 9 (Agilent Technologies Inc., Santa Clara, CA, USA) for further data 
analysis. Quality control on samples was performed by assessing internal hybridization control 
(BioB, BioC, BioD and Cre) plots, the 3’/5’ ratio of GAPDH, sample correlation matrix, and 
Principle Components Analysis (PCA). PCA is a valuable visualization tool to compare the 
expression profile of samples.  Samples representing the same experimental condition should be 
more similar and group closer in a PCA plot. Additionally, the probe sets were processed with 
the robust multi-array average algorithm (RMA, GeneSpring) to adjust background, normalize 
genes to the median, and perform log-transformation for the perfect matched values. The 
normalized data were then subjected to identify differentially expressed genes by five algorithms: 
RMA, GC-RMA, GS-GCOS, GS-dChip, PLIER. Probe sets were filtered to remove the low-
intensity unreliable expression measurements. Present (P) call was at least 50% present in all 
arrays of the selected group. Probe sets lists past the filter criteria were further analyzed by One-
Way ANOVA. Only genes with fold change more than 2 between at least two groups and P < 
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0.05 were defined as significant differentially expressed genes. These genes were used for 
further analysis.    
2.8  Acquirement of MHP- and DLHP- related genes by intersection 
The probe set lists of differentially expressed genes compared between different 
biological stages with fold change more than 2 analyzed by the software GCOS, dChip, and 
GeneSpring (5 algorithms: RMA, GC-RMA, GS-GCOS, GS-dChip, PLIER) were exported in 
excel files: E85vsE90, E85vsE95, E90vsE95, E85+E90vsE95, and E85vsE90+E95. The 
principle of this comparison is to take the data of early-stage chips as Basement group (B), while 
the data on late-stage chips were taken as Experiment group (E). A gene with fold change (FC) 
higher than 2 means expression (Absolute intensity, AI) of this gene at the experiment group is 
2-fold higher than its expression (AI) at the basement group. Overlapping genes generated with 
the 3 software in each group were combined by intersection of 7 data sets. This combination 
intended to reduce the number of targeted genes. Overlapping genes among the three gene 
groups of E85vsE95, E90vsE95, and E85+E90vsE95 were combined by intersection and taken as 
MHP- related genes. These genes were differentially expressed at E8.5 and E9.0 (when MHP 
presents) and genes at E9.5 (when MHP disappeared). A gene with FC more than 2 in the MHP-
related gene lists means its expression (AI) at E9.5 is 2-fold higher than its expression (AI) at 
E8.5 and/or E9.0, and is defined as MHP-up-regulated genes. Similarly, a MHP-down-regulated 
gene is the expression (AI) of this gene at E9.5 is 2-fold lower than its expression (AI) at E8.5 
and/or E9.0. Logically, overlapping genes among the three gene groups of E85vsE95, E85vsE90, 
and E85vsE90+E95 were combined by intersection as DLHP- related genes. These genes were 
differentially expressed at E8.5 (when DLHPs do not exist) and genes at E9.0 and E9.5 (when 
DLHPs develop and retain). A DLHP-up-regulated gene is defined as a gene with FC more than 
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2 in the DLHP-related gene lists, which means its expression (AI) at E9.5 is 2-fold higher than 
its expression (AI) at E8.5 and/or E9.0. In the same way, a DLHP-down-regulated gene is 
defined as a gene with FC less than 2 in the DLHP-related gene lists. The expression (AI) of this 
gene at E9.5 is 2-fold lower than its expression (AI) at E8.5 and/or E9.0. 
 
2.9 Verification of microarray results by One-step Quantitative Real time polymerase chain 
reaction (qRT-PCR) 
Differentially expressed genes analyzed by microarray analysis were randomly selected 
from the MHP- and DLHP- related gene lists. Expression pattern of these genes were verified by 
LightCycler® 2.0 System (Roche Applied Science, ID, USA) and compared with microarray to 
validate the microarray quality.  
Primers for these chosen genes were designed by a free online primer design tool Primer 
3.0 software (http://www.genome.wi.mit.edu ) (Rozen and Skaletsky, 2000) according to primer 
design principles (Kampke et al., 2001) (Table 2.1). Then the designed primers were checked by 
the Basic Local Alignment Search Tool (BLAST) (http://www.ncbi.nlm.nih.gov/blast) to make 
sure their specificity (Altschul et al., 1990). Then the primers were synthesized by First-base 
technologies and used for RT-PCR. The RT-PCR results were analyzed by recording the 
threshold cycle (Ct) of each reaction which was the cycle number at which the reporter 
fluorescence generated passed by a fixed base line. Ct value of 30 or less was selected as 




Table 2.1   Primers for genes selected for validation by real-time PCR 
Gene Forward Reverse Product size(bp) 
Ckb aagttctcggaggtgctcaa agtttcactccgtccaccac 158 
Col3a1 cacgcaaggcaatgagacta tggggtttcagagagtttgg 125 
Sall4 agtgatgtggcttgtgacca aacccgcttctttccaaaat 186 
Rhobtb3 tcagccaaaagcctgaattt tatgcaaacgctcaggtcac 165 
Lyrm4 gaaattcaagccctggtgaa tgtcctgggcttctcttgat 123 
Ammecr1 tccttggacacactttgtgg tctctctctcgctcgctctc 143 
Fgf9 gtgcgagtgcatgagtgagt ttgaagtatggcagctgtgc 139 
Socs2 gggactgcctttaccaacaa cacatagctgcattcggaga 145 
Cyp26a1 ttcgggttgctctgaagact tcctccaaatggaatgaagc 191 
Arg1 tcacctgagctttgatgtcg cacctcctctgctgtcttcc 187 
Fabp7 ccagctgggagaagagtttg tttctttgccatcccacttc 113 
Hoxd13 gaaaagggtgccttacacca tgtccttcacccttcgattc 161 
Oxct1 tcattttggaggaagccatc ggtagttcctgcagctttgc 134 
Sh3gl3 cacctgagaaagctggaagg aatgccgcctctacaaacac 200 
Prtg ggaattccctcacccaaaat tcgtcttccgggataatctg 116 
Nr6a1 ctgtttccgtcccagatgat tgttgcaaatgctcctcttg 132 
Phlda2 tcagcgctctgagtctgaaa cagcaagcacgggaatatct 188 
Hoxc10 cgcctggagattagcaagac gatccgattctctcggttca 105 
Lpl gggctctgcctgagttgtag ccatcctcagtcccagaaaa 167 
Trps1 aatgccaccagtgttccttc gttggcctcctgtttgacat 104 
Idh1 aggttctgtggtggagatgc gacgcccacgttgtatttct 193 
Pcolce cgctctgaccctaagacagg tgaccgcttgtactgctttg 159 
Hoxa10 cgcctagagatcagccgtag gattcggttttctcggttca 105 
Ttr ccttcgactcttcctcctttg gacagcatccaggactttgac 112 
 
The QuantiTect® SYBR® Green one-step RT-PCR kit (Qiagen, Cat 204243) was used 
and all the reagents were provided by the kit and the procedure was following the manufacturer’s 
protocol. The SYBR Green RT-PCR master mix was prepared while keeping LightCycler® 
capillaries (20 µl) (Roche, Cat 11909339) cooled in LightCycler® centrifuge adapter (Roche, 
Cat 1909312). The following reagents were added in a tube, with the amount was for one 
reaction use: 10 µl of 2 x QuantiTect SYBR Green RT-PCR Master Mix, 0.5 µl of 10 µM left 
primer and right primer, 0.2 µl of QuantiTect RT Mix, and appropriate RNase-free water, mixed 
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thoroughly and dispensed into PCR capillaries. 10 ng of template RNA was added into each 
individual PCR capillary, and mixed thoroughly for 10 mins in the cooled centrifuge adapter. 
The PCR capillaries were put in the LightCycler and the program was started according to 
standard program as: 50°C 20 mins for reverse transcription, 95°C for 15 mins for initiation, 
followed by 40 cycles of amplification with the cycle parameters were: denaturation at 94°C for 
15 secs, annealing at 60°C for 25 secs, and extension at 72°C for 20 secs.  
2.10   Hierarchical clustering of the MHP- and DLHP- related genes by dChip 
Hierarchical clustering was used to check the data quality of MHP- and DLHP- genes to 
see if replicate samples or samples at the same stage and of the same tissue are clustered together. 
The clustering algorithm of genes was used as follows: the distance between two genes is 
defined as 1 - r where r is the Pearson correlation coefficient between the standardized intensity 
values of the two genes across the samples used. Two genes with the closest distance are first 
merged into a super-gene and connected by branches with length representing their distance, and 
are then excluded for subsequent merging events. Then the next pair of genes with the smallest 
distance is chosen to merge and the process is repeated to merge all the genes.  
2.11 To estimate the biological functions of the MHP- and DLHP- genes by Gene Ontology 
(GO) analysis and pathway studies 
The MHP- and DLHP- genes were subjected to a functional annotation tool of Gene 
Ontology (GO) from the database for annotation, visualization and integrated discovery (DAVID) 
website. GO ontology terms were analyzed to identify enriched biological processes, molecular 
functions, and cellular components within each group. The probe sets found in each GO category 
with a significant enrichment (a P-value cutoff of 0.01 to be used as significant) to be 
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differentially expressed between different stages will be saved as a list under the name of the GO 
term. 
2.12  Culture of the Neuroectodermal Cells  
The Neuroectodermal (NE4C) cell line was obtained from American Tissue Culture 
Collection (ATCC, Manassas, VA, USA). It was derived from the cerebral vesicles of 9-day-old 
mouse embryos lacking the functional p53 genes (Schlett et al., 1997). The NE4C cell line is 
neural stem cells with doubling time of approximately 12 hours. The characteristics of NE4C cell 
line and culture condition are well established (Schlett and Madarasz, 1997). NE4C cells were 
cultured in complete growth medium: Eagle’s Minimum essential medium (MEM) (Sigma, Cat. 
M5650) supplemented with 10% non-heat inactivated fetal bovine serum (FBS), and 2 mM L-
glutamine.  The culture flasks should be pre-coated with 15 µg/ml poly-L-lysine (Sigma, Cat. No. 
P-9155) at least 2 hours in advance. 
 
2.12.1  Thawing of NE4C cells 
The frozen NE4C cells was taken out from the liquid nitrogen storage tank, and thawed 
immediately in a 37°C water bath with gentle agitation. The cells were transferred to a centrifuge 
tube and mixed with 9.0 ml complete growth medium and spun at 125 g/min for 5 mins to 
remove the cytotoxic, cryoprotectant dimethyl sulphoxide (DMSO). The cell pellet was 
suspended with 10 ml of complete growth medium and transferred into a 75 cm2 poly-L-lysine 
coated culture flask and incubated at 37°C humidified atmosphere supplied with 5% CO2 
incubator. The culture medium was changed 24 hours after thawing to remove dead cells and cell 
debris.   
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2.12.2  Subculture of NE4C cells 
The monolayer of NE4C cells was subjected to subculture when 80% of cellular 
confluence was reached. The medium used for subculture was pre-warmed in 37°C water bath 
before use. The culture flask was shaken slightly and the culture medium was discarded. The 
cells were washed with 1x PBS to remove any remaining cell debris and culture medium which 
contains trypsin inhibitor. Then the cells were incubated with 2.5 ml of 1x Trypsin at 37°C for 5 
mins to allow quick detachment of cells from the bottom of the flask which can be observed 
under an inverted microscope. The trypsin activity was inactivated by adding 10ml of MEM with 
10% FBS and centrifuged at 125 g/min for 5 mins. The cell pellet was suspended with 10ml 
culture medium and divided into a 75 cm2  poly-L-lysine  pre-coated  culture flask with estimated 
cell number of 4 x 104 viable cells/cm2. The subcultured cells were placed at a 37°C incubator 
supplied with 5% CO2.   
 
2.12.3  Cryopreservation of NE4C cells 
NE4C cells were cryopreserved for storage purpose. The culture medium was first 
removed and the cells were washed with 1x PBS, followed by trypsinisation as mentioned in the 
subculture step. MEM with 10% FBS was used to inactivate trypsin, and the cell pellet was 
suspended with the complete cell culture medium supplemented with 10% DMSO and 
transferred to cryovials. These cryovials with NE4C cells in cryopreservation reagents were 
placed in a freezing container, Mr. Frosty (Nalgene, Rocjester, NY) to achieve temperature of -
80°C gradually before long-term storage in liquid nitrogen tank.  




2.13  Quantitative real time PCR 
Quantitative real time PCR was used to quantitatively assess the gene expression in 
NE4C cells.  Because we can acquire enough RNA from the cultured NE4C cells by RNeasy 
mini kit, two-step RT-PCR method was used for it is more convenient and comparable.    
 
2.13.1  Total RNA isolation for NE4C cells 
Total RNA was extracted from NE4C cells grown in 6-well plates using the RNeasy mini 
kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Cultured cells were 
washed with PBS and detached from the dish by typsinization. Trypsin activity was inactive by 
MEM with 1 0 % FBS. Cell p ellets were lysed  b y 3 5 0  μl of RLT buffer contain in g  1 % of β-
mercaptoethanol (β-ME) and were homogenized by a 21-gauge needle fitted to a syringe for 15 
times. The cell lysate was mixed with 350 μl of 70% ethanol by pipetting and transferred to the 
RNeasy Mini column placed in a 2 ml collection tube and centrifuged at 13000 rpm for 30 secs. 
The flow throu g h was discard ed  and  the spin  column  was washed  b y 3 5 0  μl of Buffer RW1 
twice, 500 μl of Buffer RPE, and dried by centrifugation for 1 min to ensure no leftover of 
reagents for the elution step. Finally the total RNA was eluted using 30 μl of RNase-free water in 
a 1.5 ml collection tube supplied by the RNeasy mini kit. The purity and concentration of total 
RNA was measured by NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, 
Wilmington, USA). NanoDrop was used to measure RNA quality by UV spectrophotometer to 
compare the absorbance ratio between the wavelength of 260 and 280 nm. It is reported that ratio 





2.13.2 First strand cDNA synthesis 
First strand cDNA was synthesized by the SuperScript III first strand synthesis system 
(Invitrogen, Carlsbad, USA). In a nuclease-free microcentrifuge tube, 2 μg of total RNA, 50 ng 
of random primers, and 1μl of 10 mM dNTP mix were mixed together, topped up to 13 μl with 
RNase-free water, and heated to 65 °C for 5 mins. The heated mixture was then incubated on ice 
and added to a mixtu re of 4  μl of 5  x First-Strand Buffer, 1μl of 0.1 M DTT, 1 μl of 
RNaseOUTTM Recombinant RNase Inhibitor (Cat.No. 10777-019, 40 Unit/μl), and 1μl of 
SuperScriptTM III RT (200 Unit/μl). The mixture was then incubated at 25 °C for 5 mins, 50 °C 
for 60 mins, 70 °C for 15 mins, cool at 4 °C, used for PCR reaction or stored at -20 °C.  
 
2.13.3 Quantitative real time polymerase chain reaction (qRT-PCR) 
PCR reaction was done using the QuantiTectTM SYBR® Green PCR kit (Qiagen, Hilden, 
Germany) on the LightCycler system (Roche Applied Science, ID, USA) according to the 
manufacturer’s protocol. Primers were designed using Primer 3 software and their specificities 
were confirmed by nucleotide BLAST from the NCBI website as described in 2.9. The primers 
were synthesized by 1st Base (1st Base, Singapore) and sequences were listed in Table 2.2.   
 
Table 2.2 Primers for qRT-PCR. 
Gene Symbol Forward primer Reverse primer Product size 
β-actin gttaccaactgggacgacatg tcgtagatgggcacagtatg 275bp 
Gapdh atcaccatcttccaggag atggactgtggtcatgag 304bp 




The SYBR Green master mix was prepared in a centrifuge tube with the amount for one 
reaction u se of: 1 0  μl of 2  x Qu antiTect SYBR Green PCR Master Mix, 0 .5 μl of 1 0  μM left 
primer and right primer, 10 ng of the first strand cDNA as template, and topped up with 
appropriate RNase-free water. The master mix with the cDNA template was mixed thoroughly 
and appropriate volumes were dispensed into the LightCycler capillaries pre-cooled in 
lightCycler centrifuge adapter. The LightCycler was programmed as: 95°C 15 mins for initiation, 
followed by 40 cycles of amplification with the cycle parameters were: 94°C 15 secs for 
denaturation, 60°C 25 secs for annealing, and 72°C 20 secs for extension. The PCR capillaries 
were placed into the LightCycler and the cycling program was started with a melting curve 
analysis of PCR products performed.  
 
2.14 siRNA transfection  
For siRNA transfection, NE4C cells were cultured in the maintaining medium. The 
transfection was carried out using forward transfection method as recommended by 
DharmaFECT transfection reagents (DF1)-siRNA transfection protocol.  Briefly, NE4C cells 
seeded in 6-well-plate were transfected with siRNA (Negative control, Positive control, and 
target genes) and DF1 complex 24 hours after seeding. Positive control was GAPDH siRNA. 
Optimization of transfection conditions was performed several times before formal experiments, 
including the transfection parameters of NE4C cell number, siRNA concentration, amount of 
DF1 transfection reagent and exposure time of NE4C cells to the transfection reagents. 
Triplicates were done for normal NE4C cells, negative siRNA, siGAPDH, and two sequences of 




2.15 Proliferation assay  
Proliferation assay was done by MTS method performed using the CellTiter96 Aqueous 
non-radioactive proliferation assay (MTS, Promega Corp., Madison, WI, USA). This is a 
colorimetric method for determining the number of viable cells in proliferation assays. The main 
components in the assay are the tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) and phenazine ethosulphate 
(PES). MTS is chemically reduced by the mitochondrial dehydrogenase activity in the viable 
cells into a soluble purple-color formazan, the absorbance of which can be measured directly at 
490nm. The quantity of the formazan formed (absorbance level) is directly proportional to the 
number of viable cells in the sample (Promega, 2007). The PES is an electron coupling reagent 
which enhances the chemical stability of MTS.  
NE4C cells were seeded in 6-well-plate (8 x 104 cells/well) and transfected 24 hours after 
seeding using the optimized transfection condition: siRNA 5nM, DF1 5μl, exposure time of cells 
to transfection reagents was 24 hours. 48 hours post-transfection, 400 μl/well of MTS reagent 
was added into the transfected NE4C cells containing 2 ml of MEM without FBS. The cells were 
then incubated at 37°C for 4 hours. The absorbance of the formazan formed was measured 
hourly using the GENios Microplate Reader (Tecan, Mannedorf, Switzerland).  
 
2.16 Adhesion assay 
96-well plate was pre-coated with 20 μg/ml fibronectin (BD, Franklin lakes, NJ, USA) or 
20 μg/ml Collagen I (Corn ing , Lowell, MA, USA) in 1 0 0  μl of PBS at 4 °C overn ight. Wells 
were then washed with PBS and blocked with 100 μl of 1% bovine serum albumin (BSA) 
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(Sigma-Aldrich, St.Louis, MO, USA) at 25°C for one hour. Wells were then washed twice with 
PBS and air-dried in the hood and stored at 4°C for later use.   
48 hours post transfection NE4C cells were trypsinized and resuspended in MEM without 
FBS and reseeded in the pre-coated 96-well plate at a concentration of 1 x 104 cells/well in 100 
μl for Collagen I and 3 x 104 cells/well in 100 μl for fibronectin. Within each treatment group, 
the wells were divided into the washed group and the unwashed group. For the washed group, 
wells were washed thrice with PBS after the cells were allowed to attach for 30 mins at 37°C in a 
humidified incubator containing 5% CO2. Nothing was done for the unwashed group. MTS assay 
was performed to determine the number of adhered cells. 20 μl of MTS reagent diluted with 100 
μl of MEM withou t FBS was ad d ed into  each well of the washed  g rou p, wh ile 2 0  μl of MTS 
reagent was directly added into each well of the unwashed group. Absorbance of formazan 
formed was taken at 490 nm one hour after MTS was added and was taken hourly for 4 hours. 8 
replicates were done for the washed group and unwashed group within each treatment group. 3 
blanks were done for control with 20  μl of MTS reagent d ilu ted  with 100  μl of MEM without 






























3.1  Mouse embryos were dissected at different time points during neurulation 
Mouse embryos were dissected at three stages of E8.5, E9.0, and E9.5 during neurulation 
which were critical for neural tube formation. Mouse embryo pictures were shown in Fig. 3.1.  
In Fig. 3.1.A, it shows one mouse embryo with 10 somites before turning at E8.5 in the posture 
of “U”. The embryo is relatively transparent with cut edge amnion attached to the embryo body 
difficult to be torn away. Closed somites can be distinguished clearly at the mid-region along the 
neuroaxis. The two openings at the upper head fold and the bottom region are prominent. While 
in Fig. 3.1.B, the mouse embryo at the E9.0 stage with 20 somites was in the posture of “C” after 
turning. The rostral extremity of the neural tube is closed already, but the caudal region still 
remains open. A prominent ridge in the mid of the lateral body wall, at approximately the level 
of 11 to 12 somite region indicates the site of the forelimb bud. Cranially at the upper forelimb, 
the closed somites are difficult to count, but somites can be easily distinguished caudally from 
the forelimb bud region.  Characteristics of embryos at this stage also include the indented otic 
and the optic pit at the ostral region, the transparent heart that was discernable. The amnion is 
easily torn away and the body of the embryo seems much smoother than at the E8.5 stage. At 
E9.5 as shown in Fig. 3.1.C, the mouse embryo grows much larger in size and not transparent 
any more. The outlines of the forebrain, midbrain and hindbrain become much clearer, and the 
forebrain vesicle subdivides into telencephalic and diencephalic vesicles. The posterior opening 
becomes a hole immediately adjacent to the closed neural tube which is the posterior neuropore 
(PNP) as designated by an arrow in Fig. 3.1.C. The forelimb bud becomes obvious at the 11 to 
12 somites level, and a distinct condensation of the hind limb bud appears at just the upper level 





the forelimb bud region was designated as 11, and the somites were counted caudally till the one 
that is forming. The somite number at this stage is from 27 to 30, and the somite number of the 
mouse embryo in Fig. 3.1.C is 29. Practically, there are developmental differences among 
embryos between different litters or even from the same litter. Somite number was used as an 
indicator when selecting embryos for cryo-section. Mouse embryos with somite number of 9 to 
12, 19 to 22, and 27 to 30 were selected and used as E8.5, E9.0 and E9.5 embryos (Copp et al., 
1982; Shum and Copp, 1996a).   
 
Fig. 3.1. Photographs A, B, and C represent embryos dissected at the three different timing 
of neurulation.  (The three pictures were taken under the same magnification and scale bar 
equals 200μm.) AMN: amnion; SM: somite; HNF: head neural fold; PNF: posterior neural fold; 
FB: forebrain; MB: midbrain; HB: hindbrain; OP: optic pit; OT: otic pit; FLB: forelimb bud; 
HLB: hind limb bud; PNP: posterior neuropore. Red line indicates areas to be transversely cut.  
 
3.2  Transverse sections through spinal region of mouse embryos 
Transverse sections of 8um were sectioned by cryostat and quickly stained by 
haematoxylin. Fig. 3.2.A shows mode 1 of E8.5 embryos. Transverse sections of mouse embryo 
with 12 somites demonstrate mode 1 during neurulation process. The straight arrow in Figure 
3.A indicates the median hinge point (MHP) at the upper middle of hind gut and notochord, the 
A B C 
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neuroectoderm at both sides of the MHP remains straight and elevated, and the whole 
neuroectoderm demonstrated a V-shaped morphology.  
Fig. 3.2.B shows mode 2 of E9.0 embryos with 20 somites. The two bilateral arrows in 
figure 3.B indicate the bending sites of dorsolateral hinge points (DLHPs) along the 
neuroectoderm, while the arrow in the middle point to MHP. The morphology of neuroectoderm 
in mode 2 is like a diamond, the length of the DLHP bending sites to the MHP varies according 
to somite number or stage of embryos.  The bending NT becomes more prominent compared 
with the NT in mode1. The size of paraxial mesoderm in mode 2 and mode 3 is reduced 
compared with the mesoderm surrounding the NT at mode 1, implicating less influence of 
paraxial mesoderm on neurulation at later stage.   
The morphology of mode 3 at E9.5 mouse embryo is demonstrated in Fig. 3.2.C. The 
MHP is not distinguished, the whole neuroepithelium bends and the DLHPs become more 
powerful with the tips of the neural folds become sharpen and stretch to connect towards each 
other, implicating that NT may play more important roles at the end of neural tube closure.  
It is estimated that the posterior neuropore is about 40 to 60 um in length along the neuroaxis 
(van Straaten et al., 1992). 5 sections of 8 µm across the closure sites were selected for 
microdissection by LCM, and a total of 15 sections from 3 embryos were microdissected and 
pooled for extracting RNA for one sample. Such selection is made because if selecting less 
sections, the RNA extracted from the LCM samples is not enough for microarray, and more 
embryos will be needed; while if selecting more sections from the same embryo, the sections 
from the sites may be closed too long or be too far from the closing site and may not be proper to 
represent the closing status. The RNA from LCM samples will be amplified and used for 





Fig. 3.2 Transverse sections through the posterior neuropore of mouse embryos at E8.5, 
E9.0, and E9.5 demonstrate three modes of spinal neurulation. Sections were quickly stained 
by Haematoxylin and pictures were taken under microscope attached to the LCM system under 
the same magnificent of x40. Arrow in A points to the MHP, the upper two arrows in B point to 
DLHPs, and the lower one point to MHP.  
 
3.3 Procurement of selected tissues by LCM 
Targeted NT and MD tissues were selected and microdissected separately by the Arcturus 
LCM system. The sections were observed under microscope and only those sections with the 
typical features for each mode were used for microdissection. Fig. 3.3 shows the microdissction 
process of the mode 2 section. Fig. 3.3.A shows the picture of the section with a diamond-shaped 
NT viewed under microscope, and a CapSure Macro LCM cap was situated on it, after a 
selection, the NT was microdissection by laser and attached to the film under the cap as shown in 
Fig. 3.3.B. The cap with the NT was lifted up but the unwanted tissues were still left on the 
section as shown in Fig. 3.3.C. Fig. 3.3.D shows the NT microdissected just now. NT from 
sections of about 5 embryos were dissected on one MicroCap and the cap with microdissected 
tissues was transferred to be incubated in extraction buffer under the help of the CapSure 
Insertion Tool for RNA extraction. Then another round microdissection of the paraxial MD 
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tissue was carried out on the same section using a clean MicroCap. The paraxial MD was 
selected immediately adjacent to the selected NT with a comparable size as shown in Fig. 3.3.E. 
Fig. 3.3.F shows the remaining tissues left on the slides after the second microdissection and the 
microdissected MD tissue is shown in Fig. 3.3.G.  Background colors on different pictures were 
slightly different because of the different distance from the objective light. The tissue cells seem 
to be a little bit unclear and this may be due to three reasons: first reason may be due to the 
Microcap situated onto the sections, the light must traverse the translucent film when taking 
pictures; another reason is due to no cover slip on the tissue as usual; last but not least is may be 
due to the quickly stain method which is just for determining targeted tissues so the staining is 



















Fig. 3.3 A representative example demonstrating precise procurement of selective 
populations of cells by laser capture microdissection (Haematoxylin staining; Magnification 
of pictures of the three modes taken by LCM machine is 40 times.) (A-G, mode 2, E9.0). 
Quickly stain and isolation of neuroepithelium and mesenchymal cells from E9.0 mouse embryo 
transverse sections though posterior neuropore region. (A), Sections were quickly-stained by 
Haematoxylin. Neuroepithelium in E9.0 was in Diamond shape. (B) and (E), Selected 
populations of cells were targeted with laser and attached to membrane on the Microcap used for 
their isolation. (C) and (F), After lifting off the membrane, selected cell populations were 
removed from the tissue section. (D) and (G), Isolated cell populations stuck to the membrane, 














3.4 Assessment of Quality and quantity of total RNA extracted from laser capture 
microdissected NT and MD samples 
The quality of starting total RNA is important for the success of microarray analysis 
(Jones et al., 2006; Tomita et al., 2004).  I assessed the quality and quantity of total RNA 
carefully using a combined method of Nanodrop and Agilent 2100 bioanalyzer. The very low 
sample consumption of 1-2 µl is one advantage of Nanodrop and it was used to measure RNA 
quantity for LCM samples. 
The Agilent 2100 Bioanalyzer is an advanced innovative lab-on-chip technology to 
assess RNA quality and quantity widely used in the gene expression profiling platforms (Bustin, 
2002; Mueller et al., 2000). It detects RNA samples applied on a micro-fabricated chip via laser 
induced fluorescence. Total RNA samples as small as 50 pg can be used for assessment. RNA 
ladder was used to estimate the RNA band sizes. RNA Integrity Number (RIN) (Schroeder et al., 
2006) was calculated according to the shape of the curve in the electropharogram by Agilent 
2100 expert software. A RIN of 7-10 is indicative of High RNA quality and used for microarray 
work, whereas a RIN of 1 indicates a completely degraded RNA sample (Fleige and Pfaffl, 2006; 
Jones et al., 2006).  
All of the 18 RNA samples had good quality with RIN number of more than 7.5, and the 
quantity were more than enough for minimum requirement of starting RNA for amplification 
(Table 3.1). The two peaks at positions of 18s and 28s of all 18 samples displayed by the 
electropharogram were high with all RIN numbers above 7.5,  and the gel pictures of all 18 
samples displayed by Bioanalyzer were with two clear bands at the positions of 18s and 28s      





Table 3.1 Total RNA quality and quantity of pooled microdissected samples assessed by 
Nanodrop and Agilent 2100 Bioanalyzer. 
Sample group Sample type Mode 
 




1 E8.5-NT 1 10.8±2.86 8.93±0.49 
2 E9.0-NT 2 12.73±4.47 8.13±0.55 
3 E9.5-NT 3 17.7±8.85 8.26±0.64 
4 E8.5-MD 1 15.8±4.01 8.5±0.87 
5 E9.0-MD 2 14.47±5.4 8.4±0.26 




Fig. 3.4 Assessment of total RNA of laser capture microdissected NT and MD samples by 
Agilent 2100 Bioanalyzer. Representative examples of total RNA after  microdissection, before 
amplification, tested by Bioanalyser (A, E9.0-NT1; B, E9.0-MD1). The two peaks at the position 
of 18s and 28s were high displayed by the electrophoretogram, and the two bands indicative of 
the two peaks were clearly visible in the left gel picture. The RNA quality and quantity were 







3.5 Assessment of quality and quantity of total cRNA and fragmented cRNA for 
microarray analysis 
For nanogram level amounts (in the range of 10ng to 100 ng) of starting total RNA from 
LCM samples, a two-cycle cDNA synthesis and IVT amplification is necessary to get sufficient 
amounts of labeled cRNA for microarray analysis. 15 ng of total RNA for each sample was used 
as starting material. After two cycle cDNA synthesis with IVT amplification, Biotin labeled 
cRNA were acquired. The quality and quantity of the labeled Bio-cRNA was measured by 
Nanodrop. The ratio of 260/280 was between 1.8 and 2.1 for all the 18 samples, indicating RNA 
was amplified and purified with good quality, and the quantity is above 27 μg for each sample, 
which is sufficient for hybridization on GeneChips (Table 3.2). The total amount of Bio-cRNA 
did not have obvious relation with the starting 18S/28S ratios of the starting total RNA just as 
reported by Dumur et al (Dumur et al., 2004b).  Starting total RNA with RIN more than 7 used 
in this experiment can provide sufficient amount of Bio-cRNA, indicating their good quality. 
The number of genes presented among each group was similar with the starting RIN 
number more than 7 as indicated in the hybridization results in Table 3.3. This is consistent with 
the previous study that a RIN of 7-10 is indicative of high RNA quality and good enough for 
microarray work (Fleige and Pfaffl, 2006; Jones et al., 2006). After 2 rounds of amplification and 
purification process, all of the final cRNA hybridized on the genechips were of good quality as 
indicated by the RNA260/280 ratio (Table 3.3). Then 20 µg of labeled Bio-cRNA were cleaned 
up and fragmented. The fragmented Bio-cRNA was measured by Agilent 2100 Bioanalyzer.   
Fig. 3.5 shows the Bioanalyzer electrophoretogram of the fragmented Bio-cRNA with the size 















1 E8.5-NT 1 1.89±0.10 123.35±58.26 
2 E9.0-NT 2 1.96±0.06 92.36±56.07 
3 E9.5-NT 3 2.01±0.03 79.98±20.39 
4 E8.5-MD 1 1.92±0.09 97.08±46.21 
5 E9.0-MD 2 1.99±0.01 93.94±38.25 






 Fig. 3.5 Assessment of fragmented Bio-cRNA using Agilent 2100 Bioanalyzer.  
Representative examples of fragmented Bio-cRNA after  2 rounds amplification, before 
hybridization, tested by Bioanalyser (A, E9.0-NT1; B, E9.0-MD1). The peak of fragmented Bio-
cRNA was at the size of 25bp displayed by the electrophoretogram, indicated by a clear band on 










3.6 Analysis of microarray data 
Microarrays were used to provide quantitative and comprehensive profiling of gene 
expression levels for different neurulation stages. Each stage was examined in triplicate using 
independent biological samples for each Affymetrix gene array. 10 µg of the fragmented biotin-
labeled cRNA samples was hybridized to Affymetrix Mouse 430.2.0 Genechips according to the 
manufacturer’s instructions. After probe array wash and stain steps, the probe arrays were 
scanned with an Affymetrix GeneChip Scanner and the images quantified using Affymetrix 
GeneChip Operating Software (GCOS) and saved as an image file. The resulting gene expression 
profiling from 18 microarrays were analyzed with three software: dChip, GCOS, and 
GeneSpring, providing a global view of almost all genes during different neurulation stages. 
 
3.6.1 Quality assessment of a .dat/.cel image data 
The average signal intensity of the array was set to a target signal of 500 by default. The 
expression signal of a probe set above 500 is designated as present and below 500 is designated 
as absent. Affymetrix suggested that average background values for arrays scanned with the 
GeneChip Scanner 3000 range from 20 to 100. The detected noise values (background) of all the 
samples were between 30 to 50 and comparable among triplicates in this experiments which 
indicates a less pixel-to-pixel variation on the GeneChip arrays. Poly-A controls of dap, lys, phe, 
and thr were present in all the samples with increasing values which indicate proper of the entire 
target labeling process. All of the hybridization controls of bioB, bioC, bioD, and cre were 
present with increasing values which indicate higher hybridization efficiency on gene arrays and 
a good RNA sample quality.  
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The housekeeping genes of GAPDH were used as internal control genes to assess RNA 
samples and assay quality. Measurement of hybridization signal ratios from the 3’ and 5’ ends is 
used as a quality control for robust, full-length target synthesis. The 3’/5’ ratios range is 
generally no more than 3 for the 1-cycle assay and could be higher for the 2-cycle assay due to 
additional cycle of amplification. It is reported that the ratio of hybridization signals at the 3’ and 
5’ end of GAPDH transcript could be at least ten-fold for the 2-cycle assay (Luzzi et al., 2003). 
In the current microarray analysis, the 3’/5’ ratio of GAPDH of all samples was measured  
(Table 3.3). Affymetrix GeneChips used multiple probes to measure expression for each 
transcript, and preferentially selected probes from the 3’ end of each transcript as well in order to 
minimize the influence that both RNA degradation and probe position can have on the final 
estimation of gene expression. The probe position effects are less likely influence measurement 
of whole expression data as long as the relative overall expression levels are considered (Cope et 
al., 2006).  
Two other parameters that reflect signal intensity were recommended to be used as 
measurement of sample quality for 2 round amplification microarrays, scale factor (SF) and 
percentage of presented genes (%P) (Luzzi et al., 2003).  Scale factor is the relative amount of a 
defined target intensity value compared to the average signal intensity of all probe pairs on the 
microarray. The higher the scale factor, the lower the overall signal intensity. The scale factors in 
the current microarray analysis results were below 10 and no obvious difference among groups 
(Table 3.3), indicating comparable microarray results. The percent present of probe set of all 
samples were above 43%, and differences among triplicates were below 5% (Table 3.3). These 





Table 3.3 Comparison of scale factor and percentage of number of genes presented on 










1 E8.5-NT 37.33±0.01 15.80±3.09 8.47±0.005 46.73±0.009 
2 E9.0-NT 38.85±0.01 12.07±2.21 7.63±0.011 46.00±0.02 
3 E9.5-NT 42.52±0.02 3.91±0.08 4.28±0.017 52.87±0.014 
4 E8.5-MD 41.92±0.01 12.52±3.56 7.32±0.007 46.73±0.076 
5 E9.0-MD 34.94±0.03 10.18±0.69 6.37±0.029 49.20±0.003 
6 E9.5-MD 37.42±0.01 3.10±0.23 5.70±0.008 53.73±0.007 
 
All data are presented as mean±SD, n=3. Scale factor (SF): utilized to generate an average signal 
intensity of 150 using GCOS software; Present(%) genes (%P): percentage of genes scored 
detected (“P”) by GCOS. 
 
3.6.2 Comparison of the differentially expressed genes by microarray analysis 
All raw data of the 18 samples were analyzed by three common used software, GCOS, 
dChip, and GeneSpring, with the same filtering conditions of AI > 500 and FC > 2 (Fig. 3.6). 
Five probe set lists for neuroepithelium (NT) and surrounding mesoderm (MD) were generated 
by each of the algorithms of the software.   
 
Fig. 3.6 Experiment design and comparison of the overlapped probesets among 3 analysis 




In GCOS software generated probe set lists which are summarized in Table 3.4, the total 
numbers of differentially expressed transcripts by at least 2 fold change in NT groups of E8.5 
compare with E9.0, E8.5 compared with E9.5, and E9.0 compared with E9.5 were 572, 1882 and 
1148, respectively; While the total numbers of transcripts differentially expressed in MD groups 
of E8.5 compared with E9.0, E8.5 compared with E9.5, and E9.0 compared with E9.5 were 642, 
1870 and 1194, respectively. It seems that the number of differentially expressed transcripts were 
direct proportional to the length of time in development. 2199 transcripts were differentially 
expressed when the MHP disappeared at E9.5 compared with when MHP presented at E8.5 and 
E9.0.  Among these transcripts, 1102 were from the NT, and 1097 were from MD. Besides, a 
total of 1206 transcripts were differentially expressed when the dorsolateral hinge points (DLHPs) 
presented at E9.0 and E9.5 compared with the profile just before the formation of the DLHPs at 
E8.5. Among these transcripts, 533 were from NT and 673 were from MD.    
The same raw data were analyzed by software dChip and 5 different algorithms of 
GeneSpring (Table 3.4). The number of differentially expressed genes of dChip and 3 
algorithms of GeneSpring (RMA, GC-RMA, and GS-GCOS) gave the most similar results as 
GCOS. GS-dChip gave the most nonstringent calculation with the number of differentially 
changed transcripts being the highest among all groups, while PLIER gave the most stringent 
calculation with the number of differentially changed transcripts being the lowest, especially in 
all of the NT groups. These similarities and differences indicate that every algorithm has its own 
advantages and disadvantages, and combined calculation using more software may increase the 
accuracy by presenting the overlapping genes from all software (Millenaar et al., 2006). This 
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combined application of several software is suggested when a lot of genes changed (more than 
thousands or hundreds) using only one software.   
A combined probe set list for each comparison was obtained by intersection of the 7 
probe set lists generated by the above software. A total of 442, 1318, and 892 transcripts showed 
differential expression for comparison between E8.5 and E9.0, E8.5 and E9.5, and E9.0 and E9.5 
and the numbers of these genes were listed as the  intersection of 7 data sets lists (Table 3.5). 
The overlapped genes presented a decrease in numbers compared with numbers filtered by only 
one software, the GCOS. The combined usage of 3 software presented less genes but still 
contained more than hundreds of transcripts for future analysis. This indicates the effectiveness 
of combined use of different algorithms in narrowing down the scope of studies. The gap 
between the number of differentially expressed transcripts of E8.5vsE9.5 and the number of 
E8.5vsE9.0 together with E9.0vsE9.5 add up to 16 while the gaps calculated by each one of the 
software were more than 100. This may indicate an improvement in the accuracy of filtered 
genes.      
A total of 847 differentially expressed transcripts were presented in all of the 7 probesets 
lists in E8.5+E9.0vsE9.5 group list, with 411 transcripts for NT and 436 for MD (Table 3.5). 
These genes may be involved in the formation and existence of the MHP. Besides, a total of 365 
differentially expressed probe sets were presented in all of the 7 datasets in E8.5vsE9.0+E9.5 
group list, with 215 transcripts for NT and 150 for MD (Table 3.5). These genes may contribute 
to the formation and existence of the DLHPs.  
To know the distribution of these transcripts more clearly, the transcripts from E8.5vs9.5, 
E9.0vsE9.5 and E8.5+E9.0vsE9.5 gene lists as well as the transcripts from E8.5vsE9.0, 
E8.5vsE9.5, and E8.5vsE9.0+9.5 were calculated by intersection to generate the MHP- and 
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DLHP- related transcript lists. After removal of duplicates of probesets and probesets with 
uncharacterized expressed sequences, a total of 433 transcripts were generated for MHP-related 
genes with 214 for NT and 219 for MD, and a total of 151 transcripts were found for DLHP-
related genes with 95 for NT and 56 for MD (Table 3.6). These differentially expressed 
transcripts were functionally clustered by GO file from DAVID database, and partially listed in 
tables (data not shown here). Further analysis of these genes will increase the possibility of 
finding MHP- and DLHP- related key genes. These findings may be further explored to unveil 
the neurulation mechanism. 
 
Table 3.4 Number of differentially expressed probe sets at different stages analyzed by 
different software.  
 
 dChip GCOS GeneSpring 
RMA GC-RMA GS-dChip GS-GCOS PLIER 
NT-E8.5vsE9.0 559 572 467 729 1279 703 383 
NT-E8.5vsE9.5 1698 1882 1504 2322 3241 2453 1227 
NT-E9.0vsE9.5 1328 1148 1157 1778 2718 1916 928 
NT-E8.5+E9.0vsE9.5 1237 1102 1066 1753 2658 1803 855 
NT-E8.5vsE9.0+E9.5 666 533 492 788 1533 777 414 
MD-E8.5vsE9.0 798 642 602 936 2250 870 721 
MD-E8.5vsE9.5 2148 1870 2037 2703 4576 2560 2235 
MD-E9.0vsE9.5 1287 1194 1065 1523 2679 1634 864 
MD-E8.5+E9.0vsE9.5 1406 1097 1165 1660 3137 1603 1054 




Table 3.5  Intersection of 7 datasets by Microsoft access to narrow down the scope of the 
differentially expressed transcripts.   
 
 NT MD Total  
E8.5vsE9.0 209 233 442 
E8.5vsE9.5 615 703 1318 
E9.0vsE9.5 453 439 892 
E8.5+E9.0vsE9.5 411 436 847 




Table 3.6 Calculation of MHP- and DLHP- related transcripts by Microsoft Access.  
 







































As adjacent tissues, the NT and MD share some genes in common that may function 
sequentially or together. The MHP-NT and MHP-MD transcripts as well as the DLHP-NT and 
DLHP-MD transcripts were intersected by Microsoft Access specifically to compare their 
distribution among NT and MD tissues. The comparison results were present as Venn diagrams 
in Fig. 3.7.A for MHP and Fig. 3.7.B for DLHPs. In Fig. 3.7.A, there are 69 transcripts present 
in common among both MHP-NT and MHP-MD related genes, with 55 up-regulated and 14 
down-regulated. In Fig. 3.7.B, there are 24 transcripts that in common among both DLHP-NT 
and DLHP-MD transcript datasets, with 17 up-regulated and 7 down-regulated.  
There were 136 transcripts in MHP-NT list only with 75 up-regulated and 61 down-
regulated, and 141 transcripts in MHP-MD list only with 116 up-regulated and 25 down-
regulated in Fig. 3.7.A. Similar as in Fig. 3.7.B, there are 64 transcripts in DLHP-NT list only 
with 36 up-regulated and 28 down-regulated, while there are 29 differentially changed transcripts 
in DLHP-MD list only with 17 up-regulated and 12 down-regulated. With the Venn diagram, we 







A. Venn diagram for MHP-NT and MHP-MD genes. 
 
 
B. Venn diagram for DLHP-NT and DLHP-MD genes. 
Fig. 3.7 Venn diagram of temporally expressed transcripts distributed spatially in NT and 
MD. Transcripts from NT and MD were intersected by Microsoft access, and the distribution of 
expressed genes was shown in separate groups. The numbers of separated transcripts was 
counted and Venn diagrams were drawn to show the distribution of transcripts in NT and MD. 
























3.6.3 Verification of differentially expressed genes from microarray data by RT-PCR 
To confirm that the microarray platform was acceptably measuring differential 
expression between different stages of the LCM samples, 42 differentially expressed genes from 
the MHP- and DLHP- related gene lists were selected for RT-PCR analysis. The excess RNA 
produced by the microarray target preparation was used as template for the RT-PCR work (Day 
et al., 2008). Expression pattern of all genes were consistent in RT-PCR compared with 
microarray data (Table 3.7). The expression ratios produced by RT-PCR is similar as microarray. 
There is no obvious trend that the expression ratio of RT-PCR is higher than microarray as 

















Table 3.7 Verification of differential gene expression by quantitative RT-PCR compared 
with microarray.  
 
Group gene qRT-PCR microarray(dChip) 
MHP-NT Fabp7 ↑ ↑ 
  Pcolce ↑ ↑ 
  Sall4 ↓ ↓ 
  Rhobtb3 ↓ ↓ 
  Ammer1 ↓ ↓ 
  Ttr ↓ ↓ 
  Col3a1 ↑ ↑ 
  Ckb ↑ ↑ 
  Hoxd13 ↑ ↑ 
  Lyrm4 ↓ ↓ 
 
MHP-MD Pcolce ↑ ↑ 
  Oxct1 ↑ ↑ 
  Col3a1 ↑                  ↑ 
  Fabp7 ↑ ↑ 
  Ckb ↑ ↑ 
  Fgf9 ↓ ↓ 
  Phlda2 ↓ ↓ 
  Ammercr ↓                  ↓ 
  Lyrm ↓ ↓ 
  Ttr ↓ ↓ 
   
DLHP-NT Idh1 ↑ ↑ 
  Trps1 ↑ ↑ 
  Fabp7 ↑ ↑ 
  Sh3gl3 ↑ ↑ 
  LPL ↑ ↑ 
  Phlda2 ↓ ↓ 
  Prtg ↓ ↓ 
  Arg1 ↓ ↓ 
  Nr6a1 ↓ ↓ 
  Ttr ↓  ↓ 
  Hoxc10 ↑ ↑ 
  Hoxd13 ↑ ↑ 
  
DLHP-MD Fabp7 ↑ ↑ 
  LPL ↑ ↑ 
  Trps1 ↑ ↑ 
  Cyp26a1 ↑ ↑ 
  Nr6a1 ↓ ↓ 
  Prtg ↓ ↓ 
  Phlda2 ↓                  ↓ 
  Socs2 ↑  ↑ 
  Arg1 ↓ ↓ 
  Ttr ↓ ↓ 
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3.6.4 Hierarchical clustering of differentially expressed transcripts in 3 different stages of 
mouse spinal NT and MD  
A high level analysis of Hierarchical clustering was performed using dChip V5.0 to 
further visualize the expression pattern.  A total of 584 differentially expressed probe sets from 
the comparison of MHP- and DLHP- related genes were sent into the software for hierarchical 
clustering.    
Changes in gene expression profiles of the total 18 samples, including 3 replicates for 2 
different tissues (the NT and MD) at 3 critical stages (E8.5, E9.0 and E9.5) of neurulation were 
displayed as a clustering figure as in Fig. 3.8. In the clustering figure, each row represents a gene 
and each column represents a sample with the sample name displayed on top of each column.  
On the left is the gene cluster tree which is called dendrogram and genes close to each 
other indicate that they have high similarities in their standardized expression values across the 
18 samples. Each gene in each sample was represented by a colored box and colored according 
to its expression level. On the bottom of the clustering figure is the color scale: the red color 
signifies expression level above mean expression of a probe set across all samples, the white 
color represents mean expression and the blue color represents expression level lower than the 
mean.  
Situated on the top is the sample clustering tree. The replicate samples collected for the 
same tissue at the same stage are clustered together, and samples from the same stage are 
clustered together, which indicate that samples used in this experiment have good quality, 
replicate samples have high similarity, and the data generated by microarray are reliable.  
The clustering figure was roughly divided into 4 parts from top to bottom according to 
the expression levels among the 18 samples displayed by different colors. They are numbered as 
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1, 2, 3, and 4 for each cluster. Genes in cluster 1 exhibited a down-regulation at E8.5 and E9.0 of 
both NT and MD samples, but were up-regulated at E9.5 of NT and MD. This expression pattern 
indicates that they were MHP-up regulated genes. Genes in cluster 2 with an expression pattern 
of down-regulation at E8.5, but up-regulation at E9.0 and E9.5, these genes represent DLHP-up 
regulated genes. Genes in cluster 3 showed an up-regulation at E8.5 and down-regulation at E9.0 
and E9.5 which indicate them as DLHP-down regulated genes. Finally, genes in cluster 4 
demonstrated an up-regulation at E8.5 and E9.0, but a down-regulation at E9.5 signified the 
MHP-down regulated genes.  
In the left panel on the screen also shows functional clusters, a local cluster enriched by 
genes with a particular function, by which a gene can be classified according to molecular 
function, biological process and cellular component using GO terms. 9 functionally significant 
gene clusters were displayed in the left panel with a default p-value < 0.005. They can be 
highlighted in blue as shown for the cell proliferation cluster in the clustering figure. The 
functional clusters were displayed as: a, development and enzyme linked receptor protein 
signaling pathway; b, cell proliferation; c, signal transduction activity; d, cell communication; e, 
cell motility; f, cell migration; g, nervous system development and morphogenesis. The genes in 
the same cluster can be represented by different functional clusters if they are enriched by 
several different functional terms as in cluster a and cluster g. Most of these functions were 
consistent with those from GO analysis and can assist in further investigation.  
From the hierarchical cluster tree, we can tell that all the MHP- and DLHP- related genes 
by the microarray analysis have involved in nervous system development and morphogenesis. 
More than half of the genes have the function of cell migration. These genes expressed lower at 
both NT and MD at stage E8.5, the expression signaling increase gradually at E9.0 and reach the 
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highest at E9.5 at both NT and MD gene lists.  A few genes among these function at the top of 
the map with an increased expression only in MD but decreased in NT at E9.5. Within the scope 
of cell motility the function, a few genes that involved in the enzyme linked receptor protein 
signaling pathway have a differential expression pattern with a relatively higher expression in 
NT at E8.5 and the most lower expression at E9.0 NT, while other group of genes with cell 
proliferation roles were demonstrated as have relatively higher expression levels in MD than in 
NT at all stages. At the lower 1/3 part of the map were a group of genes with signal transducer 
activity, the expression pattern of which were relatively different from the cell migration genes. 
They expressed high at E8.5 and decreased at E9.5. It seems that most of the signal transducer 
genes were from the MHP- and DLHP- down-regulated gene lists, while the genes involved in 
cell migration, cell proliferation, cell communication, and the enzyme linked receptor protein 
signaling pathway were distributed in the MHP- and DLHP- up-regulated gene lists.  
This hierarchical cluster figure displays visually and directly of the expression pattern for 
all the samples, in addition, it can help the researchers to understand the distributed pattern of 
genes with different functions. More information can also be acquired by further analysis such as 









Fig. 3.8 Hierarchical cluster map of MHP- and DLHP-related genes. The trend analysis of gene 
expression patterns for the MHP- and DLHP- related genes were conducted by hierarchical 
clustering by dChip. Upper side indicated the 18 independent samples, including three triplicates 
of 3 stages (E8.5, E9.0 and E9.5) and 2 kinds of tissues (NT and MD). Each row represents one 
gene and each column represents one sample. Left side was the clustering tree which showed the 
genes with close relationship were clustered closer (high similarity in expression value and 
possible gene functions). Right side showed different clusters for different gene groups and 
functional clusters enriched by GO ontology terms for biological processes. Detailed 
interpretation can be seen in the main text. The bottom of the map showed the color scale. Red: 
up-regulated genes. Blue: down-regulated genes. White: no changed genes. Cluster 1: MHP-up-
regulated genes; Cluster 2: DLHP-up-regulated genes; Cluster 3: MHP-down-regulated genes;   
Cluster 4: DLHP-down-regulated genes; Cluster a: Development; Enzyme linked receptor 
protein signaling pathway;  Cluster b: Cell proliferation; Cluster c: signal transduction activity;  
Cluster d: Cell communication;  Cluster e: Cell motility; Cluster f: Cell migration;  Cluster g: 
Nervous system development; Morphogenesis. 
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3.6.5   Gene Ontology enrichment of differentially expressed genes related to MHP and 
DLHP formation 
In order to assess the association of gene expression with cellular events during 
biological process, the differentially expressed genes from the 8 MHP- and DLHP- related 
groups were analyzed by gene ontology (GO) of DAVID: The online Database for Annotation, 
Visualization and Integrated Discovery (DAVID). 10 main functional gene clusters related with 
embryonic development were defined based on the functional classification terms used in GO 
(Table 3.8). Each of these clusters indicate functional-related gene groups that having similar 
biological meaning and sharing similar genes. Shared genes were counted only once to be 
included in the number (No.) of genes in each cluster. Analysis of GO enrichment revealed 
multiple developmental functions and pathways dominated by the genes associated with: growth-
related (GR), cell structure and communication (CSC), morphogenesis, cell motility and 
migration (CMM), signal transduction (ST), transcription (TX), nucleic acid metabolism and 
chromosome dynamics (NMCD), carbohydrate, lipid, and amino acid metabolism (CLAM), 
intra/inner cellular molecular transport (ICMT), and pathways such as TGF-β signaling pathway, 
FGFR signaling pathway,  and Wnt receptor signaling pathway. This table could help us interpret 
the biological events dur ing critical stages of neurulation in a group level.  
A detailed analysis of the distribution of functional clusters implicated a dynamic 
distribution of biological events during neurulation in temporal as MHP-related genes compared 
with DLHP-related genes, and in spatial as MHP-NT genes compared with MHP-MD genes, and 
DLHP-NT compared with DLHP-MD genes. Cell growth, communication, signal transduction, 
transcription, as well as molecular metabolism seems more active in earlier stages of neurulation 
than in late stages since more related genes expressed in MHP-related gene lists than in DLHP-
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related gene lists (Table 3.8). However, cell motility and morphogenetic ability seems similar in 
late stages as compared with earlier stages. Moreover, functions in development, cell maturation, 
transcription, molecular metabolism, as well as intra/inner cellular molecular transport were also 
active in late stages with many genes expressed in both DLHP-NT and DLHP-MD lists. This 
dynamic distribution of functional clusters may reveal the biological events during the process of 
neural tube closure: cells grow and differentiate fast in earlier stages while become mature in late 
stages, while requirement of morphogenesis of cells as well as neural tube are all through the 
neurulation process.  
As for the similarity or difference between the two adjacent tissues, it seems that there is 
not much difference in activity of development, cell maturation, cell structure and 
communication, morphogenesis and cell motility, signal transduction, transcription, as well as 
metabolism between NT and MD in earlier stages revealed by MHP-NT and MHP-MD related 
genes (Table 3.8). Almost all cellular events except molecule transport were more active in 
DLHP-NT than in DLHP-MD. This may be due to at the late stages of neurulation, the forces of 
NT closure comes from interior NT more than in the surrounding MD, the paraxial mesoderm in 
mode 3 is reduced and cells here more simplex (Fig.3.2).  Gene expression indicates that in 
earlier stages, genes highly expressed in both NT and MD, while in later stages, genes expressed 
mainly in NT rather than MD. This result is consistent with the hypothesis that forces for neural 
tube closure were from surrounding tissues in earlier stages while mainly depend on interior 






Table 3.8 GO analysis of MHP- and DLHP-related genes. 
Functional clusters MHP-NT 
(No. of genes) 
MHP-MD 
(No. of genes) 
DLHP-NT 
(No. of genes) 
DLHP-MD 
(No. of genes) 
Growth- related (GR) 70 67 37 10 
    Cell proliferation-related 11 6 11 2 
    Cell differentiation-
related 
18 20 5 3 
    Others (development and 
maturation) 
41 41 21 7 
Cell structure and 
communication (CSC) 
17 22 7 4 
    Cell adhesion and 
recognition-related 
10 10 7 1 
    Cytoskeleton-related 7 12 1 4 
Morphogenesis 18 18 19 6 
CMM 10 10 10 4 
ST 6 9 4 2 
TX 17 26 13 8 
NMCD 18 22 12 8 
CLAM 20 30 15 7 
ICMT 4 1 4 3 
Pathway genes 10 6 4 2 
 
CMM: Cell motility/cell migration; ST: Signaling transduction; TX: Transcription; NMCD: Nucleic acid 
metabolism and chromosome dynamics; CLAM: Carbohydrate, lipid, and amino acid metabolism; ICMT: 
Intra/inner cellular molecular transport.  
 
 
3.6.6 Transcriptomic analysis of gene expression during critical stages of neurulation 
reveals associations to diverse biological processes and multiple pathways 
Since each gene has multiple functions during different biological events, in order to 
know the most possible role that it does during the neurulation process, the functions of the 
genes enriched by GO analysis were compared with their functions recorded in NetAffex gene 
information cards and in the Pub med gene cards. Additionally, all genes in the MHP- and 
DLHP-related lists were checked in investigations of PubMed by literature research. More 
functions have been found for these genes, e.g., cell cycle, apoptosis, migration, RTK, GPCR, as 
well as intracellular signaling cascades, proteolysis, pigmentation, phosphorylation, etc. One 
common function for each gene, especially those involved in development, nervous system 
development, or neural tube closure has the privilege to be selected as possible functions during 
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neurulation process and listed in the tables below (from table 3.9 to table 3.16). These tables 
provided preliminary data and setup a framework for potential candidate genes for further 
investigation. Since all microarray analysis software gave similar fold change for each gene, 
results presented here based on the results generated by GCOS.   
The first three columns of each table presented the Affymetrix probe set ID, full name, 
and gene symbol for each gene. Fold changes between different stages for each gene were listed 
which revealed its differential expression during neurulation. Up-regulated genes in Table 3.9 
and 3.11 refer to the genes presented in NT (Table 3.9) and surrounding MD (Table 3.11) that 
expressed lower at E8.5 and E9.0 when MHP presents but their expression increased more than 2 
fold at E9.5 when MHP disappears. They may play a role in inhibiting MHP. At the same time, 
down-regulated genes in table 3.10 and 3.12 denote genes with higher expression in NT (Table 
3.10) and MD (Table 3.12) at E8.5 and E9.0 when MHP presents, but their expression decreased 
more than 2 fold at E9.5 when MHP disappears. These genes may play a part in sustaining the 
MHP. Genes listed in other four tables were related with the formation of DLHPs. Up-regulated 
genes in Table 3.13 and 3.15 refer to the genes presented in NT (Table 3.13) and surrounding 
MD (Table 3.15) that expressed lower at E8.5 in absent of DLHPs but their expression increased 
more than 2 fold at E9.0 and E9.5 when DLHPs take shape and sustain. They may motivate and 
accelerate the formation of DLHPs. At the same time, down-regulated genes in table 3.14 and 
3.16 represent genes with higher expression in NT (Table 3.14) and MD (Table 3.16) at E8.5 
before DLHPs present, but their expression decreased more than 2 fold at E9.0 and E9.5 when 
DLHPs appear. These genes may function in inhibiting DLHP formation, and inhibition of them 
can contribute to the formation of DLHPs.  
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The genes of multiple functions display a dynamic temporal and spatial difference among 
all stages. We describe most of the listed genes here and discuss their potential functions of the 
critical genes in neurulation later.  
 
3.6.6.1  Expression of genes related with cell growth  
We identified more than 60 cell growth-related genes including many that were not 
previously associated with neurulation. These genes were related with proliferation, 
differentiation, cell cycle regulation, apoptosis, cell maturation and/or embryonic development. 
Some genes have more than one function revealed by GO, but only one of the function were 
listed in the tables as mentioned above. 
Genes related with cell growth were expressed in all of the 8 MHP- and DLHP- related 
gene groups, but they were highly represented in up-regulated gene groups of MHP-NT (19 in 
Table 3.9), MHP-MD (10 in Table 3.11), DLHP-NT (9 in Table 3.13) and DLHP-MD (3 in 
Table 3.15), while less genes with the same function presented in down-regulated gene groups of 
MHP-NT (8 in Table 3.10), MHP-MD (4 in Table 3.12), DLHP-NT (3 in Table 3.14) and 
DLHP-MD (2 in Table 3.16). There were more than a dozen genes with regulation function of 
cell proliferation in the MHP-NT related gene groups revealed by GO, 5 of which have negative 
regulation function of cell proliferation. The 5 genes were: Pthr, Serpinf1, and Tgfb2 in Table 
3.9, Gtpbp4, and Spry2 in Table 3.10. And the remaining genes were: Foxp2, Hoxd13, Igf1, kdr, 
Pdgfc, Fabp7, and Cdk4 in Table 3.9, and Vzg1 in Table 3.10. There were 12 genes related with 
regulation of proliferation function in the DLHP-NT groups revealed by GO, and 5 of them were 
having negative regulation function. The 5 genes were: Igfbp3, Serpinf1, and Wnt5a in Table 
3.13, Cer1, and Rbp4 in Table 3.14. The other 6 genes were: CD40, Sox2, Fgf17, Fabp7, 
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Hoxd13 in Table 3.13, and Ccnd2, Tcfl5 in Table 3.14. There were 7 genes with function of 
proliferation revealed by GO in the MHP-MD related gene lists, Foxp2, Ccnd2, Fabp7, and Tgfbi 
in Table 3.11, and Fgf9, Spry2, Ppp1r14b in Table 3.12. In DLHP-MD related genes, 3 genes 
related with cell proliferation were listed, Fgf17, and Fabp7 in Table 3.15, and Rbp4 in Table 
3.16. Theoretically, when the genes of Gtpbp4 and Spry2 with negative regulation of cell 
proliferation function expressed in MHP-down-related gene groups, growth of certain cell 
populations will be inhibited during MHP formation, but the formation of MHP has positive 
correlation with these genes. In the MHP-up-regulated gene groups, expression of genes with 
negative regulation of cell proliferation function, such as Pthr, Serpinf1, and Tgfbi may have 
negative correlation with the formation of MHP. The Absolute Intensity of these 3 genes at E8.5 
and E9.0 were low when the MHP existed, but the expression became high at E9.5 when the 
MHP was inhibited. The expression of genes with cell proliferation function in the MHP-up-
regulated groups were negatively related with the formation of MHP, for their expression were 
low at E8.5 and E9.0 when MHP existed, but the expression became high at E9.5 when the MHP 
was inhibited. Similarly, expression of genes with negative regulation of cell proliferation 
function such as Cer1 and Rbp4 in DLHP-down-regulated groups were negatively correlated 
with the formation of DLHP. Because the expression of these genes were high at E8.5 when 
there was no DLHP, while their expression became low at E9.0 and E9.5 when the DLHPs forms 
and existed. Besides, the other 3 genes with negative regulation of cell proliferation function in 
the DLHP-up-regulated groups, Igfbp3, Serpinf1, and Wnt5a may have positive correlation with 
the formation of DLHP, because they were lowly expressed at E8.5 when there was no DLHP, 
but highly expressed at E9.0 and E9.5 when the DLHP were formed and existed. It is postulated 
that these two groups of genes may act on the same populations of genes with reverse actions. 
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Likewise, genes with regulation function of cell proliferation function in DLHP-up-regulated 
groups, such as CD40, Sox2, Fgf17, may have positive correlation with formation of DLHPs, 
while genes with regulation of cell proliferation function in the DLHP-down-regulated groups, 
such as Ccnd2 and Tcfl5, may have negative correlation with formation of DLHPs.  
Genes regulating cell cycle were highly down-regulated in MHP-NT group (5 genes of 
Gtpbp4, Seh1l, Aspm, Ppp1cb, Rbbp4 in Table 3.10), and DLHP-NT group (Ccnd2 in Table 
3.12), but few of the cell cycle genes were up-regulated in MHP-NT group (Cdk4 in Table 3.9). 
Genes with apoptosis function were mainly expressed in the up-regulated groups: MHP-NT-up 
(3 genes of Psme3, Eya1, and Rnf216 in Table 3.9), MHP-MD-up (3 genes of Actc1, Tia1, and 
Psme3 in Table 3.10), DLHP-NT-up (Dhcr24 in Table 3.13), DLHP-MD-up (Actc1 and Alx3 in 
Table 3.15), and only one expressed in the MHP-MD-down-regulated group (Rffl in Table 3.12). 
The expression patterns of cell cycle and apoptosis genes shows that growth is regulated during 
the presence or absence of MHP and DLHPs in addition to the universal growth feature in 
neurulation stage embryos.  
Cell differentiation at the end of neurulation became active, which were reflected by the 
expression pattern of genes with function of cell differentiation revealed by GO. Most of the cell 
differentiation genes were up-regulated in the MHP- and DLHP- related groups, including Epha7, 
Top2b, Tubb3, Isl1, Mtap2, Rncr2, Nefl2, Onecut2 in MHP-NT-up-regulated group (Table 3.9), 
Irx5, Cutl1, Dclk1, Kif5c, Mtap1b, and Stmn3 in MHP-MD-up-regulated group (Table 3.11), 
which may be positively correlated with the differentiation of cells at the MHP; and Socs2, 
Foxd1, Hoxc10, and Lpl in DLHP-NT-up-regulated group (Table 3.13), and Socs2 in DLHP-
MD-up-regulated group (Table 3.15), which may be positively correlated with the differentiation 
of cells at the DLHPs. A few genes with function of cell differentiation were presented in the 
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down-regulated gene groups, including Cxcr4, Aspm, Ttc3 in MHP-NT-down-regulated group 
(Table 3.10),  Ubc in MHP-MD-down-regulated group (Table 3.12). These genes may be 
negatively related with cell differentiation at MHP. Nrcam, Alcam, Ptprz1, and Ret in DLHP-
NT-down-regulated group (Table 3.14), Ptprz1 were presented in DLHP-MD-down-regulated 
group (Table 3.16), which may be negatively correlated with cell differentiation at DLHPs. The 
formation of MHP and DLHPs by bending and folding of the neural folds during neurulation 
were accompanied with cell morphogenesis (Colas and Schoenwolf, 2001). It was revealed by 
GO that some of the cell differentiation genes have function involved in morphogenesis which 
were important for neurulation. These genes include:  Nefl, Nefm, Ttc3, Epha7, Isl1, and Top2b 
in MHP-NT-up-regulated group (Table 3.9), Cxcr4 in MHP-NT-down-regulated group (Table 
3.10), Dclk1 and Kif5c in MHP-MD-up-regulated group (Table 3.11), Alcam and Foxd1 in 
DLHP-NT-up-regulated group (Table 3.13), Nrcam and Ptprz1 in DLHP-NT-down-regulated 
group (Table 3.14).  
 
3.6.6.2 Cell structure and adhesion related genes: 
Cell structure and adhesion related genes provide mechanical support and transport for 
the process of neural tube closure. The extracellular matrix interacting with cell surface receptors 
via cytoskeleton-mediated events are important for cell shape and polarization. Cytoskeleton has 
a potential role for formation and movement of the neural folds, while the initiation of fusion at 
the tips of the closing neural folds could be facilitated by cell adhesion molecules. In the current 
microarray results, the cell structure and adhesion related genes were dominantly expressed in 
the up-regulated groups: 15 in Table 3.9, 13 in Table 3.11, 5 in Table 3.13, and 3 in Table 3.15, 
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while less genes were down-regulated: 5 in Table 3.10, 4 in Table 3.14, 1 in Table 3.12 and 
3.16.  
Cytoskeleton proteins have been shown playing an essential role in neural tube defects, 
especially for cranial closure (Copp and Greene, 2010b). Actin neurofilaments are localized at 
the apical side of cells in the neural folds (Sadler et al., 1982; Zolessi and Arruti, 2001). The 
neuroepithelial cells wedged within the hinge points involves apical narrowing with the presence 
of circumferential microfilaments (Lee and Nagele, 1985), and basal expansion which may be 
due to the position of nuclei of newly formed daughter cells migrating from the apex toward the 
base of neuroepithelial cells mediated by microtubules (Smith and Schoenwolf, 1988). 
Microfilaments may play a role in stabilizing the shape of the neural folds or newly formed 
neural tube (Schoenwolf and Smith, 1990).  
Cell structure related genes such as Nefl, Nefm, Mtap2, Tubb3, Epb4.1l3, and Synpo were 
up-regulated in the MHP-NT related group (Table 9), and Seh1l was down-regulated in the 
MHP-NT group (Table 10). In the MHP-MD related groups, Kif21a, Kif5c, Mtap1b, Mtap2, 
Stmn3, Tmsb10, Mid1, Actc1, and Mgl2 were up-regulated (Table 11), while Seh1l was down-
regulated (Table 12). These are newly found genes that are not reported related with neurulation.  
Adhesion molecules were also found mostly up-regulated with a few down-regulated in the 
microarray results. Those presented in MHP-NT group include: Cdh11, Cldn5, Col3a1, Col9a1, 
Megf10, Thbs1, Edil3, Itga9 Epha7 and Nid1in Table 9, and Epha5 in Table 10. In MHP-MD 
group presented: Celsr2, Gpr98, Cad11, Cd2a1, Lgals, and Tgfbi (Table 11). Expression of 
these genes were high at E9.5 when MHP disappeared compared with at E8.5 and E9.0 when 
MHP existed,  this may imply that adhesion may not be important for MHP formation. 
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In DLHP-NT related groups, CD44, Fat4, Antxr, and Postn were up-regulated (Table 13), 
while Alcam, Nrcam, and Ret were down-regulated (Table 14). This expression pattern indicates 
that cell adhesion was actively regulated during the formation of DLHP and imply an essential 
role of adhesion function in initiation of neural tube closure.  
It is noticed that 2 of the 4 adhesion molecules in DLHP-NT-down-regulation group, 
CD44, and Sdc4, were found related with neural tube defects. Both CD44 and Sdc4 belong to 
GAG genes, the former was involved in tube morphogenesis and the later played a role in cell 
proliferation. Celsr2, Epha5, and Epha7, which were found in MHP-related gene groups were 
also found related to neural tube defects, though their roles were not confirmed.    
 
3.6.6.3 Transcription factors and NMCD molecules: 
The activity of transcription factors were found active through stages of neurulation in 
both NT and MD. Many genes with function of differentiation and proliferation are 
transcriptional factors in molecule level, some of them also play roles in morphogenesis, which 
was a critical process for neurulation. Many NMCD genes were transcription factor, too. They 
were important in regulation of gene expression, mutation of which lead to all kinds of diseases. 
The transcription factors, Zic3 and Twist 1 in Table 3.9, Jmjd3, Zic2 and Sall4 in Table 3.10, 
Celsr2 in Table 3.11, Wnt5a in Table 3.13, were well known critical genes to neural tube 







3.6.6.4 Genes linked to multiple pathways 
There were 4 main pathways revealed by GO biological process: Transmembrane 
receptor protein tyrosine kinase signaling pathway (TRPTK), enzyme linked receptor protein 
signaling pathway (ERP), Wnt receptor signaling pathway (Wnt), and regulation of transforming 
growth factor beta receptor signaling pathway (TGFbR). The TRPTK pathway has high 
similarity with ERP pathway since they have 11 common genes: Epha7, Ddr2, Fgf17, Fgf9, Igf1, 
Kdr, Pdgfc, Ror1, Ret, Mrf1l, and Tgfb2. In addition, TRPTKS pathway has another 3 genes 
found in the neurulation process: Epha5, Rgs2, and Arid5b, while ERP pathway has one more: 
Rgmb. 6 Wnt pathway genes were found: Wnt5a, Wif1, Frd3, Frd5, Celsr2, and Sostdc1. In 
addition, Fgf9 was a known Wnt pathway related gene. TGFbR pathway genes include: Onecut2, 
Thbs1, Prdm16, Gdf10 (Bmp3b), and Cer1. Furthermore, gene analysis by NetAffyx center and  
literature research also revealed 5 more pathways: GPCR, Notch (Dtx4), Fgf (Fgf9, Fgf17, and 
Igf1), Smoothened (Tgfbr2 and Fgf9), and PDGF (Arid5b). Among these, GPCR pathway has 
more genes: Gper, Edg3, Edg2, Cxcr4, Vzg1, Gng4, Rgs2 (also known as TRPTK pathway gene), 
and Celsr2 (also known as Wnt pathway gene). These pathway genes were differentially 
expressed among stages of neurulation in NT and/or MD. Further investigation of their function 









Table 3.9 MHP-NT related up-regulated genes  
    Fold change  
Probe set Gene name Gene Symbol 85vs95 90vs95 85+90vs95 gene function  
1452163_at E26 avian leukemia oncogene 1, 5' domain Ets1 6.38 6.91 6.63 differentiation 
1441956_s_at cut-like homeobox 1 Cutl1 2.52 3.07 2.78 differentiation 
1449077_at erythroid associated factor Eraf 3.39 2.47 2.86 differentiation 
1418698_a_at ferrochelatase Fech 2.25 2.06 2.15 differentiation 
1415978_at tubulin, beta 3; tubulin, beta 3, pseudogene 1 Tubb3 10.24 2.43 3.93 differentiation 
1455325_at 
myocardial infarction associated transcript (non-protein 
coding) Rncr2 2.98 2.82 2.89 differentiation 
1460044_at one cut domain, family member 2 Onecut2 5.59 3.07 4 differentiation 
1456688_at topoisomerase (DNA) II beta Top2b 4.06 2.59 3.16 differentiation 
1434194_at microtubule-associated protein 2 Mtap2 7.21 3.06 4.29 differentiation 
1454672_at neurofilament, light polypeptide Nefl 3.16 4.27 3.63 differentiation 
1451991_at Eph receptor A7 Epha7 6.9 6.51 6.7 differentiation 
1450723_at ISL1 transcription factor, LIM/homeodomain Isl1 3.41 4.08 3.71 differentiation 
1438658_a_at sphingosine-1-phosphate receptor 3 Edg3 2.4 2.49 2.44 differentiation 
1426801_at septin 8 Sept--8 2.34 1.93 2.11 proliferation 
1437401_at insulin-like growth factor 1 Igf1 4.35 5.66 4.92 proliferation 
1419123_a_at platelet-derived growth factor, C polypeptide Pdgfc 2.7 1.97 2.28 proliferation 
1426397_at transforming growth factor, beta receptor II Tgfbr2 3.22 2.96 3.09 proliferation 
1454867_at meningioma 1 Mn1 3.99 3.92 3.95 proliferation 
1417092_at parathyroid hormone receptor 1 Pthr 2.35 4.75 3.14 proliferation 
1416168_at serine (or cysteine) peptidase inhibitor, clade F, member 1 Serpinf1 6.69 2.26 3.38 proliferation 
1440626_at homeo box D13 Hoxd13 29.86 7.57 15.03 proliferation 
1449379_at kinase insert domain protein receptor Kdr 2.15 2.23 2.19 proliferation 
1438231_at forkhead box P2 Foxp2 2.85 2.27 2.53 proliferation 
1450779_at fatty acid binding protein 7, brain Fabp7 26.49 7.8 12.05 proliferation 
1422440_at 
similar to Cell division protein kinase 4 (Cyclin-dependent 
kinase 4) (PSK-J3) (CRK3); cyclin-dependent kinase 4 Cdk4 2.18 1.98 2.08 cell cycle 
1418078_at proteaseome (prosome, macropain) 28 subunit, 3 Psme3 2.64 2.84 2.74 apoptosis 
1457424_at eyes absent 1 homolog (Drosophila) Eya1 2.35 5.63 3.31 apoptosis 
1437532_at ring finger protein 216 Rnf216 2.57 2.12 2.32 apoptosis 
1450757_at cadherin 11 Cdh11 5.27 2.45 3.35 adhesion 
1417839_at claudin 5 Cldn5 3 2.75 2.87 adhesion 
1427883_a_at collagen, type III, alpha 1 Col3a1 14.84 4.92 7.39 adhesion 
1428571_at collagen, type IX, alpha 1 Col9a1 3.16 4.01 3.54 adhesion 
1429841_at multiple EGF-like-domains 10 Megf10 4.94 3.42 4.05 adhesion 
1416808_at 
similar to Nidogen precursor (Entactin); nidogen 1; similar 
to Nid1 protein Nid1 4.13 4.65 4.37 adhesion 
1421811_at thrombospondin 1; similar to thrombospondin 1 Thbs1 3.23 3.1 2.4 adhesion 
1460285_at integrin alpha 9 Itga9 1.84 2.53 2.13 adhesion 
1433474_at EGF-like repeats and discoidin I-like domains 3 Edil3 2.75 2.6 2.67 adhesion 
1436568_at junction adhesion molecule 2 Jam2 5.78 3.52 4.38 adhesion 
1440595_at erythrocyte protein band 4.1-like 3 Epb4.1l3 2.41 2.5 2.46 
cytoskeleton 
organization 
1422520_at neurofilament, medium polypeptide Nefm 10.77 19 13.75 
cytoskeleton 
organization 









similar to COUP-TFI; nuclear receptor subfamily 2, group 
F, member 2 Nr2f2 3.08 5.34 3.91 migration 
1429372_at SRY-box containing gene 11 Sox11 2.1 1.87 1.98 transcription 
1454758_a_at TSC22 domain family, member 1 Tsc22d1 1.93 1.86 1.89 transcription 
1444615_x_at 
runt-related transcription factor 1; translocated to, 1 
(cyclin D-related) Runx1t1 5.02 5.41 5.21 transcription 
1435670_at transcription factor AP-2 beta Tcfap2b 9.04 8.3 8.65 transcription 
1437556_at zinc finger homeodomain 4 Zfhx4 6.26 8.32 7.15 transcription 
1438737_at zinc finger protein of the cerebellum 3 Zic3 4.09 6.05 4.88 transcription 
1418733_at twist homolog 1 (Drosophila) Twist1 2.85 7.47 4.13 transcription 
1440870_at PR domain containing 16 Prdm16 4.22 5.2 4.66 NMCD 
1439123_at PHD finger protein 21A Phf21a 2.74 2.14 2.4 NMCD 
1441333_at 
trichorhinophalangeal syndrome I (human); similar to 
Trps1 protein Trps1  3.63 2.62 3.05 NMCD 
1421923_at SH3-domain binding protein 5 (BTK-associated) Sh3bp5 3.56 2.17 2.69 
intracellula 
signaling cascades 
1433919_at ankyrin repeat and SOCS box-containing 4 Asb4 2.71 2.44 2.57 
intracellula 
signaling cascades 
1418364_a_at ferritin light chain 1 Ftl1 3.26 1.88 2.39 transport 
1437165_a_at procollagen C-endopeptidase enhancer protein Pcolce 6.57 3.37 4.45 proteolysis 
1424886_at protein tyrosine phosphatase, receptor type, D Ptprd 4.61 2.7 3.4 dephosphorylation 
1417750_a_at solute carrier family 25, member 37 Slc25a37 2.11 2.22 2.16 transport 
1425315_at dedicator of cytokinesis 7 Dock7 3.2 1.9 2.38 pigmentation 
1448346_at cofilin 1, non-muscle Cfl1 2.22 1.76 1.96  
1460436_at 
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 
1 Ndst1 2.43 1.97 2.17 GAG synthesis 
1423091_a_at glycoprotein m6b Gpm6b 14.4 11.81 12.98 Glycoprotein 
1455604_at frizzled homolog 5 (Drosophila) Fzd5 2.92 3.07 2.99 Wnt signaling 
 
 
Table 3.10 MHP-NT related down-regulated genes 
 




gene function 1 85vs95 90vs95 85+90vs95 
1421144_at 
retinitis pigmentosa GTPase regulator 
interacting protein 1 Rpgrip1 -8.06 -3.99 -6.03 differentiation 
1416484_at tetratricopeptide repeat domain 3 Ttc3 -2.33 -2.38 -2.36 differentiation 
1458560_at 
asp (abnormal spindle)-like, microcephaly 
associated (Drosophila) Aspm -3.69 -3.1 -3.39 differentiation 
1448710_at chemokine (C-X-C motif) receptor 4 Cxcr4 -2.59 -2.59 -2.59 differentiation 
1448606_at lysophosphatidic acid receptor 1 Vzg1 -3.45 -3.12 -3.32 proliferation 
1423143_at GTP binding protein 4 Gtpbp4 -3 -4 -3.5 proliferation 
1436584_at sprouty homolog 2 (Drosophila) Spry2 -3.67 -3.77 -3.72 proliferation 
1431328_at 
protein phosphatase 1, catalytic subunit, beta 
isoform Ppp1cb -3.22 -3.58 -3.4 cell cycle 
1456260_at retinoblastoma binding protein 4 Rbbp4 -2.47 -2.53 -2.5 cell cycle 
1419967_at SEH1-like (S. cerevisiae) Seh1l -3.16 -3.08 -3.12 cell cycle 
1437920_at Eph receptor A5 Epha5 -3.71 -3.25 -3.48 adhesion 
1426865_a_at neural cell adhesion molecule 1 Ncam1 -3.77 -3.89 -3.83 adhesion 
1449799_s_at plakophilin 2 Pkp2 -4.92 -3.52 -4.22 adhesion 
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1438556_a_at tropomodulin 3 Tmod3 -2.77 -3.16 -2.97 
cytoskeleton 
organization 
1422719_s_at nucleoporin 50 Nup50 -2.9 -2.52 -2.71 morphogenesis 
1440346_at Jumonji domain containing 3 Jmjd3 -3.14 -2.78 -2.96 transcription 
1418024_at NMDA receptor-regulated gene 1 Narg1 -3.22 -3.14 -3.18 transcription 
1421933_at chromobox homolog 5 (Drosophila HP1a) Cbx5 -3.43 -4.16 -3.79 transcription 
1424153_s_at sal-like 4 (Drosophila) Sall4 -4.66 -9.97 -7.31 transcription 
1449578_at suppressor of Ty 16 homolog (S. cerevisiae) Supt16h -2.8 -2.27 -2.54 transcription 
1434644_at transducin (beta)-like 1 X-linked Tbl1x -2.51 -2.84 -2.67 transcription 
1421301_at zinc finger protein of the cerebellum 2 Zic2 -2.86 -2.67 -2.76 transcription 
1450035_a_at 
PRP40 pre-mRNA processing factor 40 
homolog A (yeast) Prpf40a -2.53 -2.79 -2.66 NMCD 
1452540_a_at 
similar to Hist1h2bj protein; histone cluster 
1, H2bl; predicted gene Hist1h2bm -2.23 -2.5 -2.37 NMCD 
1418227_at 
origin recognition complex, subunit 2-like (S. 
cerevisiae) Orc2l -2.69 -3.83 -3.26 NMCD 
1427262_at inactive X specific transcripts Xist -3.53 -3.14 -3.34 NMCD 
1447869_x_at Rho-related BTB domain containing 3 Rhobtb3 -6.77 -3.55 -5.16 transport 
1452454_at 
SDA1 domain containing 1; similar to SDA1 
domain containing 1 Sdad1 -2.55 -3.38 -2.97 transport 
1426269_at 
predicted gene 14338; vesicle-associated 
membrane protein 7 Vamp7 -2.36 -2.73 -2.55 transport 
1416062_at TBC1 domain family, member 15 Tbc1d15 -4.58 -3.44 -4.01 
regulation of Rab, 
GTPase, Ras activity 
1417695_a_at sterol O-acyltransferase 1 Soat1 -4.46 -3.94 -4.2 CLAM 
1458347_s_at transmembrane protease, serine 2 Tmprss2 -3.81 -2.82 -3.32 proteolysis 
1450954_at YME1-like 1 (S. cerevisiae) Yme1l1 -2.79 -3.75 -3.27 proteolysis 
1418014_a_at 
betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 1  B4galt1 -2.5 -1.65 -2.68 GAG synthesis 
1423674_at 
ubiquitin specific peptidase 1; predicted gene 
5841 Usp1 -2.71 -3.25 -2.98 
regulation of cellular 
response to stress 
 
 
Table 3.11 MHP-MD related up-regulated genes  
 
    Fold change  
Probe set Gene name Gene Symbol 85vs95 90vs95 85+90vs95 gene function  
1421072_at Iroquois related homeobox 5 (Drosophila) Irx5 4.37 5.65 4.93 differentiation 
1441956_s_at cut-like homeobox 1 Cutl1 4.27 2.78 3.37 differentiation 
1436659_at doublecortin-like kinase 1 Dclk1 3.39 2.73 3.02 differentiation 
1452163_at E26 avian leukemia oncogene 1, 5' domain Ets1 2.15 2.04 2.09 differentiation 
1451991_at Eph receptor A7 Epha7 16.12 5.92 2.5 differentiation 
1418467_at 
SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily d, member 3 Smarcd3 2.49 2.32 2.4 differentiation 
1450397_at microtubule-associated protein 1B Mtap1b 4.64 4.73 4.68 differentiation 
1434194_at microtubule-associated protein 2 Mtap2 10.93 4.93 6.79 differentiation 
1422945_a_at kinesin family member 5C Kif5c 5.09 2.59 3.44 differentiation 
1435113_x_at stathmin-like 3 Stmn3 3.58 4.47 2.29 differentiation 
1419247_at regulator of G-protein signaling 2 Rgs2 3.36 3.15 3.25 differentiation 
1438232_at forkhead box P2 Foxp2 3.62 2.86 3.2 proliferation 
1448123_s_at transforming growth factor, beta induced Tgfbi 6.73 2.93 4.09 proliferation 
1450779_at fatty acid binding protein 7, brain Fabp7 45.52 3.94 7.26 proliferation 
1430127_a_at cyclin D2 Ccnd2 2.26 2.24 2.25 cell cycle 
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1431708_a_at cytotoxic granule-associated RNA binding protein 1 Tia1 2 1.93 13.1 apoptosis 
1418078_at proteaseome (prosome, macropain) 28 subunit, 3 Psme3 2.91 2.63 1.96 apoptosis 
1415927_at 
actin, alpha, cardiac muscle 1; similar to alpha-actin (AA 
27-375) Actc1  25.11 8.85 8.66 apoptosis 
1435336_at 
cadherin, EGF LAG seven-pass G-type receptor 2 
(flamingo homolog, Drosophila) Celsr2 2.21 2.41 2.31 adhesion 
1450567_a_at collagen, type II, alpha 1 Col2a1 3.64 3.09 3.35 adhesion 
1455439_a_at lectin, galactose binding, soluble 1 Lgals1 2.02 2.07 2.04 adhesion 
1445740_at G protein-coupled receptor 98  Gpr98 6.77 4.92 5.7 adhesion 
1446245_at Cadherin 11 Cad11 2.78 2.47 2.62 adhesion 




actin, alpha, cardiac muscle 1; similar to alpha-actin (AA 
27-375) Actc1 25.11 8.85 8.66 
cytoskeleton 
organization 




predicted gene 3787; predicted gene 9844; predicted gene 
8034; similar to thymosin, beta 10; thymosin, beta 10 Tmsb10 3.35 2.85 3.08 
cytoskeleton 
organization, 
1418370_at troponin C, cardiac/slow skeletal Tnnc1 5.69 8.6 6.85 
cytoskeleton 
organization 
1450641_at vimentin Vim 3.96 2.2 2.83 
cytoskeleton 
organization 




1456062_at natriuretic peptide precursor type A Nppa 8.89 8.86 8.87 
regulation of tube 
size 
1441107_at 
doublesex and mab-3 related transcription factor like 
family A2 Dmrta2 2.64 4.95 3.44 transcription 
1436931_at 
regulatory factor X, 4 (influences HLA class II 
expression) Rfx4 6.16 10.03 7.63 transcription 
1444615_x_at 
runt-related transcription factor 1; translocated to, 1 
(cyclin D-related) Runx1t1 4.96 4.95 4.95 transcription 
1418157_at 
similar to COUP-TFI; nuclear receptor subfamily 2, group 
F, member 2 Nr2f1 9.17 60.82 15.9 transcription 
1437556_at zinc finger homeodomain 4 Zfhx4 2.94 3.77 3.3 transcription 
1423895_a_at CUG triplet repeat, RNA binding protein 2 Cugbp2 2.55 3.72 3.02 NMCD 
1417440_at 
similar to AT rich interactive domain 1A isoform a; AT 
rich interactive domain 1A (SWI-like) Arid1a 5.24 2.95 3.77 NMCD 
1421923_at SH3-domain binding protein 5 (BTK-associated) Sh3bp5 2.24 2.33 2.77 
intracellula 
signaling cascades 
1434369_a_at crystallin, alpha B Cryab 3.18 2.19 2.59 
response to 
abiotic stimulus, 
1425315_at dedicator of cytokinesis 7 Dock7 3.81 2.11 2.72 pigmentation 
1436545_at deltex 4 homolog (Drosophila) Dtx4 2.42 1.88 2.12 
signal 
transduction 
1449010_at heat shock protein 4 like Hspa4l 4.27 3.29 3.71 
response to 
protein stimulus, 
1449059_a_at 3-oxoacid CoA transferase 1 Oxct1 5.23 3.25 2.87 CLAM 
1440286_at F-box and leucine-rich repeat protein 16 Fbxl16 3.07 3.07 3.07 CLAM 
1448987_at acyl-Coenzyme A dehydrogenase, long-chain Acadl 2.9 2.16 2.47 CLAM 
1448553_at myosin, heavy polypeptide 7, cardiac muscle, beta Myh7 20.09 32.15 24.7 CLAM 
1425506_at myosin, light polypeptide kinase Mylk 2.25 1.92 2.07 phosphorylation 
1435486_at p21 protein (Cdc42/Rac)-activated kinase 3 Pak3 7.75 6.04 6.79 phosphorylation, 
1424886_at protein tyrosine phosphatase, receptor type, D Ptprd 4.98 3.09 3.81 dephosphorylation 
1437165_a_at procollagen C-endopeptidase enhancer protein Pcolce 5.26 2.77 3.63 proteolysis 
1431057_a_at protease, serine, 23 Prss23 5.45 5.1 5.27 proteolysis, 
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1439500_at secernin 1 Scrn1 4.56 4.98 4.76 transport 
1455106_a_at 
similar to creatine kinase, brain; predicted gene 12892; 
creatine kinase, brain Ckb 10.66 5.82 7.52 
cellular 
homeostasis 
1438239_at similar to midline 1; midline 1 Mid1 2.32 2.81 2.54 proteolysis 
1434249_s_at tripartite motif-containing 9 Trim9 3.76 4.74 4.19 cell-cell signaling, 
1454867_at meningioma 1 Mn1 3.03 4.7 3.69 ossification 
1433551_at 
vesicle amine transport protein 1 homolog-like (T. 
californica) AI427515 2.79 3.17 2.97 
oxidation 
reduction 
1449340_at sclerostin domain containing 1 Sostdc1 2.43 2.95 2.67 Wnt signaling 
1438101_at Frizzled homolog 3 (Drosophila) Fzd3 3.71 3.93 2.34 Wnt signaling 
 
 
Table 3.12   MHP-MD related down-regulated genes 
 
Probe set Gene name Gene Symbol 
Fold Change 
gene function 85vs95 90vs95 85+90vs95 
1454373_x_at ubiquitin B; similar to Ubc protein;  Ubc -8.07 -4.84 -6.45 differentiation 
1438718_at fibroblast growth factor 9 Fgf9 -3.17 -2.74 -2.96 proliferation 
1436584_at sprouty homolog 2 (Drosophila) Spry2 -3.59 -3.64 -3.61 proliferation 
1436716_at 
Protein phosphatase 1, regulatory (inhibitor) 
subunit 14B Ppp1r14b -2.95 2.9 -2.93 proliferation 
1434432_at 
ring finger and FYVE like domain containing 
protein Rffl -3.72 -2.93 -3.33 apoptosis 
1419967_at SEH1-like (S. cerevisiae Seh1l -2.62 -3.36 -2.99 
cytoskeleton 
organization 
1452085_at GATA zinc finger domain containing 1 Gatad1 -2.88 -2.58 -2.73 transcription 
1440346_at Jumonji domain containing 3 Jmjd3 -3.44 -2.43 -2.93 transcription 
1457473_at 
chromodomain helicase DNA binding protein 
1 Chd1 -2.84 -2.73 -2.78 NMCD 
1427263_at inactive X specific transcripts Xist -5.57 -3.39 -2.48 NMCD 
1456565_s_at 
mitogen-activated protein kinase kinase 
kinase 12 Map3k12 -4.28 -3.79 -4.03 NMCD 
1448606_at 
endothelial differentiation, lysophosphatidic 




1417695_a_at sterol O-acyltransferase 1 Soat1 -5.02 3.51 -4.27 CLAM 
1458347_s_at transmembrane protease, serine 2 Tmprss2 -5.69 -4.3 -4.99 proteolysis  
1421556_at 
serine (or cysteine) peptidase inhibitor, clade 
A, member 3A Serpina3a -7.41 -10.63                  -5.89 proteolysis 
1451440_at chondrolectin Chodl -4.56 -2.83 -3.69 GAG binding 
1418014_a_at 
betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 1  B4galt1 -2.21 -2.77 -2.51 GAG synthesis 












Table 3.13 DLHP-NT related up-regulated genes  
 




gene function 85vs90 85vs95 85vs90+95 
1454086_a_at LIM domain only 2 Lmo2 2.35 4 3.18 differentiation 
1419430_at 
cytochrome P450, family 26, subfamily 
a, polypeptide 1 Cyp26a1 3.25 2.59 2.92 differentiation 
1418876_at forkhead box D1 Foxd1 5 3.14 4.07 differentiation 
1439798_at homeo box C10 Hoxc10 14.02 18.44 16.2 differentiation 
1416168_at 
serine (or cysteine) peptidase inhibitor, 
clade F, member 1 Serpinf1 2.96 6.69 4.83 differentiation 
1415904_at 
lipoprotein lipase; similar to 
Lipoprotein lipase precursor (LPL) Lpl 6.25 3.63 4.94 differentiation 
1449109_at 
suppressor of cytokine signaling 2; 
predicted gene 8000 Socs2 3.43 3.55 3.49 differentiation 
1449473_s_at CD40 antigen CD40 3.71 2.54 3.12 proliferation 
1456781_at SRY-box containing gene 2 Sox2 -6.7 -4.92 -5.78 proliferation 
1440626_at homeo box D13 Hoxd13 3.42 20.1 11.8 proliferation 
1423062_at 
insulin-like growth factor binding 
protein 3 Igfbp3 3.64 3.52 3.58 proliferation 
1456239_at fibroblast growth factor 17 Fgf17 3.56 4.23 3.89 proliferation 
1437673_at 
wingless-related MMTV integration 
site 5A Wnt5a 3 4.58 3.79 proliferation 
1450779_at fatty acid binding protein 7, brain Fabp7 3.4 26.49 14.9 proliferation 
1418129_at 24-dehydrocholesterol reductase Dhcr24 3.03 5.28 4.15 apoptosis 
1459749_s_at 
FAT tumor suppressor homolog 4 
(Drosophila) Fat4 5.25 4.98 5.12 adhesion 
1451446_at anthrax toxin receptor 1 Antxr1 3.12 5.34 4.23 adhesion 
1423606_at periostin, osteoblast specific factor Postn 3.88 2.86 3.37 adhesion 
1456292_a_at vimentin Vim 3.25 4.16 3.71 Cytoskeleton organization 
1416361_a_at 
dynein cytoplasmic 1 intermediate 
chain 1 Dync1i1 4.18 2.94 3.56 intracellular transport, 
1459790_x_at aristaless-like homeobox 3 Alx3 4.05 4.02 4.04 transcription 
1436050_x_at 
hairy and enhancer of split 6 
(Drosophila) Hes6 2.39 2.07 2.23 transcription 
1446408_at homeo box A10 Hoxa10 16.06 12.8 14.4 transcription 
1434286_at 
trichorhinophalangeal syndrome I  
(human); similar to Trps1 protein Trps1 3.59 2.92 3.26 transcription 
1433638_s_at homeo box D8 Hoxd8 3.07 2.55 2.81 transcription 
1417392_a_at 
solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 7 Slc7a7 4.11 5.44 4.78 transmembrane transport 
1416561_at glutamic acid decarboxylase 1 Gad1 2.49 3.93 3.21 cell-cell signaling 
1434642_at 
hydroxysteroid (17-beta) 
dehydrogenase 11 Hsd17b11 3.77 2.47 3.12 CLAM 
1419821_s_at 
isocitrate dehydrogenase 1 (NADP+), 
soluble Idh1 3.06 2.58 2.82 CLAM 
1423078_a_at sterol-C4-methyl oxidase-like Sc4mol 4.04 3.08 3.56 CLAM 









Table 3.14 DLHP-NT related down-regulated genes 
 




gene function 85vs90 85vs95 85vs90+95 
1452284_at, 
1427019_at 
protein tyrosine phosphatase, 
receptor type Z, polypeptide 1 Ptprz1 -5.33 -4.29 -4.75 differentiation 
1424007_at growth differentiation factor 10 Gdf10 -3.96 -2.77 -3.26 differentiation 
1426225_at retinol binding protein 4, plasma Rbp4 -2.68 -3.1 -2.87 proliferation 
1450256_at 
cerberus 1 homolog (Xenopus 
laevis) Cer1 -3.97 -3.3 -3.6 proliferation 
1456515_s_at 
transcription factor-like 5 (basic 
helix-loop-helix) Tcfl5 -3.7 -6.22 -4.64 proliferation 
1448229_s_at cyclin D2 Ccnd2 -2.37 -2.27 -2.32 cell cycle 
1423760_at CD44 antigen Cd44 -2.35 -3.29 -2.74 adhesion 
1426301_at 
activated leukocyte cell adhesion 
molecule Alcam -2.26 -2.41 -2.33 adhesion 
1434709_at 
neuron-glia-CAM-related cell 
adhesion molecule Nrcam -3.19 -2.66 -2.9 adhesion 
1417654_at syndecan 4 Sdc4 -4.41 -7.62 -5.47 adhesion 
1434283_at 
similar to modulator recognition 
factor 2; AT rich interactive domain 
5B (MRF1-like) Arid5b -5.37 -2.68 -3.58 migration 
1436359_at ret proto-oncogene Ret -6.84 -8.59 -7.61 morphogenesis 
1447360_at TSC22 domain family, member 1 Tsc22d1 -3.16 -2.22 -2.61 transcription 
1428825_at, 
1428826_at 
nuclear receptor subfamily 6, group 
A, member 1 Nr6a1 -7.45 -9.7 -8.43 transcription 
1455345_at PHD finger protein 15 Phf15 -2.06 -2.91 -2.41 NMCD 
1419549_at arginase, liver Arg1 -5.84 -5.77 -5.81 CLAM 
1455593_at 
protein tyrosine phosphatase, 
receptor type Z, polypeptide 1 Apob -8.75 -19.58 -12.1 CLAM 
1443824_s_at carbonic anhydrase 7 Car7 -4.24 -4.85 -4.53 CLAM 
1441927_at synaptotagmin VII Syt7 -2.45 -3.18 -2.77 plasma membrane organization 
1416855_at growth arrest specific 1 Gas1 -2.11 -2.18 -2.15 Shh signaling 
1447669_s_at 
guanine nucleotide binding protein 
(G protein), gamma 4 Gng4 -5.8 -4.59 -5.12 GPCR 
 
 
Table 3.15 DLHP-MD related up-regulated genes  
 




gene function 85vs90 85vs95 85vs90+95 
1449109_at 
suppressor of cytokine signaling 2; predicted gene 
8000 Socs2 3.19 4.28 3.73 differentiation 
1456239_at fibroblast growth factor 17 Fgf17 7.53 8.77 8.15 proliferation 
1450779_at fatty acid binding protein 7, brain Fabp7 11.55 45.52 28.6 proliferation 
1415927_at 
actin, alpha, cardiac muscle 1; similar to alpha-actin 
(AA 27-375) Actc1 2.84 25.11 14 apoptosis 
1459790_x_at aristaless-like homeobox 3 Alx3 3.41 5.49 4.45 apoptosis 
1450757_at cadherin 11 Cdh11 2.42 4.02 3.22 adhesion 
1418599_at collagen, type XI, alpha 1 Col11a1 2.36 4.58 3.47 adhesion 
1429438_at BCL6 interacting corepressor Bcor 2.24 2.5 2.37 transcription 
1436050_x_at hairy and enhancer of split 6 (Drosophila) Hes6 2.63 2.95 2.79 transcription 
1449530_at trichorhinophalangeal syndrome I (human); similar Trps1 2.46 2.98 2.72 transcription 
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to Trps1 protein 
1417392_a_at 
solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 7 Slc7a7 2.39 3.72 3.05 
transmembrane 
transport 
1423078_a_at sterol-C4-methyl oxidase-like Sc4mol 4.13 5.3 4.71 CLAM 
1419430_at 
cytochrome P450, family 26, subfamily a, 
polypeptide 1 Cyp26a1 3.55 4.49 4.02 CLAM 
1415904_at 
lipoprotein lipase; similar to Lipoprotein lipase 
precursor (LPL) Lpl 4.95 4.04 4.5 CLAM 
 
 
Table 3.16 DLHP-MD related down-regulated genes 
 




gene function 85vs90 85vs95 85vs90+95 
1452284_at 
protein tyrosine phosphatase, 
receptor type Z, polypeptide 1 Ptprz1 -2.32 -3.44 -2.77 differentiation 
1426225_at retinol binding protein 4, plasma Rbp4 -2.75 -3.89 -3.22 proliferation 
1449582_at caudal type homeo box 1 Cdx1 -3.26 -9.84 -4.9 transcription 
1428826_at 
nuclear receptor subfamily 6, group 
A, member 1 Nr6a1 -4 -5.35 -4.58 transcription 
1435386_at Von Willebrand factor homolog Vwf -2.24 -3.26 -2.66 adhesion 
1447583_x_at 
G protein-coupled estrogen 
receptor 1 Gper -3.93 -6.24 -4.83 GPCR 
1451461_a_at aldolase C, fructose-bisphosphate Aldoc -3.61 -7.5 -4.87 CLAM 
1419549_at arginase, liver Arg1 -8.92 -16.35 -11.6 CLAM 
1452270_s_at 
cubilin (intrinsic factor-cobalamin 
receptor) Cubn -4.76 -5.82 -5.24 vesicle-mediated transport 
1425425_a_at Wnt inhibitory factor 1 Wif1 -3.35 -5.62 -4.2 Wnt signaling 
1437339_s_at 
proprotein convertase 
subtilisin/kexin type 5 Pcsk5 -2.69 -4.37 -3.33 proteolysis 
 
NMCD: Nucleic acid metabolism and chromosome dynamics; CLAM: Carbohydrate, lipid, and 
amino acid metabolism (CLAM). 
 
 
3.6.6.5  Expression profiling of GAG genes during neurulation:  
GAG associated genes have been found abundantly expressed during neurulation, 
including core proteins, synthesis enzymes, and binding proteins. Core protein Sdc4 were found 
differentially expressed in the DLHP-NT-down regulated gene list (Table 3.14). Differentially 
expressed GAG synthesize enzymes including the initiation enzyme B4galt1 (Table 3.10) and 
chain modification enzyme Ndst1 (Table 3.9). In addition, many GAG binding proteins have 
been found by data analysis, such as Igf1 (Table 3.9), Thbs1 (Table 3.9), Ncam1 (Table 3.10), 
Postn (Table 3.13), Aplp1, Lpl (Table 3.13, 3.15), CD44 (Table 3.14), Has2 (Table 3.15), Fgf9 
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(Table 3.12), Chall, Col11a1 (Table 3.15), Lyve1, and Vwf (Table 3.16). Some of the above 
mentioned genes have been reported to have association with neurulation such as Ndst1 and Sdc4, 
but most of them were first reported in this research area. The abundant expression of GAG 
associated genes implicate that GAGs play critical roles in neurulation.  
3.6.6.6  Expression of NTD genes during the neural tube closing process of mouse embryo 
Around 50 genes related with NTD have been shown presented in the microarray data, 13 
of which were presented in the MHP- or DLHP-related gene lists, while the rest of them have 
been found differentially expressed by at least one software. Among them, some are key 
members of certain pathways, some are transcription factors, cell cycle regulators or cell 
adhesion components that have been found highly involved in neurulation, such as Zic2 and Zic3 
(Shh signaling), Prakaca (negative regulator of Shh signaling), Bmp2 (Bmp signaling), Lrp6 
(Wnt signaling),  Cyp26a1 and Aldh1a1 (RA signaling), Celsr2 and Cer1 (cell adhesion 
molecules), Ccnd2, Cdk4 (cell cycle regulator), Jmjd3, Sall4, Twist1, T (brachyury) 
(Transcription factors), as well as some GAG genes such as Ndst1, Postn, CD44. The presence 
of these genes in the microarray results may be indicator for finding new critical genes, and the 
potential role of them for bending of MHP and DLHPs will be discussed and investigated further. 
 
3.7  Studies on phenotypic alterations in NE4C cells after silencing B4galt1 gene 
In the current microarray results, dozens of GAG associated genes have been found 
differentially expressed. The GAG synthesizing enzyme, B4galt1, was down-regulated in both 
MHP-NT and MHP-MD groups, implying that it may play a role in formation of MHP and its 
sustaining.   
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GAGs have been implicated in the process of neural tube closure, but their function in 
neurulation in spinal region has not been studied in detail (Copp and Bernfield, 1988b). Though 
they participate in many biological processes such as cell signaling and development, their 
functions depend on the biosynthesis enzymes and chain modifications. Galactosyltransferase are 
responsible for initiating the synthesizing of tetra-link between the GAGs and their core proteins 
which is most important for functions of GAGs in biological processes. It is also responsible for 
specifically transferring Gal from UDP-gal to the acceptor substrate, which is a very important 
step for synthesizing many glycoconjugates. B4galt1 is one of the Galactosyntransferases whose 
structure and dynamics of the catalytic function has been known clearly, but as for its biological 
functions in mammalian cells, it is seldom investigated.  In order to know the possible function 
played by B4galt1 in neurulation, we knockdown its mRNA in NE4C cells by siRNA and check 
its effects on cell behaviors. 
 
3.7.1 Optimization of the transfection parameters for knocking down of B4galt1 mRNA 
expression by siRNA 
To silence B4galt1 expression in NE4C cells using chemically synthesized siRNA, 
optimization experiments were first conducted in order to obtain good and stable silencing effect. 
The optimizations for the transfection efficiency include cell number, FBS concentration, 
transfection reagent type and amount, and incubation time. Firstly, parameters for seeding cells 
such as cell number, FBS concentration, and growth time to confluence in 6-well plate were 
optimized by triplicates experiment. It was found that 8 x 104 cells/well, growing in MEM with 
5% FBS could get the most ideal results, 40%, 75%, 85% confluence seeding after 24 hours, 48 
hours, and 72 hours. Higher cell numbers or FBS concentration led to over confluence, and cells 
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not grow well under less cell number and lower FBS concentration. Secondly, transfection 
reagent type, amount, and incubation time were optimized using positive control of silencing 
select GAPDH siRNA (Ambion, Inc. Cat No.4390850) and siNegtive control (Ambion, Inc. Cat 
No.4390844), both of which were from Ambion. We compared the use of transfection reagents 
SiportAmine (Ambion), Oligofactamine (Invitrogen) and DharmaFECT1 (Dharmacon). 5 µl of 
siPORTAmine can give a silencing efficiency of 40% with 10% cell death rate, while 20 µl of 
Oligofectamine can achieve 90% silencing efficiency with 20% cell death rate. Both of the two 
reagents were toxic and less effective for NE4C cells. In the end, 5 µl of transfection reagent of 
DharmaFECT1, 5 nM of siRNA, 24 hours of exposure time led to the highest and most stable 
transfection efficiency of 87.84% (Fig. 3.9) for GAPDH siRNA with the least cell death, and the 

























































Fig. 3.9 Silence effect of positive siRNA targeting GAPDH mRNA in NE4C cells. Under 
optimized parameters, GAPDH mRNA expression was silenced more than 80% compare that in 
the non-targeting siRNA transfected group. The optimized parameters in the transfection: 8 x 
104/well in 6-well plate with 5 µl DF1 and 5 µM siRNA. Data are expressed as mean ±SEM, n=3, 
unpaired student t-test, **P<0.01.  
 
 
Fig. 3.10 Cell morphology after transfection. Under optimized transfection conditions DF1 
transfection reagents did not adversely affect NE4C cell morphology at 48 hrs. (A) Normal cells 
under maintaining medium at 48 hrs. (B) Control non-targeting siRNA. (C) GAPDH siRNA. 







3.7.2  Knockdown of B4galt1 mRNA expression by siRNA was gene-specific  
To detect whether the expression of B4galt1 could be knockdown under the same 
transfection condition, 2 different siRNAs targeted to 2 different regions of B4galt1 mRNA were 
used for screening (Fig. 3.11.A and Fig. 3.11.B).  Both sequences of the siRNA achieved the 
significant knockdown efficiency of more than 80%, and repeated triplicate experiment results 
showed that both of these two sequences could obtain an average of more than 70% knockdown 






B4galt1 mRNA    NM 022305.3 
siRNA1               Ambion ID s66638 
sense:                  5’-GGAUCGCACAUACAAAGGAtt-3’ 
Antisense:           5’-UCCUUUGUAUGUGCGAUCCgg-3’ 
GC%:                 47.5% 
siRNA2             Ambion ID s66639 
sense:                5’-CCAUGUUCAAUCGAGCUAAtt-3’ 
Antisense:         5’-UUAGCUCGAUUGAACAUGGtg-3’ 






















































 Fig. 3.11 Knockdown effects of two different siRNA sequences targeting B4galt1 mRNA in 
NE4C cells. (A) Design and synthesis of siRNAs against B4galt1. Schematic representation of 
the primary structure of mouse B4galt1 mRNA (gi: NM_022305.3) and two target sites of 
siRNAs. The blue boxes of I to VI represent six exons of B4galt1, and siRNA1 was on the VI 
exon while siRNA2 was on the III box. The sense chain of siRNA1 was from the 1269 to 1287bp, 
while the sense chain of siRNA2 was from the 855 to 873bp in the direction of 5’ to 3’. (B) 
Sequence of siRNA duplexes. The two siRNA sequences were designed against B4galt1 in the 
modification of the nucleotide “T” substituted by “U” by Ambion, Inc. (C) Both two sequences 
achieved a silencing efficiency of more than 70%. From then on, both of them were used in the 
following experiments. Data were expressed as mean±SEM, n=3. One-way ANOVA, 
***P<0.001; Turkey’s Multiple Comparison test,***P<0.001, compared to control siRNA. 
 
3.7.3 Reduction of B4galt1 expression by siRNA in the NE4C cells inhibited cell 
proliferation 
B4galt1 has been shown to be involved in positive regulation of epithelial cell 
proliferation during wound healing. To investigate the effect of suppression of B4galt1 
expression on NE4C cell proliferation, NE4C cells were transfected in triplicate with the two 
sequences of siRNA targeting B4galt1 gene or scrambled siRNA (control). 48 hours after 
transfection, cells were trypsinized and cell proliferation was measured by direct cell counting 
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using MTS method. Fig. 3.12 shows the effect of silencing B4galt1 mRNA expression on NE4C 
cell proliferation. Both of the two sequences of siRNA targeting B4galt1 show significant 
inhibition on NE4C cell growth. Reduction of B4galt1 mRNA expression by siRNA inhibited 
NE4C cell growth by 7.996% (sequence 1, *P<0.05) and 20.81% (sequence 2, ***P<0.0001), 
respectively.  
 
Fig. 3.12 Reduction of B4galt1 expression inhibited NE4C cell proliferation. Direct counting 
of viable cell number by MTS method 48 hours after transfection show that cell proliferation was 
significantly inhibited by 7.996% (sequence 1 in A, *P<0.05) and 20.81% (sequence 2 in B, 
***P<0.0001), respectively. Experiments were performed in triplicate and results were expressed 
as mean ± SEM. One-way ANOVA, *P<0.05; Turkey’s Multiple Comparison test, *P<0.05. 
 
3.7.4 Knockdown of B4galt1 expression in NE4C cells inhibited cell adhesion to fibronectin 
and collagen I 
Surface B4galt1 was known to be interacted with cell adhesion molecules such as E-
cadherin or Collagen IV. To investigate the effect of suppression of B4galt1 expression on NE4C 
cell adhesion to fibronectin and collagen I, NE4C cells were transfected with two sequences of 
siRNA targeting B4galt1 gene or the control scrambled siRNA for 48 hours and the cells were 
re-seeded into the fibronectin- and collagen I-coated 96-well plates. The cells were allowed to 
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attach for 30 minutes and the adhesion ability were counted using MTS method. The adhesion 
ability was found significantly inhibited on both substrates by sequence 1. Sequence 2 has 
decreasing trends, but not significantly different, the p-values were slightly higher than 0.05, and 
the arrow bars were as similarly low as sequence 1 which imply it has inhibiting functions on 
adhesion. Fig. 3.13 shows that NE4C cell adhesion to fibronectin were reduced by 12.09 
(sequence 1, **P<0.01) and 1.478 (sequence 2, P=0.449), respectively. The adhesion ability of 
NE4C cells to Collagen I were reduced by 21.79 (sequence 1, *P<0.05) and 11.17 (sequence 2, 
P=0.065), respectively.  These results demonstrate that silencing of B4galt1 inhibits the adhesion 



























































































Fig. 3.13 Suppression of B4galt1 expression inhibited the adhesion ability of NE4C cells to 
fibronectin and Collagen I. NE4C cells were transfected with two sequences of siRNA 
targeting B4galt1 and the control scrambled siRNA. 48 hours after transfection, NE4C cells were 
trypsinized and resuspended in MEM without FBS and re-seeded into 96-well-plates pre-coated 
with fibronectin or collagen I. The cells were allowed to attach for 30 mins and MTS method 
was used to measure the number of attached cells. Data were expressed as mean ± SEM. One-






























Neurulation is a complex process including several different but consecutive events. Its 
molecular mechanism was not comprehensible partly because of the finding of critical genes for 
this process was mainly by mutation studies. Associations among different genes are not very 
clear because different studies use different investigation conditions and platforms are not 
comparable. The purpose of this study was to set up a reliable framework in transcriptomic level 
at critical stages of neurulation, which was well studied and accepted by most investigators in 
this area. This framework of neurulation genes not only reflect the comprehensive feature of 
neurulation, but provide a basis for further investigating their regulation during normal and 
abnormal conditions.   
 
4.1   A reliable transcriptomic profiling for mouse neurulation was generated by using laser 
capture microdissection (LCM) in combination with microarray   
In order to increase the accuracy and reliability of the transcriptomic profiling of mouse 
neurulation, several strategies have been employed during the design and carrying out of the 
project. First, LCM technology was used to provide more homogenous tissues for microarray 
analysis, and the microdissected tissues were directly involved in neurulation; second, several 
technical methods were used to increase its reliability, so quality of RNA used on microarray 
was good;  third, combined use of several software help to target genes with high possibility 
involving in neurulation; last but not least, gene expression pattern was consistent with reported 





4.1.1 Gene expression in neurulation: microdissection versus whole mount tissue for 
microarray 
Microarray is a good technology for monitoring the gene expression changes during 
biological process. The important thing is to afford the proper tissue samples. The more accurate 
the tissue samples, the more accurate the microarray results. El-Serag et al compared the gene 
expression of Barrett’s esophagus using LCM microdissected glandular epithelium and biopsied 
whole tissues separately (El-Serag et al., 2009). They found that LCM sampling can not only 
meet the diagnostic purpose with 74% probe sets overlapped with whole mount biopsy samples, 
but also provide more information for investigating pathogenesis. A similar result was obtained 
by another independent investigation comparing gene expression in two adjacent tissues in 
prostate cancer using both whole mount and microdissected tissues (Sanati et al., 2009). Analysis 
using microdissected tissues can identify less transcripts but with more significant differences in 
expression.    
In this current study, LCM was exploited to microdissect NT and MD from the whole 
mount embryo to increase the accuracy of tissue samples used for microarray analysis and with 
the hope to identify significant genes with more precision. The transcriptomic profiling with the 
expression of more than 39000 transcripts covering 34000 well known mouse genes provided a 
full view of neurulation spatially and temporally. More than thousands of differentially 
expressed genes between different stages by microarray analysis showed evidence for the 
successful use of LCM in microarray analysis. Moreover, around hundreds to thousands of 
MHP- and DLHP-related genes grant a precise and significant guide for further biological 




4.1.2 A reliable protocol was established for transcriptomic analysis of laser microdissected 
mouse neural tissues with Affymetrix genechips  
RNA quality is assurance for successful microarray analysis. A simple, low-cost and 
reliable protocol for RNA preservation by optimizing was developed by using three strategies for 
the LCM microdissected samples: mouse embryos were snap frozen immediately after dissection, 
RNAlater-ICE was applied directly on the cryosections, and a quick staining method.  
Frozen method has the advantages of protecting histological details as well as yielding 
RNA of higher quality than paraffin-embedded sections or PF or ethanol fixed sections 
(Perlmutter et al., 2004). It has been used as a gold standard for gene expression analysis with 
laser microdissected samples (Espina et al., 2006; Stemmer et al., 2006). Stemmer K, et al fixed 
the kidney samples in RNAlater before cryosection and found its tissue morphology is damaged 
compared with snap-frozen with liquid nitrogen (Stemmer et al., 2006). During the preliminary 
experiment, the whole mount embryos were soaked in RNAlater before embedding and found 
the tissues could not freeze and attach on the slides well, the morphology of the tissue could not 
be well distinguished. Then RNAlater-ICE was applied directly on the cryosections. This novel 
usage of RNAlater-ICE protected the RNA quality without damaging the tissue morphology 
(Fig.3.3 and Fig.3.4).  
 Haematoxylin (H) and eosin (E) staining has been a canonical staining methods for 
mouse embryo tissue sections, and this methods was also identified as an acceptable staining 
methods for frozen sections used for LCM (Espina et al., 2006). In the current experiment, the 
usage of haematoxylin only is enough for the staining effects and met the requirement of LCM 
work. Haematoxylin was found adequate for distinguishing the NT and MD easily under LCM 
and targeted cell populations can be microdissected without contamination from the adjacent 
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tissues. The optimized quick-staining method has the advantage of saving time and reduces the 
possibility of RNase contamination.  
Using the optimized protocol, total RNA with good quality and quantity can be obtained 
from LCM microdissected mouse embryo tissues by two times microdissection from the same 
section (Fig.3.4 and Table 3.1). A comprehensive transcriptomic profiling has also been 
obtained from these LCM RNA samples for analysis of gene expression during the closing 
process of neural tube.  
 
4.1.3 Combined use of several software reduced the number of candidate genes by 
microarray analysis 
Transcriptomic expression profiling with microarray analysis can explore differentially 
expressed genes during developmental process simultaneously in an abundance manner. In the 
current study, samples collected in triplicate for NT or MD at three stages were hybridized on 
Affymetrix Mouse Genome 2.0 2 GeneChip. The transcriptomic expression profiling was 
globally analyzed by different software for data normalization followed by identification and 
clustering of differentially expressed genes. 
Microarray analysis is critical for arriving to the very similar true status of the biological 
process. GCOS, dChip, and GeneSpring are three well known software using different 
algorithms that are widely used for analyzing Affymetrix GeneChips. Differentially expressed 
genes between any two stages during neurulation were around or more than thousands (Table 
3.4), which implies the difficulty for targeting critical genes. After intersection of differentially 
expressed genes in 7 datasets by Microsoft access, the common genes filtered by the three 
software were combined together, and the genes were narrowed down to around hundreds.  
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Further analysis was performed to reveal the MHP and DLHP related genes according to 
the growth features of neurulation. A total of 214 transcripts were revealed differentially 
expressed for MHP-NT related genes, and 219 for MHP-MD related genes, 95 for DLHP-NT 
related genes, and 56 for DLHP-MD related genes (Table 3.6). Detailed information of the genes 
regarding their spatial and temporal existing - whether they are up-regulated and down-regulated 
between different stages or where they present - in both NT and MD or NT only or MD only - 
were also revealed by analysis tools (Fig.3.7). The microarray data were further validated by 
real-time PCR. Functional analysis by the online software Gene Ontology of the MHP- and 
DLHP- related genes revealed numerous cellular biological functions, such as differentiation, 
proliferation, adhesion, migration, as well as multiple cellular pathways. Most of the genes are 
multifunctional and also involved in several pathways or cascades in different biological contexts. 
Each gene was specified a function according to combined knowledge from NetAffix and 
literature research as well.  
Further analysis by GO revealed that these genes were more than enough for biological 
exploration. The combined usage of different software helps us to increase the accuracy, 
reliability and possibility to increase the accuracy of our downstream investigation. These genes 
are designated more reliable in that they are really differentially expressed during the neural tube 







4.2 Microarray findings: neurulation-associated genes setup a framework for future 
functional studies with multiple functions and pathways 
 
4.2.1 Transcriptomic analysis of gene expression during critical stages of neurulation 
reveals associations to diverse biological processes 
Previous studies found numerous genes with cell biological functions are essential for 
neural tube closure, and NTDs are found among mouse mutants of the proliferation, 
differentiation, cell cycle, cell viability  regulation, cytoskeleton and signal transduction as well 
as transcription factors that affect chromatin structure. Analysis of differentially expressed genes 
with different functions may aid to provide critical candidate genes for investigating NTDs. 
 
4.2.1.1 Cell proliferation and differentiation are essential functions for formation of MHP 
and DLHPs 
Differentiation and proliferation are two facets of a coin for the development of neural 
tube. The neurulation stage embryo is a proliferating system. Neuroepithelial cells have a high 
proliferation rate before some of them exit the cell cycle and differentiate after the neural tube 
closure, indicating the essential role of the balance between proliferation and differentiation for 
successful neural tube closure (Copp and Greene, 2010b). Animal models displayed neural tube 
defects when the balance between neural proliferation and differentiation was disrupted (Lakkis 
et al., 1999; Smitherman et al., 2000; Takeuchi et al., 1995). The imbalance between neural 
proliferation and differentiation can destroy the consistent process of bending and apposition of 
the dorsolateral neural folds which were essential for closure of the neural tube.  
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There were many genes with functions related with proliferation and/or differentiation, as 
well as other cell-growth related functions such as cell cycle and apoptosis in the microarray 
results. They were differentially expressed during the neurulation process and distributed among 
almost all the MHP- and DLHP- related gene groups. From a global view, growth was active 
during the process of MHP- and DLHP- formation for the many genes with function of 
proliferation and differentiation differentially expressed and tightly regulated by the cell cycle 
and apoptosis genes.  
During the neurulation process, proliferation and differentiation commences in different 
axial level at different timepoints and do not proliferate and differentiate in the same manner 
within each level and stage. Analysis of the spatial and temporal expression patterns along the 
different axial levels at different stages could reveal potential mechanisms that regulate when 
and where cell growth commence and exit. I discussed here several of the many genes whose 
biological functions have been studied and found related with neural tube development, leaving 
more to be explored in the future.  
Epha7 is a member of the Eph family of tyrosine protein kinase receptors, mice with 
Epha7 inactivation exhibit cranial NTDs (Holmberg et al., 2000), but the exact mechanism was 
not known. Ephrin tyrosine kinase receptors and their ligands ephrins have been proposed as 
Hox targets. A recent research showed that expression of Epha7 was directly controlled by the 
expression of Hoxa13 and Hoxd13 in developing limbs (Salsi and Zappavigna, 2006). Epha7 
contains multiple Hoxa13/Hoxd13 binding sites in the promoter region, mutation of any one was 
sufficient to abolish its transcription activation. Further investigation demonstrated that 
HOXD13 mutation in patients with brachydactyly-polydactyly syndrome fails to bind and 
transactivate Epha7 promoter, which ascertained Epha7 as a direct downstream target of Hoxd13 
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during limb development. Hox genes encode transcription factors and were first identified as 
providing positional information along the anterior-posterior body during embryonic 
development. In addition, they are proposed as regulators for cell division, cell adhesion, 
migration, and morphological differentiation (Ulijaszek et al, 1998). Hox-deficient mice display 
delayed closure of neural tube (Redline et al., 1992). Hoxd13 and Epha7 were presented in the 
MHP-NT-up-regulated group and their expression seems to have a negative correlation with 
MHP formation. Hoxd13 was also presented in the DLHP-NT-up-regulated group, which means 
that its expression initiated at E9.0 when the DLHPs begin to form, and the expression increased 
dramatically at E9.5 during the existence of DLHPs, and at the same time, the expression of 
Epha7 was induced to increase at E9.5. This expression pattern implies a possible hypothesis that 
Epha7 may be a downstream target of Hoxd13 during neurulation, and it may play a role in 
initiating the closure of neural tube as postulated (Holmberg et al., 2000).  
 FGFs are a class of diffusible glycoproteins with multiple functions during embryonic 
development. They are found related with neural induction, dorsoventral and antero-posterior 
patterning of the neural tube during neurulation. Fgf9 was presented in MHP-MD-down-
regulated group, consistent with previous study that Fgf9 RNA was detected in intermediate 
mesoderm of late-stage gastrulation mouse embryos, as well as spinal cord motor neurons.  
Fgf9 was shown to increase the expression of Spry2 and Spry4 in mouse embryo pancreas 
mesenchyme. Spry2 was also found induced by Fgf signaling in limb embryogenesis which 
functions as FGF-induced feedback inhibitor. In situ hybridization showed that Spry2 was highly 
expressed at PNP of mouse/chick embryo with an expression pattern similar to Spry4. Here in 
the same group presented Spry2 gene with similar expression pattern as Fgf9, but its potential 
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function in neurulation was poorly known. If any, it was postulated that Spry2 may be induced 
by Fgf signaling and play a role in regulating cell proliferation during neurulation.  
Cutl1(Table 3.9), or Cux1, presented in both MHP-NT-up-regulated and MHP-MD-up-
regulated groups, is a homeodomain transcription factor known to play multiple roles in 
development including cellular proliferation, differentiation, cell motility, and cell cycle 
progression. It is conserved among vertebrates and contains four DNA binding domains 
including three Cut repeats and one Cut homeodomain. The role of Cutl1 in neurulation is not 
studied. Expression of Cutl1 at E9.5 NT and MD by microarray displays more than 2 fold higher 
than at E8.5 and E9.0. Phosphorylation of Cutl1 by several kinases such as PKA or PKC has 
been shown to inhibit its DNA binding activity, and further affects Cutl-1-mediated proliferation 
and migration (Michl et al., 2006). It is known that targeted mutation of MARCKS ( a substrate 
of PKC) results in exencephaly, and the PKA-deficient mouse model develops localized spinal 
NTDs displaying a dorsal expansion of Shh signal at the ventral tube (Huang et al., 2002). As a 
recent study found that Cutl1 was a novel target of PKA that can be directly phosphorylated at 
serine 1215 in NIH3T3 fibroblasts, and the Cutl1 target genes involved in proliferation and 
migration such as DNA polymerase A and Dkk2 was also modulated by PKA-induced 
phosphorylation (Michl et al., 2006), it is postulated that PKA-down-regulation of Shh may be 
due to the down regulation of Cutl1 and its target genes.   
Cutl1 may participate in the formation of neural tube through a novel PARticular 
pathway (Wilson et al., 2009), a cascade of molecular interactions involving the protease-
activated receptors (PARs) and their productive cleavage by cell-associated tissue proteases 
(Copp and Greene, 2010a). PARs belong to the G protein-coupled receptor (GPCR) family. 
Double mutant of PAR1 and PAR2 results in cranial neurulation defect (Camerer et al., 2010). A 
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number of serine proteases can activate PAR1 and PAR2 in the neurulation stage embryo with 
matriptase was one of them. Matriptase inhibitor HAI-2 knockout mice develop exencephaly and 
spina bifida, and these NTDs can be rescued by genetic depletion of matriptase (Szabo et al., 
2009). The mechanism of neurulation defects led by PARs was not clear. A study reported that 
PAR2 can increase DNA binding activity of Cutl1 by regulating two DNA binding domains 
presented in all cux-1 isoforms, the cut repeat 3 and the cut homeodomain (Wilson et al., 2009). 
In my microarray results, PARs inhibitor HAI-2 was down-regulated in both NT and MD, with 
high expression at E8.5 and E9.0 and decreased expression at E9.5 fish out by the GCOS 
software, while Cutl1, which can be increased by PARs was up-regulated in both MHP-NT and 
MHP-MD groups. These expression pattern were consistent with their reported functions and 
shed light on their potential role during neurulation by regulating the PAR or GPCR signaling, 
Though the probe sequence of Par1 (or its substitute name Pas5a) and Par2 were not included in 
the Affymetrix genechips, quite a number of GPCR signaling genes were found differentially 
expressed in the MHP- and DLHP- related gene groups, and further investigation are needed to 
unravel the mechanism.  
Cutl1 was also found functioned at the G1/S transition and accelerating cell cycle 
progression into S phase in p110 CDP/Cux cells (Sansregret et al., 2006). This evident was 
confirmed by the mouse embryo fibroblasts obtained from Cutl1 z/z mutant mice which 
displayed a longer G1 phase and slower proliferation rate than normal cells. This led to a 
possibility that Cutl1 may be involved in the formation of hingepoint by regulating the number 
of S phase cells whose nucleus position will be at the bottom of the neuroepithelium.   
Proliferation depends largely on the environment of cells as well as different kinds of 
growth factors.  Regulation of proliferation may affect the tissue size and the responding of 
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progenitor cells to differentiation inducers. Proliferation during mammalian embryogenesis is 
regulated during the G1 phase of the cell cycle (Pardee, 1989).  
D-type cyclins play a major role in positive regulation of G1 phase progression and S-
phase entry (Baldin et al., 1993; Quelle et al., 1993; Lukas et al., 1994a,b; Musgrove et al., 
1994;Resnitzky et al., 1994; Resnitzky and Reed, 1995). Cyclin Ds bind and activate cyclin-
dependent kinases 4 and 6 (CDK4 and CDK6) to phosphorylate and functionally inactivate the 
retinoblastoma protein (pRb), thereby start a new round of DNA synthesis and promote cell cycle 
progression from mid to late G1 (Matsushime et al., 1992, 1994; Bates et al., 1994; Tamet al., 
1994; Meyerson and Harlow, 1994; reviewed in Sherr, 1994; Weinberg, 1995). The cyclin D-
CDK4-pRB interplay may be involved in multiple signaling cascades such as membrane tyrosine 
kinase receptors, and the cyclic AMP-dependent signaling pathway (Lukas et al., 1996; Peeper et 
al., 1997).  
The neuroepithelium of neurulation stage has high proliferation rate with cell recycle 
times as short as 4-6 hours, thus the cell cycle activating gene Ccnd2 and CDK4 are expected to 
be highly expressed while the Rb gene is inhibited to some degree.  In the current microarray 
exploring, many genes involved in regulation of proliferation and cell cycle have been found 
differentially expressed during the neural tube closure in the spinal region. The cell cycle 
initiation genes, both Ccnd2 and CDK4, were found differentially expressed during spinal 
neurulation. The Ccnd2 was up-regulated in mesenchymal gene list with a fold change of 2.3 at 
E9.5 compared with E9.0 and E8.5 (Table 3.11). It also displayed an increasing trend in 
neuroepithelium at E9.5 compared with E9.0. The expression pattern of CDK4 in NT was up-
regulated at E9.5 compared with E9.0 and E8.5 (Table 3.9). The expression intensity of CDK4 in 
surrounding mesenchyme was high at all three stages but no obvious difference.   
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The gene Rbbp4, a histone binding protein that can bind Rb directly and regulate 
proliferation (Qian et al., 1993), was down-regulated in neuroepithelium, with a fold change 
similar to Ccnd2 and CDK4 (Table 3.10). This may be an indication that Ccnd2/CDk4 complex 
is the main regulator of G1/S transition through regulating the binding of Rbbp4 with Rb during 
spinal neurulation.  
Ccnd2 was reported as developmental regulators and was first detected at the time of 
primitive streak formation and the expression domain expands gradually to the distal region of 
the embryo. The expression increases in posterior tissues such as ectoderm and mesoderm cells 
and coincide with the occurrence of a proliferation burst (Wianny et al., 1998).  The expression 
of Ccnd2 is also detected in the dorsal closing neural tube, and the main site is the 
neuroectoderm.  
FGF signaling, Shh signaling as well as Wnt signaling pathways are known cell cycle 
regulators during the caudal neural plate (Lobjois et al., 2004). FGF signaling preserves the 
proliferative domain in the immature caudal neural plate by maintaining the cyclin D2 expression 
and inhibiting cyclin D1 expression which may be realized by down-regulation of Shh-signaling. 
Reduction of FGF signaling in the neural groove results in the decreasing of Cyclin D2 and 
activation of Cyclin D1, which may depend on Shh signaling. Wnt3a, a gene mutation of which 
lead to NTD in mouse embryos, was also found expressed in the caudal region of the embryo and 
positively regulate the expression of Cyclin D2 (Cauthen et al., 2001; Megason and McMahon, 
2002). Ccnds are also transcriptional targets of the Wnt-beta-catenin signaling involved in 
regulation of cell proliferation by promoting the G1/S progression. After neural tube closure, the 
expression of both cyclins were constrained to the dorsal neural tube by the regulation of Wnt 
signaling. This restriction may contribute to the neuronal differentiation.  
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TGF-beta family members, including BMPs have been found expressed in the roof plate 
and the dorsal neural tube. They are supposed to induce the dorsal cell growth by anti-
phosphorylation of Rb gene in growing cells (Laibo, et al, 1990; Basler et al, 1993; liem et al 
1997). The increased expression of TGFbr2 (Table 3.9) and the decreased expression of Rbbp4 
may indicate their involvement in the cell growth control in spinal neurulation. 
Another cell growth regulator found in the gene lists are REG-gama, also known as 
Psme3 (Table 3.11). It belongs to the REG family of proteasomal activators, mainly found in the 
nucleus, may play a role in chromosomal stability dur ing mitosis and is implied to be a regulator 
of cell cycle transition and cell proliferation (Zhou, 2006). It was reported to facilitate the 
degradation of cyclin-dependent kinase inhibitor p21 which is a cell cycle inhibitor preventing 
the G1/S transition. Mice deficient of REG-gamma were significantly reduced in body size while 
REG-gamma deficient embryonic fibroblasts have delayed entry from G1 to S phase in the cell 
cycle (Murata et al., 1999). So far there is no reported data regarding the role of Regime in 
neurulation. The REGgama displays a similar expression pattern as Ccnd2 and CDK4 in the 
microarray results, which indicate highly an involvement in the cell cycle regulation of spinal 
neurulation. 
It was noticed that some of these genes also play important roles in cell cycle regulation 
and cell differentiation. This founding is consistent with reports that cell cycle parameters can 
affect the apico-basal position of nuclei within the NE. This affection of the cell shaping from 
rectangular to wedge shape may explain the obvious difference of cell shape between cells in 
hinge points and in non-bending regions. For example, cells become wider at the basal side and 
narrower at the apical side at the bending regions. Many other genes with function as cell cycle 
regulator were found differentially expressed, such as up-regulated genes Tubb3 (Table 3.9), and 
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down-regulated genes Seh1l and Ppp1cb (Table 3.10). This finding indicates that genes 
regulating proliferation and differentiation are essential during the formation of MHP and 
DLHPs in neurulation and may have the potential possibility for further investigation in 
mammalian neurulation.      
 
4.2.1.2 Cell structure and adhesion molecules changes at different stages during 
neurulation   
Contracted actin microfilaments existed in the apical regions of neuroepithelial cells, 
especially within the closing neural tube, implying an embryonic morphogenesis model that 
bending of an epithelial sheet was induced by a “purse-string” contraction of actin 
microfilaments (Baker and Schroeder, 1967; Wessells et al., 1971; Burnside, 1973; Karfunkel, 
1974; Nagele and Lee, 1980; Sadler et al., 1982). The molecular mechanism under the 
morphogenetic event known as apical constriction where columnar cells in the bending neural 
tube are converted into wedge-shaped cells is unclear, except that the known genes are actin-
binding (Shroom) (Hildebrand and Soriano, 1999; Martin, 2004) and actin related (p190RhpGap, 
a negative regulator of Rho GTPase in the process of regulating actin dynamics) (Brouns et al., 
2000).  
Recent studies confirmed the importance of cytoskeleton in the neuroepithelium but 
question the role of cytoskeleton in the bending of the neural tube especially in the spinal region. 
Mutation of most of the cytoskeleton proteins can lead to NTDs which were mainly cranial 
NTDs. Only mutation of Shrm and Mlp (Wu et al., 1996) were found to result in spinal NTDs in 
addition to cranial NTDs. Shrm was found highly expressed in both neuroepithelium and the 
paraxial mesoderm with increasing expression pattern. In addition, there are many cytoskeleton 
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organization or regulation genes that have been presented in the spinal neurulation gene lists with 
a fold change more than 2. Among these genes, most of them are in the MHP-related gene lists 
with increasing expression pattern. Only few of them such as Seh1l, Tmod3 (Table 3.10), Cubn 
(Table 3.16) displayed a decreasing expression pattern. Most of them have been reported to play 
important roles in nervous system development. For example, Actc1 (Table 3.11) has been found 
differentially expressed during gastrulation by a microarray screening. The cell shape changing 
from columnar to wedge shape seems essential for the localized bending of the neuroepithelium 
at the midline and dorsolateral hinge points. This changing displays at least two features, the 
narrower of the cell apex and the broadening of the cell base.  Shrm and Mlp have been related 
with the contraction of the cell apex. Whether there is any other cytoskeleton genes involved in 
this process remains unknown. Though no direct evidence showed their relationship with NTDs 
or neurulation process, there remains a gap for further investigation.  
As for the basal expansion, it is thought to be related with the different nuclei positions at 
different phases of the cell cycle. Studies have demonstrated that the bending regions of the 
neuroepithelium contain more cells in S-phase than nonbending regions in either chick (Smith 
and Schoenwolf 1987) or mouse (Gerrelli and Copp, 1997). Since position of the nuclei during 
S-phase are mainly located in basal of the cells, the above results may support the hypothesis that 
local retardation of the cell cycle may result in a local accretion of S-phase cells, these cells 
adopting a wedge shape to form the bending of the hinge points.  However, the molecular 
mechanism of how they know to modulate the cell cycle at the S-phase is not clear. There are 
many genes involved in the cell cycle regulation especially the G1/S phase transition have been 
discussed. Here, we also found some genes that play roles in both cytoskeleton regulation and 
cell cycle. For example, Mtap2, a microtubule cytoskeleton organization gene in the MHP-NT-
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up group (Table 3.9), has been found as a regulator of GNP differentiation by inhibiting the cell 
cycle arrest protein p27. This may be an indication that some cytoskeleton proteins may be 
involved in the spinal neurulation by regulating cell cycle process. 
The obvious importance of cell adhesion is in the contraction and fusion of the neural 
edges at the dorsal midline of embryos. Holmberg found expression of Epha5 and Epha7 in the 
cranial NT instead of spinal NT by in situ hybridization, and inactivation of Epha5 or Epha7 
receptor results in NTDs (Holmberg et al., 2000). In my microarray data, Epha7 was found 6 
fold higher in expression at E9.5 than in E8.5 and E9.0 in NT (Table 3.9), though the expression 
signal intensity is relatively low, only just above average of 500. This finding indicates that 
Epha7 may be important for the maintaining of DLHPs and its increasing trends of expression in 
NT may also support its role in closure and fusion of neural folds. It could not be detected by in 
situ hybridization at spinal region may be due to the high threshold of the ISH method, or its 
relatively lower expression itself (Brunskill et al., 2008).  Expression signals of Epha5 (Table 
3.10) is lower and demonstrate a decreasing trends in the microarray data sets indicating that 
Epha5 and Epha7 played different roles in spinal neurulation though mutation of both of them 
can leads to NTDs. We also found many other adhesion molecules differentially expressed in the 
microarray analysis and have not been previously reported in relation with neurulation process, 
such as Cdh11, Celsr2, Cldn5, Col2a1, Col3a1, Col9a1, Col11a1, Ncam1, Postn, Tgfbi, Alcam, 
Nrcam, Megf10, Nid1, Pkp2, Lgals1, Vwf, et al. Tgfbi and Epha7 were known molecules that 
involved in RTK signaling, in addition to many other RTK signaling molecules reported here, 
indicating an involvement of RTK pathway in neurulation. The expression pattern of Ncam1 was 
found decreased in E9.5 NT compared with in E9.0 and E8.5 (Table 3.10) while N-cadherin 
Cdh11 (Table 3.9) was increased in E9.5 NT compared with in E9.0 and E8.5 in the microarray 
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results. It is consistent with the report that Ncam and N-cadherin were produced in the neural 
tube and was implicated in fusion of the neural fold, though Ncam-mutation mice and N-
cadherin mice do not produce NTD (Cremer et al., 1997; Radice et al., 1997b), a family based 
study discovered a significant association between human NTDs and single-nucleotide 
polymorphisms (SNPs) within the gene Ncam1 (Deak et al., 2005). This finding confirmed their 
presence in spinal neurulation and its potential role in neurulation may be speculated. Collagen 
molecules were found increasedly expressed in spinal neurulation with Col3a1, Col9a1 in NT 
and Col2a1, Col3a1 in MD, but their roles remains further investigated. The colocalization of 
TGFbeta1 with collagen, fibronectin and proteoglycans has been reported in chick lung 
morphogenesis, it should not be surprising to find for the first time that the colocalization of 














4.2.2 Expression profiling of NT and MD during critical stages of neurulation provided 
dynamic relationships to multiple signaling pathways  
Among the 4 pathways revealed by GO biological process, Wnt signaling pathway is the 
most studied during neurulation, TGFbR signaling pathway is related with BMP signaling, which 
was found critical for MHP- and DLHP- formation, while TRPTK pathway has the most high 
number of genes involved, most of them were overlapped with ERP pathway. In addition, the 
pathway genes found by information from the NetAffyx center and literature research are also 
important and worth an investigation for their role in playing the harmonious of neurulation. 
 
4.2.2.1 Wnt signaling   
In addition to the 6 genes revealed by GO biological process as described in results 
3.6.6.4, a further exploration in the original microarray data disclosed a total of 30 Wnt signaling 
pathway genes that were detected presenting in the microarray expression profiling, including 
Wnt ligands, receptors and regulators, 12 of them were differentially expressed during the spinal 
neurulation with a fold change of more than 2: Wnt3a, Wnt5b, Sfrp1, Lrp1, Frzb, Frd2, Frd6, 
Dvl, Lrp2, Dkk1, Cer1 and Celsr2. These additional genes help us in elucidating the role played 
by Wnt signaling with the focus on the 6 genes that presented in the MHP- and DLHP- related 
groups.  
Wnt signaling play multiple roles in neurulation, including PCP signaling in shaping the 
neural plate and the canonical Wnt signaling in neural tube progenitor proliferation, as well as in 
dorso-ventral patterning and antero-posterior patterning. Wnt5a and its cell surface receptor Fzd5 
were up-regulated in the MHP-NT and DLHP-NT groups, binding of these two proteins 
initiating signal transduction for proliferation neural precursors (Cayuso and Marti, 2005). As 
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Wnt receptor, Fzd has the seven-transmembrane-spanning segment with a Wnt-binding site in 
the form of a cystein-rich domain (CRD). Down-regulation of Wnt inhibitor Wif1 and up-
regulation of Wnt receptor Fzd3 in MD groups confirmed the positive role of Wnt signaling 
during HP formation.  
Several findings suggest a posteriorization pathway of Wnt-FGF-HOX genes ((Ding et al., 
1998; Fekany-Lee et al., 2000; McGrew et al., 1997). The expression of proliferation genes 
Fgf17 and Hoxd13 in the same group as of Wnt5a in the DLHP-NT-up-regulated group may 
implicate potential interactions among these genes.  
High expression of Wnt5a was observed in the tail bud, the PNP region and extending 
several somites cranially around the ventral curvature. In addition, expression of Wnt5a on the 
serially cut sections existed in all tissues adjacent to the tail bud but not the notochord. The 
signal is very strong in the recently closed neural tube and the dorsally open neural plate, but 
becomes confined to the apical region and is gradually decreased (Gofflot et al., 1997; Gofflot et 
al., 1998). There are no comparison sections from younger stages such as E9.0 and E8.5. But the 
relatively strong expression in the PNP region and the decreasing expression pattern cranially 
indicate a consistency with the microarray finding using three different stages. The expression 
pattern of Wnt5a and Wnt5b in E9.5 mouse embryos was reported in a study using in situ 
hybridization (Gofflot et al., 1998). The expression pattern of Wnt5b were similar as Wnt5a 
except the expression intensity is relatively lower, and expression in the tail bud mesenchyme 
increases than the caudal neuropore and recently closed neural tube. It is similar as in the 
microarray findings that caudal sections expressed more than cranial sections.  
The process of convergence extension existed in both gastrulation and neurulation under 
the control of the noncanonical Wnt/frizzled pathway (PCP pathway). Blocking convergent 
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extension in gastrulation by mutation of the core PCP genes during gastrulation leads to neural 
tube defects such as Ct (Fz), Lp (Vang), Crash (Celsr), Circletail (Scrbl) and Craniorachischisis 
in Dvl1/Dvl2 double mutant embryos. A hypothesis was postulated that disrupted mesodermal 
convergent extension suppressed the notochord development which induces a broadened MHP 
and lead to neurulation failure.  Broaden of MHP may be the reason for failure of neural folds 
contraction regarding the NTDs induced (2003). Another model support a disorganized MHP 
yielded by an unusually wide zone of neuroepithelial cells due to convergence extension defect. 
There are not many data support the roles played by Wnt signaling during neurulation. A 2003 
experiment provided data regarding the role of PCP signaling in the medial neural tissue for 
proper NT closure, but denied its requirement for formation of the hinge points, fusion of the 
neural folds or in the medially moving dorsal epidermis.  The presence of so many Wnt signaling 
genes as well as the differential express of key genes such as Wnt5a, Frd2, Sfrp1, Cer1 (Table 
3.14), and Celsr2 (Table 3.15) support their potential important roles in spinal neurulation. 
Genes with function of neuron differentiation were also found strikingly different 
between E8.5 and E9.5 stage embryos. Though the role of cell differentiation in NTC has been 
rarely reported, this data may afford a platform for further studies.  Dkk1 was an interesting gene 
by playing as a negative regulator of Wnt and BMP pathways in addition to response to retinoic 
acid (RA) regulation (del, I et al., 2003; Glinka et al., 1998). This blocking activity of Wnt 
signaling may be due to its interaction with the Wnt co-receptor LRP, Frizzled, and kremen 
(Kong and Zhang, 2009). Though abundance expression of Dkk1 was found in E6.5 and E7.5 
mouse embryonic cells, Dkk1 mutation mouse embryos were lethal at early stages (Grotewold et 
al., 1999). Kong X et al reported that overexpression of Dkk1 promotes differentiation of ESCs 
(mouse embryonic stem cells) toward neuroectoderm. No expression pattern has been reported at 
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neurulation stage embryos so far. Herein, I reported for the first time of the expression pattern of 
Dkk1 during neurulation stage mouse at the spinal region. It was found expressed lower in both 
NT and MD at E8.5, then expression level increased first at E9.0 MD, but expression not 
changed in NT at E9.0.  While during the following stage of E9.5, expression level increased 
more than 2 fold at E9.5 NT, but decreased at the surrounding MD. This expression pattern is 
logically indicating the close relationship of Dkk1 with DLHP formation. When the balance of 
regulating factors of MHP and DLHP changed, it was one of the factors that initiated expression 
in MD tissue when MHP was decreasing and then its signals was transducted into NT to give a 
hand in the formation of DLHP. The transcriptome study provided an important indication for 
future studies of the role of differentiation in DLHP formation.    
Sostdc1, an ectodermal BMP inhibitor and Wnt signaling modulator, was up-regulated in 
the MHP-MD group. Several lines of evidence shows that it may play a role as cross linker 
among several pathways, for example, it was shown to integrate BMP, Shh and FGF signaling in 
tooth development (Ahn et al., 2010; Ding et al., 1998; Fekany-Lee et al., 2000; Laurikkala et al., 
2003). Though its role in neurulation was seldom studied, the differential expression in the 
microarray result holds a promising interesting for further exploration.  
 
4.2.2.2 TGFβ signaling  
The transforming growth family beta (TGFbeta), including the BMP members and non-
BMP members, are expressed in the dorsal-most surface ectoderm, the dorsal neural tube as well 
as the roof plate. Numerous studies support the requirement of BMP signaling in mouse 
neurulation (Sollowayand Robertson, 1999; Zhang and Bradley, 1996), but few reports regarding 
the function of non-BMP Tgf members in neurulation. In the 4 Tgf pathway genes revealed by 
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GO biological process, Cer1 was presented in the DLHP-NT-down-regulated group (Table 3.14), 
while the other genes, Onecut2, Thbs1 and Prdm1b were in the MHP-NT-up-regulated group 
(Table 3.9). Cer1 was an antagonist of members of the TGF family. Cer1 has been shown 
binding directly to Nodal and BMP proteins and behaves as antagonists during gastrulation in 
both mouse and Xenopus (Belo et al., 2000; Hsu et al., 1998; Jones et al., 1995). The role of 
Cer1 may be compensated by another BMP antagonist Noggin for Cer1-/-  mice embryos do not 
display any defects but Cer1-/- Noggin-/- double mutant mice display the same defects as 
Noggin-/- mice.  
To know more about the role of TGF pathway in neurulation, the expression pattern of 
BMP members were searched among the original microarray data. BMP signaling, like Shh, is 
necessary to prevent DLHPs formation. They may play a role in cell proliferation during early 
stage of neurulation. Its antagonist, noggin, secreted from the tips of the neural folds, overcomes 
BMP-mediated inhibition and enables DLHPs formation. There are 8 BMP genes have been 
detected, but only 4 genes have obvious differentially expressed trends among the three stages in 
NT and/or MD: BMP1, BMP2, Bmpr1a, and Msx1.  
BMP signaling is necessary and sufficient to inhibit DLHPs. Bmp2 expression was 
correlated with upper spinal neurulation, and Bmp2-null embryos exhibited premature, 
exaggerated DLHPs, in addition, local release of Bmp2 inhibits neural fold bending. In the 
microarray expression profiling, Bmp2 was highly expressed in E8.5 and E9.0 NT and decreased 
in E9.5 NT. This differential expression was consistent with reported. The expression pattern of 
Bmp1 was conversely different with Bmp2. It was consistently increased in NT at E9.0 and E9.5 
compared with at E8.5, and the expression signal was also significantly increased in MD at E9.5 
compared with at E9.0 and E8.5. This expression pattern was quite similar as Msx1, a BMP 
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mediated transcription factor. The role of Bmp1 in neurulation is seldom investigated previously. 
The differentially expressed pattern indicated a potential role in neurulation which may be 
mediated by Msx1. Moreover, expression of Bmpr1a was also slightly increased at E9.5 
compared with at E9.0 and E8.5 in either NT or MD. It is known that caBMPRIa can promote 
proliferation in dorsal neural patterning, and embryos lacking Bmpr-lA gene die at gastrulation 
without forming any mesoderm. It is postulated here that Bmpr1a may play a role in cell 
proliferation in either NT or MD, may by interacting with Bmp2 signaling.    
 
 4.2.2.3 Shh signaling 
The Shh signaling pathway has been deeply studied during neural tube closure. It was 
shown expressed ventrally and played roles in supporting MHP formation and preventing DLHP 
formation, while BMP and Wnt proteins expressed dorsally and play differing roles in supporting 
DLHP formation. Though there was no direct Shh signaling components detected in the MHP- 
and DLHP- related groups, the current microarray work successfully detected numerous of these 
genes and their family members or close partners in the original datasets, many of which were 
reported for the first time and hold a huge importance for future investigation.  For example, 
there were 13 key components of known Shh signaling genes detected, including Shh ligands, 
Shh receptors, transcription factors, and regulated factors. 5 of these genes were differentially 
expressed at different stages during neurulation process: Patched related protein TRC8, 
Smoothened homologue of Smoh, Sufu, Gas1, and Shroom in Shh pathway. 
Expression pattern of Sufu and Smoh in NT were greatly similar with increasing trend, 
E8.5<E9.0<E9.5. Though Shh was not detected, but its direct receptor, patch2, was detected, 
though its absolute intensity was lower than 500, its increasing expression pattern in NT, FC > 2 
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in E9.5 compared with E8.5. Sufu was known as a Shh signal transduction inhibitor, genetic 
knockout of Sufu lead to exencephaly and cardiac defects. Another two Shh negative regulators 
and also NTD genes, Fkbp8 and Prkaca, displayed highly similar expression pattern during 
spinal neurulation with FC > 2 in E9.5 vs. E8.5 MD. The expression pattern of the above genes 
was consistent with the role of Shh pathway in neural tube defects. Shh play more important 
roles in MHP formation but inhibition of Shh signaling was important for the DLHP formation.  
Gas1, a GPI-linked protein, was found to be a negative regulator of Hh signaling and has anti-
proliferation effects (Allen et al., 2007; Stebel et al., 2000). A recent study found it function as a 
positive regulator of Hh signaling being expressed in many regions in mouse embryos before or 
after neurulation and may acts to help transform the hh protein gradient into the observed activity 
gradient (Martinelli and Fan, 2007). In the microarray results, Gas1 was found highly expressed 
at E8.5 neuroepithelium, but down-regulated at E9.0 and E9.5 groups, indicating a role in the 
formation of DLHP. When Shh supports the MHP and inhibits the DLHP, Gas1 expressed highly 
to suppress the Shh function, while expression of Shh decreased, expression of Gas1 reduced 
accordingly but still remains highly expressed at E9.0 and E9.5 NT, indicating it may also play a 









4.2.3 Expression profiling of GAG/PG genes implicate their essential roles in neural tube 
closure 
GAGs have been found expressed in the sites of active neurulation (Copp and Bernfield, 
1988b). Sulfated GAG and hyaluronate accumulated in the PNP and decreased progressively 
cranially.  Newly synthesized glycoconjugates presented especially in the active neurulation sites 
such as the PNP region and the recently closed neural tube region, in the basement membrane, 
beneath the neuroepithelium and around the notochord. Different newly synthesized GAGs 
distributed in different axial levels during neurulation. In cranial neurulation, interstitial matrix 
hyaluronate may increase extracellular space within the mesenchyme of the neural folds. 
Decrease expression of hyaluronate in chick embryo produces spinal neural tube defects (Copp 
and Bernfield, 1988a). 
 
4.2.3.1 GAG core proteins 
The role of GAG core proteins in development have been investigated. Sdc2 and Sdc4 
were found differentially expressed with reverse expression patterns in the MHP- and DLHP- 
gene lists. Expression of Sdc2 increased gradually during neurulation while Sdc4 decreased 
profoundly by a FC of 5. Other GAG core proteins such as Sdc1, Gpc1, Gpc4, Gpc3, HSPG2, 
Keratin were highly expressed, while Bgn, Sdc3, Gpc6, and Gpc2 were present but expression 
intensities were lower.  
Sdc1 appears first during mouse embryogenesis, but Sdc1 deficient mice show no defects 
in morphogenesis (Bellin et al., 2002). Sdc3 deficient mice exhibits impaired neural migration in 
development, altered feeding behavior, and partial resistance to obesity. Both Sdc1 and Sdc3 
were presented in the microarray screening but showed no obvious changes during the mouse 
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spinal neurulation. There is yet no Sdc2-deficient mice, however, Xenopus Sdc2 has shown to be 
vital for left-right asymmetry in embryonic development (Chen et al., 2004; Kramer and Yost, 
2002). Knockout of Sdc4 in mice is vital and does not demonstrate macroscopic abnormalities 
(Ishiguro et al., 2000a; Ishiguro et al., 2000b). Down-regulation of Sdc4 in zebra fish and 
Xenopus shows the necessity of this gene for normal neural crest migration and cell movement 
in convergent extension. In the above mentioned experiments, the scientists are able to show that 
xSdc4 functions in the non-canonical Wnt pathway interacting with xDsh and synergizing with 
xFz7 (Munoz et al., 2006). Sdc4 activates xDsh, and the activation of Sdc4 is regulated by 
fibronectin and xFzd7 by Wnt ligands. This involvement of Sdc4 in the non-canonical Wnt 
pathway may be conserved among vertebrates. Redundancy of Sdc4 with other HSPGs or other 
components of the Wnt pathway may explain the Sdc4-deficient mice with no defects in 
gastrulation.  
 
4.2.3.2 GAG synthesis enzymes 
GAG synthesis enzymes were found in the microarray comparison, including the B4galt1, 
the chain elongation enzyme Ext2, and modification gene Ndst1. B4galt1 is one of the GAG 
synthesis initiation enzyme and its expression during spinal neurulation decreased, while the 
other enzymes, the chain elongation enzyme Ext2, and modification gene Ndst1 were expressed 
increasingly as neurulation processes. Genes from the same family demonstrate a similar 
expression trend, for example, expression of B3galt6 decreased, while Ext1, Ndst2, Hs6st1 
demonstrate an increasing trend. In addition, numerous (around 13) GAG genes were found 
highly expressed during spinal neurulation but no obvious difference, whereas a lot of GAGs 
(around 20) were present with relatively lower intensities. Ext gene family were first found as 
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hereditary multiple exostoses (HME) (Solomon,L. 1964) and involved in HS biosynthesis by 
adding alternating GlcNAc and GlcA residues to HS chains (McCormick et al., 2000). Ext1 and 
Ext2 are type II transmembrane proteins comprising an N-terminal cytoplasmic tail, a 
transmembrane domain, a stalk, and a large globular domain that is likely to have enzymatic 
activity. Ext1 and Ext2 form a hetero-oligomeric complex in vivo and accumulate in the Golgi 
apparatus. Ext2 in an Ext1-defect cell line do not have significant glycosyltransferase activity. 
The Drosophila homologue of this gene family ttv has been identified as an HS chain elongation 
enzyme (Bellaiche et al., 1998; Lin and Wells, 1997). Hh molecules can not move in the ttv 
mutants indicating the involvement of HSPG in an essential morphogenetic pathway, the Hh 
pathway. Further studies using ttv mutants found that only Hh signaling is affected but not 
Wingless and FGF signaling. Ext1 is an ER-localized glycoprotein and its expression increases 
the synthesis of cell surface HS. The many highly presented HSs may be explained by the 
increased expression of Ext1 and Ext2, both of which have the GlcNAc transferase and GlcA 
transferase activities that catalyze the elongation of HS chains. Ext1-deficient mice fail to 
gastrulates and result in embryonic lethality indicates the importance of HS in tissue 
morphogenesis (Yamaguchi et al., 2010). The potential specific roles of HS in spinal neurulation 
can be studied in specific neural cell types by conditional inactivation of Exts. 
GlcNAc N-deacetylase/N-sulfotransferase (NDST) genes are the first HS modification 
enzymes when the HS chains are elongated to catalyze GlcNAc N-deacetylation/N-sulfation. Its 
expression level is affected by the level of Ext1 and Ext2, which, thus, influence the HS structure 
(Presto et al., 2008). Overexpression of Ext2 in HEk 293 cells improved expression and N-
glycosylation of NDST1, and HS sulfation, whereas overexpression of EXT1 had differing 
effects.  It is speculated that NDST1 competes with EXT1 for binding to EXT2 because an 
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immunoprecipitation experiment proposed an interaction between EXT2 and NDST1. NDST1 
activity increased in EXT1 deficient fibroblast. In the microarray results, Ndst1 expression 
pattern is consistent with Ext2 which support the above description about the interaction between 
Ext2 and Ndst1. A previous experiment shows the affection of Ndst on both Wg and FGF 
receptor pathways (Pallerla et al., 2007), though no known human pathology is found related 
with this gene family. Studies through Ndst-knockout mice shows that Ndst genes are more 
likely to compensate each other which can explain why no human pathology were found related 
with this gene family.  
B4galt1 belongs to the family of  Golgi glycosyltransferase with a product to be a type II 
transmembrane protein (Amado et al., 1999). This family have 7 members, but B4galt1 is shown 
to be the most efficient in galactosylating the structures of glycoproteins. It is also the only one 
that is found expressed in murine lactating mammary glands and function as a lactose synthase. 
Another experiment ensures that B4galt1 is highly expressed in lactating mammary glands and 
ubiquitously expressed at lower levels in other adult and fetal human organs. However, the 
B4galt activity levels did not correlate with its mRNA levels measured in fetal and adult mouse 
brains. It’s known that glycosyltransferase I and II are essential for initiation of the synthesis of 
proteoglycans by link the GAGs onto associated core proteins.  In addition, the b4GalT gene 
family shows sequence similarity with UDP-GalNAc: polypeptide GalNAc-transferases in the 
putative catalytic sites, so they may also involved in the synthesis of GAGs by transferring 
GalNAc. In the microarray results, expression of B4galt1 was high at E8.5, but decreased 
obviously in both NT and MD. It’s observed that another three genes, B3galt6, Krt2-8, and Kral-
18 was decreased, too. The former one belongs to a similar glycosyltranserase family, while the 
later two were highly related with the B4galt1 involved product, keratin. 
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It is a very complicated scenario that many GAG genes and their synthesis enzymes and 
binding proteins were highly expressed during the mouse spinal neurulation, but some of the 
synthesis enzymes increasingly expressed while other enzymes were decreasingly expressed. 
The level of GAGs as well as their binding proteins may affect the differential expression level 
of the GAG synthesis enzymes. But the specific mechanism remains to be further investigated.  
 B4galt1 is a type II membrane protein share common B4galt gene features as well as the first 
mammalian, UDP-Gal: bGlcNAc, b1,4-galactosyltransferase (b4Gal-T), was cloned by 
transfection cloning strategy in 1986, followed by the identification of 6 other members in the 
same galactosyltransferase family, b4Gal-T2 to T7. They are type II transmembrane proteins 
with common domain structures. They have conserved sequence motifs in association with the 
putative catalytic region which give them genetic and functional redundancy in sharing 
specificity for donor nucleotide, reaction mechanism and often transferring to the same position 
of acceptor sugars. The b4GalT gene family shows sequence similarity with UDP-GalNAc: 
polypeptide GalNAc-transferases in the putative catalytic sites.  
 
4.3 B4galt1 may be involved in neurulation by affecting cell proliferation and adhesion 
The present study has shown that expression of B4galt1 was significantly down-regulated 
in neuroepithelial cell lines. Knockdown of the expression of B4galt1 by siRNA inhibited NE4C 
cell growth in culture, reduced its adhesion capacity in vitro, suggesting the possible functions of 
B4galt1 in neuroepithelial growth and development. 
Glycosaminoglycans (GAGs) are ubiquitously distributed on cell surface and in 
extracellular matrix. GAGs are participating in many biological processes such as tissue 
assembly, proliferation, differentiation, adhesion, motility, control of cell growth, and 
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morphogenesis by interacting with different proteins, growth factors, morphogens, or ligands, etc 
(Zhang, 2010b). Studies show that mutation in GAG core proteins or their biosynthetic enzymes 
in Drosophila, Xenopus or mouse influence the function of several growth factor pathways that 
are essential for growth and morphogenesis (Munoz et al., 2006; Princivalle and de, 2002; Yip et 
al., 2002). GAG synthesis is initiated by sequential addition of four monosaccharides (Xyl-Gal-
Gal-GlcA) which links the sugar chains to core proteins. Galactosyltransferase play essential 
roles in GAG biosynthesis and extending of their sugar chains which determine the GAG 
heterogeneity and binding specificity and further their biological functions (Fransson et al., 2000; 
Silbert and Sugumaran, 2002; Zhang, 2010b). There are 7 members in the β4Gal-T family, they 
located at different chromosomal loci with exclusive specificity for the donor substrate UDP-Gal, 
and all transfers Gal in a β1,4-linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl (Amado 
et al., 1999). Among these family members, β4Galt1 is the most profoundly studied for its 
structure and expression. 
 
4.3.1 B4galt1 affects NE4C cell proliferation 
Surface GalTase has been suggested to function during cellular proliferation. In several 
studies, specifically perturbating GalTase could inhibit cell growth in vivo and in vitro. Further 
studies identified that surface GalTase and/or its galactosylated substrates  controlling cell 
growth by delivering  a growth inhibitory signal which may be epidermal growth factor (EGF) 
receptor (Hinton et al., 1995). There is so far no report regarding whether B4galt1 expression has 
any effect on neuroepithelial cell proliferation. To answer this question, NE4C cells originating 
from the mouse neuroepithelial cell were transfected with two sequences of siRNA targeting 
B4galt1 gene or scrambled siRNA (control). Decreased expression of B4galt1 gene by silencing 
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both sequences was shown to significantly inhibit the NE4C cell growth, which is consistent 
with the reported studies. Both two sequences of siRNA were designed to target different 
residues of the catalytic domain of B4galt1 which face the lumen side of the Golgi. The catalytic 
domain is the most important part for the functions of the gene B4galt1. It is responsible for 
recognizing the nucleotide donor by its N-terminal domain, and binding the acceptor substrate by 
its C-terminal domain. Mutation in catalytic domain may induce conformational change which 
may affect the bounding states of the enzyme, and further affect the binding specificity to 
different mental ions or sugar-nucleotides of the enzyme. This changing may result in cellular 
glycans with altered sugar residues and affect the normal cellular processes (Qasba et al., 2008).  
According to the results of this study, it is hypothesized that the silencing of B4galt1 may affect 
cell growth by two potential mechanisms: (1) The binding specificity was abrogated so that the 
expression of GAGs and their distribution in cells changed which may change the cell growth 
rate accordingly. (2) The conformational change in the catalytic domain of B4galt1 affect the 
binding specificity of this gene to its ligands such as growth factors and further affect the cell 
proliferation as reported in other cell types. In a previous study, removing the terminal galactosyl 
residues in cytoplasmic domain by beta-galactosidase digestion will lose the growth inhibitory 
activity of isolated plasma membranes and specific glycoproteins (Wieser and Oesch, 1988). 








4.3.2 B4galt1 affects NE4C cell adhesion 
The GalTase was shown playing a role in cell adhesion in studies investigating primary 
spermatocytes. GalTase was shown to present on the surface of the mature sperm and mediating 
the sperm-egg reorganization and binding (Nixon et al., 2001). It was also expressed by 
spermatocytes and Sertoli cells and localized at the areas of putative germ cell-Sertoli cell 
contact region where it may mediate cell adhesion of the two cell types, while anti-GalTase 
antibodies inhibited the initial adhesion of spermatocytes to Sertoli cell monolayers (Miller et al., 
1992; Shur, 1993). Most GalTase was found confined to the basal cell surface where it may 
mediate cell adhesion to the underlying basal lamina. The mechanism of GalTase to be an 
adhesion molecule was designated as the cytoplasmic extension of this molecule targeting its 
protein to the cell surface where it functions as a cell adhesion molecule.  
As is well known, GAGs were involved in the critical process of neural tube closure 
(Copp and Bernfield, 1988b; Yip et al., 2002). In the current study, there were also many GAG 
genes as well as B4galt1 having been found differentially expressed in NT and MD during the 
critical stages of neural tube closure. What does it mean of the colocolization of GAG genes with 
adhesion genes for the neurulation process? What’s the potential role of B4galt1 during this 
process? Does it have any interaction with adhesion molecules during this process? To answer 
these questions, the expression of B4galt1 was reduced by targeted silencing and its interaction 
with collagen and fibronectin was investigated in mouse neuroepithelial NE4C cells. Experiment 
results showed that reduced expression of B4galt1 can significantly inhibit the adhesion ability 
of NE4C cells to collagen and fibronectin. Mutation in different residues on the catalytic domain 
of B4galt1 got different results. As discussed above (in 4.3.1), this alteration in adhesion ability 
may be due to the conformational change in the catalytic domain of B4galt1 gene which changed 
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its binding specificity to ligands. This mechanism may be different from the reported study that 
truncated dominant negative B4galt1 without the catalytic domain can inhibit cell adhesion in 
both F9 embryonal carcinoma cells and Swiss 3T3 fibroblasts (Shur, 1983). It is hypothesized 
that both catalytic and cytoplasmic domains can be involved in the regulation of interaction to 
adhesion molecules, and they may function individually or in combination. Here we showed by 
targeted mutation at catalytic domain alone that catalytic domain can be involved in the 
regulation of interaction ability of B4galts to adhesion molecules individually. Another potential 
mechanism for the regulation of adhesion by B4galt1 in the NE4C cell adhesion ability may be 
due to the expression and/or distribution of different proteoglycan molecules synthesized by 
B4galt1. A previous study reported that colocalization of collagen, fibronectin, and proteoglycan 
existed and functioned in chick lung morphogenesis, it should not excluded the possibility that 
the colocalization of collagen, fibronectin with different types of proteoglycans can also play 
roles in neural tube morphogenesis. Studies show that GalTase is preferentially localized on cell 
lamellipodia and filopodia by binding to its N-linked oligosaccharide substrate (Eckstein and 
Shur, 1989; Runyan et al., 1988), then it controls the lamellipodia formation by its cytoplasmic 
domains (Appeddu and Shur, 1994). As is known by an observation that directed lamelliform 
protrusions attaching to and crawl on adjacent cells during convergent extension (CE) and planar 
cell polarity (PCP) of the neural plate and the surrounding mesoderm (Keller, 2002), it is 
probable that GalTase may play a role during CE and PCP by binding to and regulating the 
formation of lamelliform protrusions. Though the above serial studies show no signs of 
interaction of GalTase to the fibronectin, which may not contain binding sites for surface 
GalTase (Appeddu and Shur, 1994), in the current study, reduction of B4galt1 can affect the 
adhesion ability of NE4C cells to fibronectin by mutation on residues of the last exon in the 
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catalytic domain. The mechanism for the different results for mutation of different residues is 
exploratory.  It may be change of three-dimensional structure of the gene which may affect the 
binding specificity or affinity of the gene. 
Western blotting could be helpful to determine whether the function changes are due to 
changes in gene transcript levels or were accompanied by similar changes in protein level.   
To further find out the mechanism by which suppression of B4galt1 inhibits NE4C cell 
proliferation and adhesion ability, a systematic gene expression profiling analysis by microarray 
could be helpful. As B4galt1 has been found to mediate Notch signaling in cultured mammalian 
cells (Chen et al., 2001) as well as affect Notch signaling in mammalian embryos during 
embryogenesis (Chen et al., 2006), and the Notch signaling has been revealed as essential for 
neural tube closure (Copp and Greene, 2010b), the study on gene expression profile after 
silencing B4galt1 in NE4C cells could also reveal whether any pathways are deregulated by 
suppression of B4galt1 in neural tube closure. 
In summary, the present study has shown for the first time in mammalian cells that 
knockdown of the expression of B4galt1 inhibited neuroepithelial cell growth and adhesion 
ability in vitro, suggesting the possibility that B4galt1 involved in morphogenesis of neural 





























5. Conclusion and future studies 
This study investigated the genetic mechanism of mammalian spinal neurulation by high-
density oligonucleotide microarray using laser capture microdissected tissues.  
Firstly, a reliable and reproducible protocol was optimized to get total RNA with good quality 
and quantity from the LCM tissue samples. It was found that snap-freezing the mouse embryos 
by liquid nitrogen immediately after dissection protects RNA quality without damage to the 
morphology of the sections. This result is supported by other studies by Xiang, C.C. et al (Xiang 
et al., 2004).   
To protect the RNA integrity during the microdissection processing time at room 
temperature, RNAlater-ICE was applied on the cryosections after cutting. The application of 
RNAlater-ICE helped protect the RNA quality especially for the MD tissues which were 
microdissected one hour later after the first microdissection of NT. The quality of the total RNA 
of the nine MD samples was found to be as good as the nine NT samples. This application is 
novel and can be taken as model for protecting RNA integrity in tissues processed at room 
temperature. 
In the quickly stain method, sections were stained in Haematoxylin followed by 
dehydration in serial concentrations of ethanol. The length of time of staining and dehydration 
was reduced from several minutes of the classical method to several seconds. This method can 
save time and reduce the possibility of RNase contamination.  
Total RNA was extracted from 18 microdissected samples. Concentrations of each 
sample were around 10 ng/μl of 11 µl, which were enough for amplification before hybridization 
on microarray chips. Quality of the total RNA was measured by Agilent 2100 bioanalyzer and 
RIN numbers of all RNA samples measured by the Analyzer were above 7.5 indicating good 
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quality of RNA for microarray analysis (Fleige and Pfaffl, 2006; Jones et al., 2006). The total 
RNA was amplified and labeled into Bio-cRNA by a two-step cDNA synthesis in combination 
with an IVT amplification. At least 27μg of Bio-cRNA was acquired from a starting 15ng total 
RNA, and these results show good quality of starting RNA and enough quantity of Bio-cRNA 
for microarray analysis (Dumur et al., 2004; Jones et al., 2006).  
Secondly, the potential genetic mechanisms of spinal neurulation were studied by 
transcriptomic expression profiling analysis. One transcriptomic profiling was acquired for each 
array by single array analysis, and this profiling provided a snapshot for each stage during the 
neural tube closing process. Comparison of profiling between different stages revealed a variety 
of differentially expressed genes and these genes may account for morphology changing of the 
neuroepithelium, from formation of MHP to DLHP till closure of the PNP. Genes with functions 
of proliferation, differentiation, adhesion, migration and cell cycle were found in most of the 
gene lists, and genes with multiple other functions such as cell polarity, proteolysis, apoptosis, 
transport, metabolism, etc, were also found in the gene lists. These above mentioned functions 
were found to be important for neural tube closure in previous studies (Copp and Greene, 2010b), 
so the potential contributions of these genes are worth exploring in the future. Genes involved in 
several pathways and signaling cascades such as Wnt, Shh, RTK, GPCR, and MAkkk were 
found in the profiling analysis. A detailed investigation of genes involved in the diverse 
biological processes and multiple pathways revealed genes that directly or indirectly regulate 
neural tube closure by mechanism of inhibiting MHP and/or accelerating DLHP formation. The 
transcriptomic profiling analysis also revealed a group of GAG associated genes. Since GAG 
genes have been found involved in diverse biological processes and interacting with multiple 
pathways (Zhang, 2010b), they hold the possibility to be critical regulators during neurulation. 
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The GAG synthesizing initiating enzyme, B4galt1, was found differentially expressed in the 
microarray data. Knockdown of B4galt1 by siRNA in the mouse neuroepithelial cells inhibited 
cell proliferation and adhesion abilities. These results indicate that GAG genes found by 
microarray analysis are worth exploring further to find their specific roles in neurulation. 
The transcriptomic profiling analysis in the current study provided a vivid description of 
the spatial and temporal expression of genes that were involved in the construction of neural tube 
during mouse neurulation, and offer a promising approach for finding the key players in specific 
events such as MHP and DLHP formation during neural tube closure. The present study provides 
a comprehensive framework for future investigations on the genetic mechanism of the spinal 
neurulation. This is the first time that a transcriptomic profiling was set up using LCM 
technology in neurulation stage mouse embryos. The selection of three critical stages with 
typical mode change increases the opportunity of picking up the most possible genes for the 
closing process of the neurulation. Based on the present findings, genes found differentially 
expressed between different developmental stages may play different roles according to their up-
stream regulating genes or down-stream targeting genes. The same gene may be involved in 
different biological events and regulating different signaling pathways and cascades.  
Further study by in situ hybridization to confine the cellular or tissue specific expression 
pattern of critical genes is therefore needed to confirm the microarray results and investigate the 
potential regulating genes. Over expression of down-regulated genes or knocking down of up-
regulated genes in neuroepithelial cells are recommended in order to reveal the functions of these 
genes and their interacting partners. The findings from the mutation studies in cells need to be 
confirmed by animal models using mutation technology. In vitro and in ova electroporation 
could provide a novel approach for investigating gene expression and regulation on embryos, 
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especially for cell-specific expressed genes.  The genes that are confirmed by mouse models can 
be used for screening susceptible population in human and/or design prevention methods and/or 
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